id	sid	tid	token	lemma	pos
ajlm-1255	1	1	abstract	abstract	ADJ
ajlm-1255	1	2	introduction	introduction	NOUN
ajlm-1255	1	3	methodology	methodology	NOUN
ajlm-1255	1	4	and	and	CCONJ
ajlm-1255	1	5	data	datum	NOUN
ajlm-1255	1	6	analysis	analysis	NOUN
ajlm-1255	1	7	review	review	NOUN
ajlm-1255	1	8	findings	finding	VERB
ajlm-1255	1	9	implications	implication	NOUN
ajlm-1255	1	10	and	and	CCONJ
ajlm-1255	1	11	recommendations	recommendation	NOUN
ajlm-1255	1	12	acknowledgements	acknowledgement	NOUN
ajlm-1255	1	13	references	reference	NOUN
ajlm-1255	1	14	about	about	ADP
ajlm-1255	1	15	the	the	DET
ajlm-1255	1	16	author(s	author(s	NOUN
ajlm-1255	1	17	)	)	PUNCT
ajlm-1255	1	18	adesola	adesola	PROPN
ajlm-1255	1	19	olalekan	olalekan	PROPN
ajlm-1255	1	20	department	department	PROPN
ajlm-1255	1	21	of	of	ADP
ajlm-1255	1	22	medical	medical	ADJ
ajlm-1255	1	23	laboratory	laboratory	NOUN
ajlm-1255	1	24	science	science	NOUN
ajlm-1255	1	25	,	,	PUNCT
ajlm-1255	1	26	university	university	NOUN
ajlm-1255	1	27	of	of	ADP
ajlm-1255	1	28	lagos	lagos	PROPN
ajlm-1255	1	29	,	,	PUNCT
ajlm-1255	1	30	idiaraba	idiaraba	PROPN
ajlm-1255	1	31	,	,	PUNCT
ajlm-1255	1	32	lagos	lagos	PROPN
ajlm-1255	1	33	,	,	PUNCT
ajlm-1255	1	34	nigeria	nigeria	PROPN
ajlm-1255	1	35	centre	centre	PROPN
ajlm-1255	1	36	for	for	ADP
ajlm-1255	1	37	genomics	genomic	NOUN
ajlm-1255	1	38	of	of	ADP
ajlm-1255	1	39	non	non	ADJ
ajlm-1255	1	40	-	-	ADJ
ajlm-1255	1	41	communicable	communicable	ADJ
ajlm-1255	1	42	diseases	disease	NOUN
ajlm-1255	1	43	and	and	CCONJ
ajlm-1255	1	44	personalized	personalized	ADJ
ajlm-1255	1	45	healthcare	healthcare	NOUN
ajlm-1255	1	46	(	(	PUNCT
ajlm-1255	1	47	cgnph	cgnph	NOUN
ajlm-1255	1	48	)	)	PUNCT
ajlm-1255	1	49	,	,	PUNCT
ajlm-1255	1	50	university	university	NOUN
ajlm-1255	1	51	of	of	ADP
ajlm-1255	1	52	lagos	lagos	PROPN
ajlm-1255	1	53	,	,	PUNCT
ajlm-1255	1	54	akoka	akoka	NOUN
ajlm-1255	1	55	,	,	PUNCT
ajlm-1255	1	56	lagos	lago	NOUN
ajlm-1255	1	57	,	,	PUNCT
ajlm-1255	1	58	nigeria	nigeria	PROPN
ajlm-1255	1	59	bamidele	bamidele	PROPN
ajlm-1255	1	60	iwalokun	iwalokun	PROPN
ajlm-1255	1	61	centre	centre	PROPN
ajlm-1255	1	62	for	for	ADP
ajlm-1255	1	63	genomics	genomic	NOUN
ajlm-1255	1	64	of	of	ADP
ajlm-1255	1	65	non	non	ADJ
ajlm-1255	1	66	-	-	ADJ
ajlm-1255	1	67	communicable	communicable	ADJ
ajlm-1255	1	68	diseases	disease	NOUN
ajlm-1255	1	69	and	and	CCONJ
ajlm-1255	1	70	personalized	personalized	ADJ
ajlm-1255	1	71	healthcare	healthcare	NOUN
ajlm-1255	1	72	(	(	PUNCT
ajlm-1255	1	73	cgnph	cgnph	NOUN
ajlm-1255	1	74	)	)	PUNCT
ajlm-1255	1	75	,	,	PUNCT
ajlm-1255	1	76	university	university	NOUN
ajlm-1255	1	77	of	of	ADP
ajlm-1255	1	78	lagos	lagos	PROPN
ajlm-1255	1	79	,	,	PUNCT
ajlm-1255	1	80	akoka	akoka	NOUN
ajlm-1255	1	81	,	,	PUNCT
ajlm-1255	1	82	lagos	lagos	PROPN
ajlm-1255	1	83	,	,	PUNCT
ajlm-1255	1	84	nigeria	nigeria	PROPN
ajlm-1255	1	85	department	department	PROPN
ajlm-1255	1	86	of	of	ADP
ajlm-1255	1	87	molecular	molecular	ADJ
ajlm-1255	1	88	biology	biology	NOUN
ajlm-1255	1	89	and	and	CCONJ
ajlm-1255	1	90	biotechnology	biotechnology	NOUN
ajlm-1255	1	91	,	,	PUNCT
ajlm-1255	1	92	nigerian	nigerian	PROPN
ajlm-1255	1	93	institute	institute	PROPN
ajlm-1255	1	94	of	of	ADP
ajlm-1255	1	95	medical	medical	ADJ
ajlm-1255	1	96	research	research	PROPN
ajlm-1255	1	97	,	,	PUNCT
ajlm-1255	1	98	yaba	yaba	PROPN
ajlm-1255	1	99	,	,	PUNCT
ajlm-1255	1	100	lagos	lagos	PROPN
ajlm-1255	1	101	,	,	PUNCT
ajlm-1255	1	102	nigeria	nigeria	PROPN
ajlm-1255	1	103	oluwabukola	oluwabukola	PROPN
ajlm-1255	1	104	m.	m.	PROPN
ajlm-1255	1	105	akinloye	akinloye	PROPN
ajlm-1255	1	106	department	department	PROPN
ajlm-1255	1	107	of	of	ADP
ajlm-1255	1	108	medical	medical	ADJ
ajlm-1255	1	109	laboratory	laboratory	NOUN
ajlm-1255	1	110	science	science	PROPN
ajlm-1255	1	111	,	,	PUNCT
ajlm-1255	1	112	oulton	oulton	PROPN
ajlm-1255	1	113	college	college	PROPN
ajlm-1255	1	114	,	,	PUNCT
ajlm-1255	1	115	moncton	moncton	PROPN
ajlm-1255	1	116	,	,	PUNCT
ajlm-1255	1	117	new	new	PROPN
ajlm-1255	1	118	brunswick	brunswick	PROPN
ajlm-1255	1	119	,	,	PUNCT
ajlm-1255	1	120	canada	canada	PROPN
ajlm-1255	1	121	olayiwola	olayiwola	PROPN
ajlm-1255	2	1	popoola	popoola	PROPN
ajlm-1255	2	2	department	department	PROPN
ajlm-1255	2	3	of	of	ADP
ajlm-1255	2	4	medical	medical	ADJ
ajlm-1255	2	5	laboratory	laboratory	NOUN
ajlm-1255	2	6	science	science	NOUN
ajlm-1255	2	7	,	,	PUNCT
ajlm-1255	2	8	university	university	NOUN
ajlm-1255	2	9	of	of	ADP
ajlm-1255	2	10	lagos	lagos	PROPN
ajlm-1255	2	11	,	,	PUNCT
ajlm-1255	2	12	idiaraba	idiaraba	PROPN
ajlm-1255	2	13	,	,	PUNCT
ajlm-1255	2	14	lagos	lagos	PROPN
ajlm-1255	2	15	,	,	PUNCT
ajlm-1255	2	16	nigeria	nigeria	PROPN
ajlm-1255	2	17	centre	centre	PROPN
ajlm-1255	2	18	for	for	ADP
ajlm-1255	2	19	genomics	genomic	NOUN
ajlm-1255	2	20	of	of	ADP
ajlm-1255	2	21	non	non	ADJ
ajlm-1255	2	22	-	-	ADJ
ajlm-1255	2	23	communicable	communicable	ADJ
ajlm-1255	2	24	diseases	disease	NOUN
ajlm-1255	2	25	and	and	CCONJ
ajlm-1255	2	26	personalized	personalized	ADJ
ajlm-1255	2	27	healthcare	healthcare	NOUN
ajlm-1255	2	28	(	(	PUNCT
ajlm-1255	2	29	cgnph	cgnph	NOUN
ajlm-1255	2	30	)	)	PUNCT
ajlm-1255	2	31	,	,	PUNCT
ajlm-1255	2	32	university	university	NOUN
ajlm-1255	2	33	of	of	ADP
ajlm-1255	2	34	lagos	lagos	PROPN
ajlm-1255	2	35	,	,	PUNCT
ajlm-1255	2	36	akoka	akoka	NOUN
ajlm-1255	2	37	,	,	PUNCT
ajlm-1255	2	38	lagos	lago	NOUN
ajlm-1255	2	39	,	,	PUNCT
ajlm-1255	2	40	nigeria	nigeria	PROPN
ajlm-1255	2	41	titilola	titilola	PROPN
ajlm-1255	2	42	a.	a.	PROPN
ajlm-1255	2	43	samuel	samuel	PROPN
ajlm-1255	2	44	centre	centre	PROPN
ajlm-1255	2	45	for	for	ADP
ajlm-1255	2	46	genomics	genomic	NOUN
ajlm-1255	2	47	of	of	ADP
ajlm-1255	2	48	non	non	ADJ
ajlm-1255	2	49	-	-	ADJ
ajlm-1255	2	50	communicable	communicable	ADJ
ajlm-1255	2	51	diseases	disease	NOUN
ajlm-1255	2	52	and	and	CCONJ
ajlm-1255	2	53	personalized	personalized	ADJ
ajlm-1255	2	54	healthcare	healthcare	NOUN
ajlm-1255	2	55	(	(	PUNCT
ajlm-1255	2	56	cgnph	cgnph	NOUN
ajlm-1255	2	57	)	)	PUNCT
ajlm-1255	2	58	,	,	PUNCT
ajlm-1255	2	59	university	university	NOUN
ajlm-1255	2	60	of	of	ADP
ajlm-1255	2	61	lagos	lagos	PROPN
ajlm-1255	2	62	,	,	PUNCT
ajlm-1255	2	63	akoka	akoka	NOUN
ajlm-1255	2	64	,	,	PUNCT
ajlm-1255	2	65	lagos	lagos	PROPN
ajlm-1255	2	66	,	,	PUNCT
ajlm-1255	2	67	nigeria	nigeria	PROPN
ajlm-1255	2	68	department	department	PROPN
ajlm-1255	2	69	of	of	ADP
ajlm-1255	2	70	biochemistry	biochemistry	NOUN
ajlm-1255	2	71	,	,	PUNCT
ajlm-1255	2	72	university	university	NOUN
ajlm-1255	2	73	of	of	ADP
ajlm-1255	2	74	lagos	lagos	PROPN
ajlm-1255	2	75	,	,	PUNCT
ajlm-1255	2	76	idiaraba	idiaraba	PROPN
ajlm-1255	2	77	,	,	PUNCT
ajlm-1255	2	78	lagos	lagos	PROPN
ajlm-1255	2	79	,	,	PUNCT
ajlm-1255	2	80	nigeria	nigeria	PROPN
ajlm-1255	2	81	oluyemi	oluyemi	ADP
ajlm-1255	2	82	akinloye	akinloye	PROPN
ajlm-1255	2	83	department	department	PROPN
ajlm-1255	2	84	of	of	ADP
ajlm-1255	2	85	medical	medical	ADJ
ajlm-1255	2	86	laboratory	laboratory	NOUN
ajlm-1255	2	87	science	science	NOUN
ajlm-1255	2	88	,	,	PUNCT
ajlm-1255	2	89	university	university	NOUN
ajlm-1255	2	90	of	of	ADP
ajlm-1255	2	91	lagos	lagos	PROPN
ajlm-1255	2	92	,	,	PUNCT
ajlm-1255	2	93	idiaraba	idiaraba	PROPN
ajlm-1255	2	94	,	,	PUNCT
ajlm-1255	2	95	lagos	lagos	PROPN
ajlm-1255	2	96	,	,	PUNCT
ajlm-1255	2	97	nigeria	nigeria	PROPN
ajlm-1255	2	98	centre	centre	PROPN
ajlm-1255	2	99	for	for	ADP
ajlm-1255	2	100	genomics	genomic	NOUN
ajlm-1255	2	101	of	of	ADP
ajlm-1255	2	102	non	non	ADJ
ajlm-1255	2	103	-	-	ADJ
ajlm-1255	2	104	communicable	communicable	ADJ
ajlm-1255	2	105	diseases	disease	NOUN
ajlm-1255	2	106	and	and	CCONJ
ajlm-1255	2	107	personalized	personalized	ADJ
ajlm-1255	2	108	healthcare	healthcare	NOUN
ajlm-1255	2	109	(	(	PUNCT
ajlm-1255	2	110	cgnph	cgnph	NOUN
ajlm-1255	2	111	)	)	PUNCT
ajlm-1255	2	112	,	,	PUNCT
ajlm-1255	2	113	university	university	NOUN
ajlm-1255	2	114	of	of	ADP
ajlm-1255	2	115	lagos	lagos	PROPN
ajlm-1255	2	116	,	,	PUNCT
ajlm-1255	2	117	akoka	akoka	NOUN
ajlm-1255	2	118	,	,	PUNCT
ajlm-1255	2	119	lagos	lagos	PROPN
ajlm-1255	2	120	,	,	PUNCT
ajlm-1255	2	121	nigeria	nigeria	PROPN
ajlm-1255	2	122	department	department	PROPN
ajlm-1255	2	123	of	of	ADP
ajlm-1255	2	124	molecular	molecular	ADJ
ajlm-1255	2	125	biology	biology	NOUN
ajlm-1255	2	126	and	and	CCONJ
ajlm-1255	2	127	biotechnology	biotechnology	NOUN
ajlm-1255	2	128	,	,	PUNCT
ajlm-1255	2	129	nigerian	nigerian	PROPN
ajlm-1255	2	130	institute	institute	PROPN
ajlm-1255	2	131	of	of	ADP
ajlm-1255	2	132	medical	medical	ADJ
ajlm-1255	2	133	research	research	PROPN
ajlm-1255	2	134	,	,	PUNCT
ajlm-1255	2	135	yaba	yaba	PROPN
ajlm-1255	2	136	,	,	PUNCT
ajlm-1255	2	137	lagos	lagos	PROPN
ajlm-1255	2	138	,	,	PUNCT
ajlm-1255	2	139	nigeria	nigeria	PROPN
ajlm-1255	2	140	citation	citation	PROPN
ajlm-1255	2	141	olalekan	olalekan	VERB
ajlm-1255	2	142	a	a	DET
ajlm-1255	2	143	,	,	PUNCT
ajlm-1255	2	144	iwalokun	iwalokun	PROPN
ajlm-1255	2	145	b	b	PROPN
ajlm-1255	2	146	,	,	PUNCT
ajlm-1255	2	147	akinloye	akinloye	VERB
ajlm-1255	2	148	om	om	PROPN
ajlm-1255	2	149	,	,	PUNCT
ajlm-1255	2	150	et	et	PROPN
ajlm-1255	2	151	al	al	PROPN
ajlm-1255	2	152	.	.	PUNCT
ajlm-1255	3	1	covid-19	covid-19	PROPN
ajlm-1255	3	2	rapid	rapid	ADJ
ajlm-1255	3	3	diagnostic	diagnostic	ADJ
ajlm-1255	3	4	test	test	NOUN
ajlm-1255	3	5	could	could	AUX
ajlm-1255	3	6	contain	contain	VERB
ajlm-1255	3	7	transmission	transmission	NOUN
ajlm-1255	3	8	in	in	ADP
ajlm-1255	3	9	lowand	lowand	ADJ
ajlm-1255	3	10	middle	middle	ADJ
ajlm-1255	3	11	-	-	PUNCT
ajlm-1255	3	12	income	income	NOUN
ajlm-1255	3	13	countries	country	NOUN
ajlm-1255	3	14	.	.	PUNCT
ajlm-1255	4	1	afr	afr	PROPN
ajlm-1255	4	2	j	j	PROPN
ajlm-1255	4	3	lab	lab	PROPN
ajlm-1255	4	4	med	me	VERB
ajlm-1255	4	5	.	.	PUNCT
ajlm-1255	4	6	2020;9(1	2020;9(1	NUM
ajlm-1255	4	7	)	)	PUNCT
ajlm-1255	4	8	,	,	PUNCT
ajlm-1255	4	9	a1255	a1255	NOUN
ajlm-1255	4	10	.	.	PUNCT
ajlm-1255	5	1	https://doi.org/10.4102/ajlm.v9i1.1255	https://doi.org/10.4102/ajlm.v9i1.1255	PROPN
ajlm-1255	5	2	review	review	NOUN
ajlm-1255	5	3	article	article	NOUN
ajlm-1255	5	4	covid-19	covid-19	PROPN
ajlm-1255	5	5	rapid	rapid	ADJ
ajlm-1255	5	6	diagnostic	diagnostic	ADJ
ajlm-1255	5	7	test	test	NOUN
ajlm-1255	5	8	could	could	AUX
ajlm-1255	5	9	contain	contain	VERB
ajlm-1255	5	10	transmission	transmission	NOUN
ajlm-1255	5	11	in	in	ADP
ajlm-1255	5	12	lowand	lowand	ADJ
ajlm-1255	5	13	middle	middle	ADJ
ajlm-1255	5	14	-	-	PUNCT
ajlm-1255	5	15	income	income	NOUN
ajlm-1255	5	16	countries	country	NOUN
ajlm-1255	5	17	adesola	adesola	ADV
ajlm-1255	5	18	olalekan	olalekan	PROPN
ajlm-1255	5	19	,	,	PUNCT
ajlm-1255	5	20	bamidele	bamidele	PROPN
ajlm-1255	5	21	iwalokun	iwalokun	PROPN
ajlm-1255	5	22	,	,	PUNCT
ajlm-1255	5	23	oluwabukola	oluwabukola	PROPN
ajlm-1255	5	24	m.	m.	NOUN
ajlm-1255	5	25	akinloye	akinloye	PROPN
ajlm-1255	5	26	,	,	PUNCT
ajlm-1255	5	27	olayiwola	olayiwola	PROPN
ajlm-1255	5	28	popoola	popoola	PROPN
ajlm-1255	5	29	,	,	PUNCT
ajlm-1255	5	30	titilola	titilola	PROPN
ajlm-1255	5	31	a.	a.	PROPN
ajlm-1255	5	32	samuel	samuel	PROPN
ajlm-1255	5	33	,	,	PUNCT
ajlm-1255	5	34	oluyemi	oluyemi	ADV
ajlm-1255	5	35	akinloye	akinloye	PROPN
ajlm-1255	5	36	received	receive	VERB
ajlm-1255	5	37	:	:	PUNCT
ajlm-1255	5	38	26	26	NUM
ajlm-1255	5	39	apr	apr	NOUN
ajlm-1255	5	40	.	.	PUNCT
ajlm-1255	5	41	2020	2020	NUM
ajlm-1255	5	42	;	;	PUNCT
ajlm-1255	5	43	accepted	accept	VERB
ajlm-1255	5	44	:	:	PUNCT
ajlm-1255	5	45	07	07	NUM
ajlm-1255	5	46	aug	aug	PROPN
ajlm-1255	5	47	.	.	PROPN
ajlm-1255	5	48	2020	2020	NUM
ajlm-1255	5	49	;	;	PUNCT
ajlm-1255	5	50	published	publish	VERB
ajlm-1255	5	51	:	:	PUNCT
ajlm-1255	5	52	30	30	NUM
ajlm-1255	5	53	sept	sept	PROPN
ajlm-1255	5	54	.	.	PROPN
ajlm-1255	5	55	2020	2020	NUM
ajlm-1255	6	1	copyright	copyright	NOUN
ajlm-1255	6	2	:	:	PUNCT
ajlm-1255	6	3	©	©	PROPN
ajlm-1255	6	4	2020	2020	NUM
ajlm-1255	6	5	.	.	PUNCT
ajlm-1255	7	1	the	the	DET
ajlm-1255	7	2	author(s	author(s	PROPN
ajlm-1255	7	3	)	)	PUNCT
ajlm-1255	7	4	.	.	PUNCT
ajlm-1255	8	1	licensee	licensee	NOUN
ajlm-1255	8	2	:	:	PUNCT
ajlm-1255	8	3	aosis	aosis	NOUN
ajlm-1255	8	4	.	.	PUNCT
ajlm-1255	9	1	this	this	PRON
ajlm-1255	9	2	is	be	AUX
ajlm-1255	9	3	an	an	DET
ajlm-1255	9	4	open	open	ADJ
ajlm-1255	9	5	access	access	NOUN
ajlm-1255	9	6	article	article	NOUN
ajlm-1255	9	7	distributed	distribute	VERB
ajlm-1255	9	8	under	under	ADP
ajlm-1255	9	9	the	the	DET
ajlm-1255	9	10	terms	term	NOUN
ajlm-1255	9	11	of	of	ADP
ajlm-1255	9	12	the	the	DET
ajlm-1255	9	13	creative	creative	ADJ
ajlm-1255	9	14	commons	common	NOUN
ajlm-1255	9	15	attribution	attribution	NOUN
ajlm-1255	9	16	license	license	NOUN
ajlm-1255	9	17	,	,	PUNCT
ajlm-1255	9	18	which	which	PRON
ajlm-1255	9	19	permits	permit	VERB
ajlm-1255	9	20	unrestricted	unrestricted	ADJ
ajlm-1255	9	21	use	use	NOUN
ajlm-1255	9	22	,	,	PUNCT
ajlm-1255	9	23	distribution	distribution	NOUN
ajlm-1255	9	24	,	,	PUNCT
ajlm-1255	9	25	and	and	CCONJ
ajlm-1255	9	26	reproduction	reproduction	NOUN
ajlm-1255	9	27	in	in	ADP
ajlm-1255	9	28	any	any	DET
ajlm-1255	9	29	medium	medium	NOUN
ajlm-1255	9	30	,	,	PUNCT
ajlm-1255	9	31	provided	provide	VERB
ajlm-1255	9	32	the	the	DET
ajlm-1255	9	33	original	original	ADJ
ajlm-1255	9	34	work	work	NOUN
ajlm-1255	9	35	is	be	AUX
ajlm-1255	9	36	properly	properly	ADV
ajlm-1255	9	37	cited	cite	VERB
ajlm-1255	9	38	.	.	PUNCT
ajlm-1255	10	1	abstract	abstract	ADJ
ajlm-1255	10	2	background	background	NOUN
ajlm-1255	10	3	:	:	PUNCT
ajlm-1255	10	4	coronavirus	coronavirus	NOUN
ajlm-1255	10	5	disease	disease	NOUN
ajlm-1255	10	6	2019	2019	NUM
ajlm-1255	10	7	(	(	PUNCT
ajlm-1255	10	8	covid-19	covid-19	PROPN
ajlm-1255	10	9	)	)	PUNCT
ajlm-1255	10	10	caused	cause	VERB
ajlm-1255	10	11	by	by	ADP
ajlm-1255	10	12	severe	severe	ADJ
ajlm-1255	10	13	acute	acute	ADJ
ajlm-1255	10	14	respiratory	respiratory	ADJ
ajlm-1255	10	15	syndrome	syndrome	NOUN
ajlm-1255	10	16	coronavirus-2	coronavirus-2	NUM
ajlm-1255	10	17	(	(	PUNCT
ajlm-1255	10	18	sars	sar	NOUN
ajlm-1255	10	19	-	-	PUNCT
ajlm-1255	10	20	cov-2	cov-2	NOUN
ajlm-1255	10	21	)	)	PUNCT
ajlm-1255	10	22	has	have	AUX
ajlm-1255	10	23	impacted	impact	VERB
ajlm-1255	10	24	heavily	heavily	ADV
ajlm-1255	10	25	on	on	ADP
ajlm-1255	10	26	global	global	ADJ
ajlm-1255	10	27	health	health	NOUN
ajlm-1255	10	28	.	.	PUNCT
ajlm-1255	11	1	although	although	SCONJ
ajlm-1255	11	2	real	real	ADJ
ajlm-1255	11	3	-	-	PUNCT
ajlm-1255	11	4	time	time	NOUN
ajlm-1255	11	5	polymerase	polymerase	NOUN
ajlm-1255	11	6	chain	chain	NOUN
ajlm-1255	11	7	reaction	reaction	NOUN
ajlm-1255	11	8	(	(	PUNCT
ajlm-1255	11	9	rt	rt	NOUN
ajlm-1255	11	10	-	-	PUNCT
ajlm-1255	11	11	pcr	pcr	NOUN
ajlm-1255	11	12	)	)	PUNCT
ajlm-1255	11	13	is	be	AUX
ajlm-1255	11	14	the	the	DET
ajlm-1255	11	15	current	current	ADJ
ajlm-1255	11	16	diagnostic	diagnostic	ADJ
ajlm-1255	11	17	method	method	NOUN
ajlm-1255	11	18	,	,	PUNCT
ajlm-1255	11	19	challenges	challenge	NOUN
ajlm-1255	11	20	for	for	ADP
ajlm-1255	11	21	lowand	lowand	ADJ
ajlm-1255	11	22	middle	middle	ADJ
ajlm-1255	11	23	-	-	PUNCT
ajlm-1255	11	24	income	income	NOUN
ajlm-1255	11	25	countries	country	NOUN
ajlm-1255	11	26	(	(	PUNCT
ajlm-1255	11	27	lmics	lmic	NOUN
ajlm-1255	11	28	)	)	PUNCT
ajlm-1255	11	29	necessitate	necessitate	ADJ
ajlm-1255	11	30	cheaper	cheap	ADJ
ajlm-1255	11	31	,	,	PUNCT
ajlm-1255	11	32	higher	high	ADJ
ajlm-1255	11	33	-	-	PUNCT
ajlm-1255	11	34	throughput	throughput	NOUN
ajlm-1255	11	35	,	,	PUNCT
ajlm-1255	11	36	reliable	reliable	ADJ
ajlm-1255	11	37	rapid	rapid	ADJ
ajlm-1255	11	38	diagnostic	diagnostic	ADJ
ajlm-1255	11	39	tests	test	NOUN
ajlm-1255	11	40	(	(	PUNCT
ajlm-1255	11	41	rdts	rdts	ADJ
ajlm-1255	11	42	)	)	PUNCT
ajlm-1255	11	43	.	.	PUNCT
ajlm-1255	12	1	objective	objective	NOUN
ajlm-1255	12	2	:	:	PUNCT
ajlm-1255	12	3	we	we	PRON
ajlm-1255	12	4	reviewed	review	VERB
ajlm-1255	12	5	the	the	DET
ajlm-1255	12	6	documented	document	VERB
ajlm-1255	12	7	performance	performance	NOUN
ajlm-1255	12	8	characteristics	characteristic	NOUN
ajlm-1255	12	9	of	of	ADP
ajlm-1255	12	10	available	available	ADJ
ajlm-1255	12	11	covid-19	covid-19	PROPN
ajlm-1255	12	12	rdts	rdts	ADJ
ajlm-1255	12	13	to	to	PART
ajlm-1255	12	14	understand	understand	VERB
ajlm-1255	12	15	their	their	PRON
ajlm-1255	12	16	public	public	ADJ
ajlm-1255	12	17	health	health	NOUN
ajlm-1255	12	18	utility	utility	NOUN
ajlm-1255	12	19	in	in	ADP
ajlm-1255	12	20	the	the	DET
ajlm-1255	12	21	ongoing	ongoing	ADJ
ajlm-1255	12	22	pandemic	pandemic	ADJ
ajlm-1255	12	23	,	,	PUNCT
ajlm-1255	12	24	especially	especially	ADV
ajlm-1255	12	25	in	in	ADP
ajlm-1255	12	26	resource	resource	NOUN
ajlm-1255	12	27	-	-	PUNCT
ajlm-1255	12	28	scarce	scarce	ADJ
ajlm-1255	12	29	lmic	lmic	ADJ
ajlm-1255	12	30	settings	setting	NOUN
ajlm-1255	12	31	.	.	PUNCT
ajlm-1255	13	1	methods	method	NOUN
ajlm-1255	13	2	:	:	PUNCT
ajlm-1255	13	3	using	use	VERB
ajlm-1255	13	4	a	a	DET
ajlm-1255	13	5	scoping	scoping	NOUN
ajlm-1255	13	6	review	review	NOUN
ajlm-1255	13	7	methodology	methodology	NOUN
ajlm-1255	13	8	framework	framework	NOUN
ajlm-1255	13	9	,	,	PUNCT
ajlm-1255	13	10	common	common	ADJ
ajlm-1255	13	11	literature	literature	NOUN
ajlm-1255	13	12	databases	database	NOUN
ajlm-1255	13	13	and	and	CCONJ
ajlm-1255	13	14	documentary	documentary	NOUN
ajlm-1255	13	15	reports	report	NOUN
ajlm-1255	13	16	were	be	AUX
ajlm-1255	13	17	searched	search	VERB
ajlm-1255	13	18	up	up	ADP
ajlm-1255	13	19	to	to	ADP
ajlm-1255	13	20	22	22	NUM
ajlm-1255	13	21	april	april	PROPN
ajlm-1255	13	22	2020	2020	NUM
ajlm-1255	13	23	,	,	PUNCT
ajlm-1255	13	24	irrespective	irrespective	ADV
ajlm-1255	13	25	of	of	ADP
ajlm-1255	13	26	geographical	geographical	ADJ
ajlm-1255	13	27	location	location	NOUN
ajlm-1255	13	28	.	.	PUNCT
ajlm-1255	14	1	the	the	DET
ajlm-1255	14	2	search	search	NOUN
ajlm-1255	14	3	terms	term	NOUN
ajlm-1255	14	4	included	include	VERB
ajlm-1255	14	5	‘	'	PUNCT
ajlm-1255	14	6	sars	sar	NOUN
ajlm-1255	14	7	-	-	PUNCT
ajlm-1255	14	8	cov-2	cov-2	NUM
ajlm-1255	14	9	and	and	CCONJ
ajlm-1255	14	10	serological	serological	ADJ
ajlm-1255	14	11	testing	testing	NOUN
ajlm-1255	14	12	’	'	PUNCT
ajlm-1255	14	13	and	and	CCONJ
ajlm-1255	14	14	‘	'	PUNCT
ajlm-1255	14	15	covid-19	covid-19	PROPN
ajlm-1255	14	16	and	and	CCONJ
ajlm-1255	14	17	serological	serological	ADJ
ajlm-1255	14	18	testing	testing	NOUN
ajlm-1255	14	19	’	'	PUNCT
ajlm-1255	14	20	.	.	PUNCT
ajlm-1255	15	1	results	result	NOUN
ajlm-1255	15	2	:	:	PUNCT
ajlm-1255	15	3	a	a	DET
ajlm-1255	15	4	total	total	NOUN
ajlm-1255	15	5	of	of	ADP
ajlm-1255	15	6	18	18	NUM
ajlm-1255	15	7	rdts	rdts	NOUN
ajlm-1255	15	8	produced	produce	VERB
ajlm-1255	15	9	in	in	ADP
ajlm-1255	15	10	eight	eight	NUM
ajlm-1255	15	11	countries	country	NOUN
ajlm-1255	15	12	,	,	PUNCT
ajlm-1255	15	13	namely	namely	ADV
ajlm-1255	15	14	china	china	PROPN
ajlm-1255	15	15	(	(	PUNCT
ajlm-1255	15	16	6	6	NUM
ajlm-1255	15	17	;	;	PUNCT
ajlm-1255	15	18	33.33	33.33	NUM
ajlm-1255	15	19	%	%	NOUN
ajlm-1255	15	20	)	)	PUNCT
ajlm-1255	15	21	,	,	PUNCT
ajlm-1255	15	22	the	the	DET
ajlm-1255	15	23	united	united	PROPN
ajlm-1255	15	24	states	states	PROPN
ajlm-1255	15	25	(	(	PUNCT
ajlm-1255	15	26	4	4	NUM
ajlm-1255	15	27	;	;	PUNCT
ajlm-1255	15	28	22.22	22.22	NUM
ajlm-1255	15	29	%	%	NOUN
ajlm-1255	15	30	)	)	PUNCT
ajlm-1255	15	31	,	,	PUNCT
ajlm-1255	15	32	germany	germany	PROPN
ajlm-1255	15	33	(	(	PUNCT
ajlm-1255	15	34	2	2	NUM
ajlm-1255	15	35	;	;	PUNCT
ajlm-1255	15	36	11.11	11.11	NUM
ajlm-1255	15	37	%	%	NOUN
ajlm-1255	15	38	)	)	PUNCT
ajlm-1255	15	39	,	,	PUNCT
ajlm-1255	15	40	singapore	singapore	PROPN
ajlm-1255	15	41	(	(	PUNCT
ajlm-1255	15	42	2	2	NUM
ajlm-1255	15	43	;	;	PUNCT
ajlm-1255	15	44	11.11	11.11	NUM
ajlm-1255	15	45	%	%	NOUN
ajlm-1255	15	46	)	)	PUNCT
ajlm-1255	15	47	,	,	PUNCT
ajlm-1255	15	48	canada	canada	PROPN
ajlm-1255	15	49	,	,	PUNCT
ajlm-1255	15	50	kenya	kenya	PROPN
ajlm-1255	15	51	,	,	PUNCT
ajlm-1255	15	52	korea	korea	PROPN
ajlm-1255	15	53	and	and	CCONJ
ajlm-1255	15	54	belgium	belgium	PROPN
ajlm-1255	15	55	(	(	PUNCT
ajlm-1255	15	56	1	1	NUM
ajlm-1255	15	57	each	each	DET
ajlm-1255	15	58	;	;	PUNCT
ajlm-1255	15	59	5.56	5.56	NUM
ajlm-1255	15	60	%	%	NOUN
ajlm-1255	15	61	)	)	PUNCT
ajlm-1255	15	62	,	,	PUNCT
ajlm-1255	15	63	were	be	AUX
ajlm-1255	15	64	evaluated	evaluate	VERB
ajlm-1255	15	65	.	.	PUNCT
ajlm-1255	16	1	reported	report	VERB
ajlm-1255	16	2	sensitivity	sensitivity	NOUN
ajlm-1255	16	3	ranged	range	VERB
ajlm-1255	16	4	from	from	ADP
ajlm-1255	16	5	18.4	18.4	NUM
ajlm-1255	16	6	%	%	NOUN
ajlm-1255	16	7	to	to	PART
ajlm-1255	16	8	100	100	NUM
ajlm-1255	16	9	%	%	NOUN
ajlm-1255	16	10	(	(	PUNCT
ajlm-1255	16	11	average	average	ADJ
ajlm-1255	16	12	=	=	NUM
ajlm-1255	16	13	84.7	84.7	NUM
ajlm-1255	16	14	%	%	NOUN
ajlm-1255	16	15	)	)	PUNCT
ajlm-1255	16	16	,	,	PUNCT
ajlm-1255	16	17	whereas	whereas	SCONJ
ajlm-1255	16	18	specificity	specificity	NOUN
ajlm-1255	16	19	ranged	range	VERB
ajlm-1255	16	20	from	from	ADP
ajlm-1255	16	21	90.6	90.6	NUM
ajlm-1255	16	22	%	%	NOUN
ajlm-1255	16	23	to	to	PART
ajlm-1255	16	24	100	100	NUM
ajlm-1255	16	25	%	%	NOUN
ajlm-1255	16	26	(	(	PUNCT
ajlm-1255	16	27	average	average	ADJ
ajlm-1255	16	28	=	=	SYM
ajlm-1255	16	29	95.6	95.6	NUM
ajlm-1255	16	30	%	%	NOUN
ajlm-1255	16	31	)	)	PUNCT
ajlm-1255	16	32	.	.	PUNCT
ajlm-1255	17	1	the	the	DET
ajlm-1255	17	2	testing	testing	NOUN
ajlm-1255	17	3	time	time	NOUN
ajlm-1255	17	4	ranged	range	VERB
ajlm-1255	17	5	from	from	ADP
ajlm-1255	17	6	2	2	NUM
ajlm-1255	17	7	min	min	NOUN
ajlm-1255	17	8	to	to	ADP
ajlm-1255	17	9	30	30	NUM
ajlm-1255	17	10	min	min	NOUN
ajlm-1255	17	11	.	.	PROPN
ajlm-1255	17	12	of	of	ADP
ajlm-1255	17	13	the	the	DET
ajlm-1255	17	14	12	12	NUM
ajlm-1255	17	15	validated	validate	VERB
ajlm-1255	17	16	rdts	rdts	NOUN
ajlm-1255	17	17	,	,	PUNCT
ajlm-1255	17	18	the	the	DET
ajlm-1255	17	19	igm	igm	PROPN
ajlm-1255	17	20	/	/	SYM
ajlm-1255	17	21	igg	igg	PROPN
ajlm-1255	17	22	duo	duo	PROPN
ajlm-1255	17	23	kit	kit	NOUN
ajlm-1255	17	24	with	with	ADP
ajlm-1255	17	25	non	non	ADJ
ajlm-1255	17	26	-	-	ADJ
ajlm-1255	17	27	colloidal	colloidal	ADJ
ajlm-1255	17	28	gold	gold	NOUN
ajlm-1255	17	29	labelling	labelling	NOUN
ajlm-1255	17	30	system	system	NOUN
ajlm-1255	17	31	was	be	AUX
ajlm-1255	17	32	reported	report	VERB
ajlm-1255	17	33	to	to	PART
ajlm-1255	17	34	elicit	elicit	VERB
ajlm-1255	17	35	the	the	DET
ajlm-1255	17	36	highest	high	ADJ
ajlm-1255	17	37	sensitivity	sensitivity	NOUN
ajlm-1255	17	38	(	(	PUNCT
ajlm-1255	17	39	98	98	NUM
ajlm-1255	17	40	%	%	NOUN
ajlm-1255	17	41	–	–	PUNCT
ajlm-1255	17	42	100	100	NUM
ajlm-1255	17	43	%	%	NOUN
ajlm-1255	17	44	)	)	PUNCT
ajlm-1255	17	45	and	and	CCONJ
ajlm-1255	17	46	specificity	specificity	NOUN
ajlm-1255	17	47	(	(	PUNCT
ajlm-1255	17	48	98	98	NUM
ajlm-1255	17	49	%	%	NOUN
ajlm-1255	17	50	–	–	PUNCT
ajlm-1255	17	51	99	99	NUM
ajlm-1255	17	52	%	%	NOUN
ajlm-1255	17	53	for	for	ADP
ajlm-1255	17	54	igg	igg	PROPN
ajlm-1255	17	55	and	and	CCONJ
ajlm-1255	17	56	96	96	NUM
ajlm-1255	17	57	%	%	NOUN
ajlm-1255	17	58	–	–	PUNCT
ajlm-1255	17	59	99	99	NUM
ajlm-1255	17	60	%	%	NOUN
ajlm-1255	17	61	for	for	ADP
ajlm-1255	17	62	igm	igm	PROPN
ajlm-1255	17	63	)	)	PUNCT
ajlm-1255	17	64	.	.	PUNCT
ajlm-1255	18	1	conclusion	conclusion	NOUN
ajlm-1255	18	2	:	:	PUNCT
ajlm-1255	18	3	we	we	PRON
ajlm-1255	18	4	found	find	VERB
ajlm-1255	18	5	reports	report	NOUN
ajlm-1255	18	6	of	of	ADP
ajlm-1255	18	7	high	high	ADJ
ajlm-1255	18	8	sensitivity	sensitivity	NOUN
ajlm-1255	18	9	and	and	CCONJ
ajlm-1255	18	10	specificity	specificity	NOUN
ajlm-1255	18	11	among	among	ADP
ajlm-1255	18	12	the	the	DET
ajlm-1255	18	13	developed	develop	VERB
ajlm-1255	18	14	rdts	rdts	NOUN
ajlm-1255	18	15	that	that	PRON
ajlm-1255	18	16	could	could	AUX
ajlm-1255	18	17	complement	complement	VERB
ajlm-1255	18	18	rt	rt	ADJ
ajlm-1255	18	19	-	-	PUNCT
ajlm-1255	18	20	pcr	pcr	NOUN
ajlm-1255	18	21	for	for	ADP
ajlm-1255	18	22	the	the	DET
ajlm-1255	18	23	detection	detection	NOUN
ajlm-1255	18	24	of	of	ADP
ajlm-1255	18	25	sars	sar	NOUN
ajlm-1255	18	26	-	-	PUNCT
ajlm-1255	18	27	cov-2	cov-2	NOUN
ajlm-1255	18	28	antibodies	antibodie	VERB
ajlm-1255	18	29	,	,	PUNCT
ajlm-1255	18	30	especially	especially	ADV
ajlm-1255	18	31	for	for	ADP
ajlm-1255	18	32	screening	screen	VERB
ajlm-1255	18	33	in	in	ADP
ajlm-1255	18	34	lmics	lmic	NOUN
ajlm-1255	18	35	.	.	PUNCT
ajlm-1255	19	1	however	however	ADV
ajlm-1255	19	2	,	,	PUNCT
ajlm-1255	19	3	it	it	PRON
ajlm-1255	19	4	is	be	AUX
ajlm-1255	19	5	necessary	necessary	ADJ
ajlm-1255	19	6	to	to	PART
ajlm-1255	19	7	validate	validate	VERB
ajlm-1255	19	8	these	these	DET
ajlm-1255	19	9	kits	kit	NOUN
ajlm-1255	19	10	locally	locally	ADV
ajlm-1255	19	11	.	.	PUNCT
ajlm-1255	20	1	keywords	keyword	NOUN
ajlm-1255	20	2	:	:	PUNCT
ajlm-1255	20	3	coronavirus	coronavirus	NOUN
ajlm-1255	20	4	disease	disease	NOUN
ajlm-1255	20	5	;	;	PUNCT
ajlm-1255	20	6	covid-19	covid-19	PROPN
ajlm-1255	20	7	;	;	PUNCT
ajlm-1255	20	8	sars	sar	NOUN
ajlm-1255	20	9	-	-	PUNCT
ajlm-1255	20	10	cov-2	cov-2	NUM
ajlm-1255	20	11	;	;	PUNCT
ajlm-1255	20	12	rapid	rapid	ADJ
ajlm-1255	20	13	diagnostic	diagnostic	ADJ
ajlm-1255	20	14	test	test	NOUN
ajlm-1255	20	15	;	;	PUNCT
ajlm-1255	20	16	lowand	lowand	ADJ
ajlm-1255	20	17	middle	middle	ADJ
ajlm-1255	20	18	-	-	PUNCT
ajlm-1255	20	19	income	income	NOUN
ajlm-1255	20	20	countries	country	NOUN
ajlm-1255	20	21	.	.	PUNCT
ajlm-1255	21	1	introduction	introduction	NOUN
ajlm-1255	21	2	coronavirus	coronavirus	NOUN
ajlm-1255	21	3	disease	disease	NOUN
ajlm-1255	21	4	2019	2019	NUM
ajlm-1255	21	5	(	(	PUNCT
ajlm-1255	21	6	covid-19	covid-19	PROPN
ajlm-1255	21	7	)	)	PUNCT
ajlm-1255	21	8	is	be	AUX
ajlm-1255	21	9	an	an	DET
ajlm-1255	21	10	emerging	emerge	VERB
ajlm-1255	21	11	respiratory	respiratory	ADJ
ajlm-1255	21	12	disease	disease	NOUN
ajlm-1255	21	13	that	that	PRON
ajlm-1255	21	14	was	be	AUX
ajlm-1255	21	15	first	first	ADV
ajlm-1255	21	16	reported	report	VERB
ajlm-1255	21	17	to	to	ADP
ajlm-1255	21	18	the	the	DET
ajlm-1255	21	19	world	world	PROPN
ajlm-1255	21	20	health	health	NOUN
ajlm-1255	21	21	organization	organization	NOUN
ajlm-1255	21	22	(	(	PUNCT
ajlm-1255	21	23	who	who	PRON
ajlm-1255	21	24	)	)	PUNCT
ajlm-1255	21	25	as	as	ADP
ajlm-1255	21	26	a	a	DET
ajlm-1255	21	27	cluster	cluster	NOUN
ajlm-1255	21	28	of	of	ADP
ajlm-1255	21	29	pneumonia	pneumonia	NOUN
ajlm-1255	21	30	of	of	ADP
ajlm-1255	21	31	unknown	unknown	ADJ
ajlm-1255	21	32	origin	origin	NOUN
ajlm-1255	21	33	from	from	ADP
ajlm-1255	21	34	wuhan	wuhan	PROPN
ajlm-1255	21	35	,	,	PUNCT
ajlm-1255	21	36	china	china	PROPN
ajlm-1255	21	37	,	,	PUNCT
ajlm-1255	21	38	in	in	ADP
ajlm-1255	21	39	december	december	PROPN
ajlm-1255	21	40	2019.1	2019.1	NUM
ajlm-1255	21	41	the	the	DET
ajlm-1255	21	42	unknown	unknown	ADJ
ajlm-1255	21	43	causative	causative	ADJ
ajlm-1255	21	44	agent	agent	NOUN
ajlm-1255	21	45	was	be	AUX
ajlm-1255	21	46	found	find	VERB
ajlm-1255	21	47	through	through	ADP
ajlm-1255	21	48	deep	deep	ADJ
ajlm-1255	21	49	sequencing	sequence	VERB
ajlm-1255	21	50	to	to	PART
ajlm-1255	21	51	be	be	AUX
ajlm-1255	21	52	severe	severe	ADJ
ajlm-1255	21	53	acute	acute	ADJ
ajlm-1255	21	54	respiratory	respiratory	ADJ
ajlm-1255	21	55	syndrome	syndrome	NOUN
ajlm-1255	21	56	coronavirus-2	coronavirus-2	NUM
ajlm-1255	21	57	(	(	PUNCT
ajlm-1255	21	58	sars	sar	NOUN
ajlm-1255	21	59	-	-	PUNCT
ajlm-1255	21	60	cov-2	cov-2	NOUN
ajlm-1255	21	61	)	)	PUNCT
ajlm-1255	21	62	on	on	ADP
ajlm-1255	21	63	7	7	NUM
ajlm-1255	21	64	january	january	NOUN
ajlm-1255	21	65	2020	2020	NUM
ajlm-1255	21	66	and	and	CCONJ
ajlm-1255	21	67	the	the	DET
ajlm-1255	21	68	disease	disease	NOUN
ajlm-1255	21	69	covid-19	covid-19	PROPN
ajlm-1255	21	70	was	be	AUX
ajlm-1255	21	71	named	name	VERB
ajlm-1255	21	72	on	on	ADP
ajlm-1255	21	73	11	11	NUM
ajlm-1255	21	74	february	february	NOUN
ajlm-1255	21	75	2020	2020	NUM
ajlm-1255	21	76	.	.	PUNCT
ajlm-1255	22	1	in	in	ADP
ajlm-1255	22	2	response	response	NOUN
ajlm-1255	22	3	,	,	PUNCT
ajlm-1255	22	4	who	who	PRON
ajlm-1255	22	5	declared	declare	VERB
ajlm-1255	22	6	covid-19	covid-19	PROPN
ajlm-1255	22	7	as	as	ADP
ajlm-1255	22	8	a	a	DET
ajlm-1255	22	9	public	public	ADJ
ajlm-1255	22	10	health	health	NOUN
ajlm-1255	22	11	emergency	emergency	NOUN
ajlm-1255	22	12	of	of	ADP
ajlm-1255	22	13	international	international	ADJ
ajlm-1255	22	14	concern	concern	NOUN
ajlm-1255	22	15	on	on	ADP
ajlm-1255	22	16	30	30	NUM
ajlm-1255	22	17	january	january	NOUN
ajlm-1255	22	18	2020	2020	NUM
ajlm-1255	22	19	and	and	CCONJ
ajlm-1255	22	20	a	a	DET
ajlm-1255	22	21	pandemic	pandemic	NOUN
ajlm-1255	22	22	on	on	ADP
ajlm-1255	22	23	11	11	NUM
ajlm-1255	22	24	march	march	NOUN
ajlm-1255	22	25	2020.1	2020.1	NUM
ajlm-1255	22	26	as	as	ADP
ajlm-1255	22	27	of	of	ADP
ajlm-1255	22	28	22	22	NUM
ajlm-1255	22	29	april	april	PROPN
ajlm-1255	22	30	2020	2020	NUM
ajlm-1255	22	31	,	,	PUNCT
ajlm-1255	22	32	an	an	DET
ajlm-1255	22	33	estimated	estimate	VERB
ajlm-1255	22	34	2	2	NUM
ajlm-1255	22	35	572	572	NUM
ajlm-1255	22	36	805	805	NUM
ajlm-1255	22	37	confirmed	confirm	VERB
ajlm-1255	22	38	cases	case	NOUN
ajlm-1255	22	39	and	and	CCONJ
ajlm-1255	22	40	178	178	NUM
ajlm-1255	22	41	551	551	NUM
ajlm-1255	22	42	confirmed	confirm	VERB
ajlm-1255	22	43	deaths	death	NOUN
ajlm-1255	22	44	from	from	ADP
ajlm-1255	22	45	covid-19	covid-19	PROPN
ajlm-1255	22	46	had	have	AUX
ajlm-1255	22	47	been	be	AUX
ajlm-1255	22	48	reported.2	reported.2	VERB
ajlm-1255	22	49	the	the	DET
ajlm-1255	22	50	first	first	ADJ
ajlm-1255	22	51	10	10	NUM
ajlm-1255	22	52	cases	case	NOUN
ajlm-1255	22	53	in	in	ADP
ajlm-1255	22	54	africa	africa	PROPN
ajlm-1255	22	55	were	be	AUX
ajlm-1255	22	56	reported	report	VERB
ajlm-1255	22	57	in	in	ADP
ajlm-1255	22	58	five	five	NUM
ajlm-1255	22	59	countries	country	NOUN
ajlm-1255	22	60	(	(	PUNCT
ajlm-1255	22	61	nigeria	nigeria	PROPN
ajlm-1255	22	62	,	,	PUNCT
ajlm-1255	22	63	algeria	algeria	PROPN
ajlm-1255	22	64	,	,	PUNCT
ajlm-1255	22	65	morocco	morocco	PROPN
ajlm-1255	22	66	,	,	PUNCT
ajlm-1255	22	67	egypt	egypt	PROPN
ajlm-1255	22	68	and	and	CCONJ
ajlm-1255	22	69	senegal).3	senegal).3	PROPN
ajlm-1255	22	70	although	although	SCONJ
ajlm-1255	22	71	earlier	early	ADJ
ajlm-1255	22	72	cases	case	NOUN
ajlm-1255	22	73	of	of	ADP
ajlm-1255	22	74	covid-19	covid-19	PROPN
ajlm-1255	22	75	in	in	ADP
ajlm-1255	22	76	many	many	ADJ
ajlm-1255	22	77	lowand	lowand	ADJ
ajlm-1255	22	78	middle	middle	ADJ
ajlm-1255	22	79	-	-	PUNCT
ajlm-1255	22	80	income	income	NOUN
ajlm-1255	22	81	countries	country	NOUN
ajlm-1255	22	82	(	(	PUNCT
ajlm-1255	22	83	lmics	lmic	NOUN
ajlm-1255	22	84	)	)	PUNCT
ajlm-1255	22	85	were	be	AUX
ajlm-1255	22	86	described	describe	VERB
ajlm-1255	22	87	as	as	ADP
ajlm-1255	22	88	imported	import	VERB
ajlm-1255	22	89	by	by	ADP
ajlm-1255	22	90	travelers	traveler	NOUN
ajlm-1255	22	91	from	from	ADP
ajlm-1255	22	92	china	china	PROPN
ajlm-1255	22	93	,	,	PUNCT
ajlm-1255	22	94	italy	italy	PROPN
ajlm-1255	22	95	,	,	PUNCT
ajlm-1255	22	96	the	the	DET
ajlm-1255	22	97	united	united	PROPN
ajlm-1255	22	98	kingdom	kingdom	PROPN
ajlm-1255	22	99	and	and	CCONJ
ajlm-1255	22	100	germany	germany	PROPN
ajlm-1255	22	101	,	,	PUNCT
ajlm-1255	22	102	community	community	NOUN
ajlm-1255	22	103	transmission	transmission	NOUN
ajlm-1255	22	104	has	have	AUX
ajlm-1255	22	105	now	now	ADV
ajlm-1255	22	106	become	become	VERB
ajlm-1255	22	107	the	the	DET
ajlm-1255	22	108	major	major	ADJ
ajlm-1255	22	109	cause	cause	NOUN
ajlm-1255	22	110	of	of	ADP
ajlm-1255	22	111	new	new	ADJ
ajlm-1255	22	112	covid-19	covid-19	PROPN
ajlm-1255	22	113	infections.3,4	infections.3,4	ADJ
ajlm-1255	22	114	early	early	ADJ
ajlm-1255	22	115	,	,	PUNCT
ajlm-1255	22	116	rapid	rapid	ADJ
ajlm-1255	22	117	,	,	PUNCT
ajlm-1255	22	118	large	large	ADJ
ajlm-1255	22	119	-	-	PUNCT
ajlm-1255	22	120	scale	scale	NOUN
ajlm-1255	22	121	diagnosis	diagnosis	NOUN
ajlm-1255	22	122	and	and	CCONJ
ajlm-1255	22	123	accurate	accurate	ADJ
ajlm-1255	22	124	diagnosis	diagnosis	NOUN
ajlm-1255	22	125	of	of	ADP
ajlm-1255	22	126	covid-19	covid-19	PROPN
ajlm-1255	22	127	is	be	AUX
ajlm-1255	22	128	one	one	NUM
ajlm-1255	22	129	of	of	ADP
ajlm-1255	22	130	the	the	DET
ajlm-1255	22	131	key	key	ADJ
ajlm-1255	22	132	interventions	intervention	NOUN
ajlm-1255	22	133	for	for	ADP
ajlm-1255	22	134	covid-19	covid-19	PROPN
ajlm-1255	22	135	containment	containment	NOUN
ajlm-1255	22	136	in	in	ADP
ajlm-1255	22	137	both	both	CCONJ
ajlm-1255	22	138	high	high	ADJ
ajlm-1255	22	139	-	-	PUNCT
ajlm-1255	22	140	income	income	NOUN
ajlm-1255	22	141	and	and	CCONJ
ajlm-1255	22	142	lmic	lmic	ADJ
ajlm-1255	22	143	settings.3	settings.3	VERB
ajlm-1255	22	144	the	the	DET
ajlm-1255	22	145	availability	availability	NOUN
ajlm-1255	22	146	of	of	ADP
ajlm-1255	22	147	the	the	DET
ajlm-1255	22	148	sars	sar	NOUN
ajlm-1255	22	149	-	-	PUNCT
ajlm-1255	22	150	cov-2	cov-2	NOUN
ajlm-1255	22	151	genome	genome	NOUN
ajlm-1255	22	152	has	have	AUX
ajlm-1255	22	153	led	lead	VERB
ajlm-1255	22	154	to	to	ADP
ajlm-1255	22	155	the	the	DET
ajlm-1255	22	156	development	development	NOUN
ajlm-1255	22	157	and	and	CCONJ
ajlm-1255	22	158	validation	validation	NOUN
ajlm-1255	22	159	of	of	ADP
ajlm-1255	22	160	various	various	ADJ
ajlm-1255	22	161	reverse	reverse	ADJ
ajlm-1255	22	162	transcriptase	transcriptase	NOUN
ajlm-1255	22	163	real	real	ADJ
ajlm-1255	22	164	-	-	PUNCT
ajlm-1255	22	165	time	time	NOUN
ajlm-1255	22	166	polymerase	polymerase	NOUN
ajlm-1255	22	167	chain	chain	NOUN
ajlm-1255	22	168	reaction	reaction	NOUN
ajlm-1255	22	169	(	(	PUNCT
ajlm-1255	22	170	rt	rt	NOUN
ajlm-1255	22	171	-	-	PUNCT
ajlm-1255	22	172	pcr	pcr	NOUN
ajlm-1255	22	173	)	)	PUNCT
ajlm-1255	22	174	in	in	ADP
ajlm-1255	22	175	vitro	vitro	X
ajlm-1255	22	176	diagnostic	diagnostic	ADJ
ajlm-1255	22	177	test	test	NOUN
ajlm-1255	22	178	kits	kit	NOUN
ajlm-1255	22	179	by	by	ADP
ajlm-1255	22	180	different	different	ADJ
ajlm-1255	22	181	manufacturers	manufacturer	NOUN
ajlm-1255	22	182	for	for	ADP
ajlm-1255	22	183	covid-19	covid-19	PROPN
ajlm-1255	22	184	diagnosis.5,6	diagnosis.5,6	PROPN
ajlm-1255	22	185	this	this	DET
ajlm-1255	22	186	diagnostic	diagnostic	ADJ
ajlm-1255	22	187	test	test	NOUN
ajlm-1255	22	188	is	be	AUX
ajlm-1255	22	189	based	base	VERB
ajlm-1255	22	190	on	on	ADP
ajlm-1255	22	191	the	the	DET
ajlm-1255	22	192	detection	detection	NOUN
ajlm-1255	22	193	of	of	ADP
ajlm-1255	22	194	genes	gene	NOUN
ajlm-1255	22	195	encoding	encode	VERB
ajlm-1255	22	196	the	the	DET
ajlm-1255	22	197	envelope	envelope	NOUN
ajlm-1255	22	198	(	(	PUNCT
ajlm-1255	22	199	e	e	NOUN
ajlm-1255	22	200	)	)	PUNCT
ajlm-1255	22	201	,	,	PUNCT
ajlm-1255	22	202	spike	spike	X
ajlm-1255	22	203	(	(	PUNCT
ajlm-1255	22	204	s	s	NOUN
ajlm-1255	22	205	)	)	PUNCT
ajlm-1255	22	206	,	,	PUNCT
ajlm-1255	22	207	nucleoplasid	nucleoplasid	NOUN
ajlm-1255	22	208	(	(	PUNCT
ajlm-1255	22	209	n	n	CCONJ
ajlm-1255	22	210	)	)	PUNCT
ajlm-1255	22	211	,	,	PUNCT
ajlm-1255	22	212	rna	rna	NOUN
ajlm-1255	22	213	-	-	PUNCT
ajlm-1255	22	214	dependent	dependent	ADJ
ajlm-1255	22	215	rna	rna	NOUN
ajlm-1255	22	216	polymerase	polymerase	NOUN
ajlm-1255	22	217	and	and	CCONJ
ajlm-1255	22	218	open	open	ADJ
ajlm-1255	22	219	reading	reading	NOUN
ajlm-1255	22	220	frame	frame	NOUN
ajlm-1255	22	221	1a	1a	NOUN
ajlm-1255	22	222	/	/	SYM
ajlm-1255	22	223	b	b	PROPN
ajlm-1255	22	224	(	(	PUNCT
ajlm-1255	22	225	e.g.	e.g.	ADV
ajlm-1255	22	226	orf1ab	orf1ab	PROPN
ajlm-1255	22	227	,	,	PUNCT
ajlm-1255	22	228	orf1a	orf1a	PROPN
ajlm-1255	22	229	,	,	PUNCT
ajlm-1255	22	230	orf1b	orf1b	PROPN
ajlm-1255	22	231	)	)	PUNCT
ajlm-1255	22	232	polyproteins	polyprotein	NOUN
ajlm-1255	22	233	within	within	ADP
ajlm-1255	22	234	the	the	DET
ajlm-1255	22	235	genomic	genomic	ADJ
ajlm-1255	22	236	rna	rna	NOUN
ajlm-1255	22	237	of	of	ADP
ajlm-1255	22	238	sars	sars	PROPN
ajlm-1255	22	239	-	-	PUNCT
ajlm-1255	22	240	cov-2.5,6,7	cov-2.5,6,7	NOUN
ajlm-1255	22	241	due	due	ADP
ajlm-1255	22	242	to	to	ADP
ajlm-1255	22	243	lack	lack	NOUN
ajlm-1255	22	244	of	of	ADP
ajlm-1255	22	245	culture	culture	NOUN
ajlm-1255	22	246	facilities	facility	NOUN
ajlm-1255	22	247	,	,	PUNCT
ajlm-1255	22	248	the	the	DET
ajlm-1255	22	249	rt	rt	ADJ
ajlm-1255	22	250	-	-	PUNCT
ajlm-1255	22	251	pcr	pcr	ADJ
ajlm-1255	22	252	method	method	NOUN
ajlm-1255	22	253	is	be	AUX
ajlm-1255	22	254	currently	currently	ADV
ajlm-1255	22	255	the	the	DET
ajlm-1255	22	256	reference	reference	NOUN
ajlm-1255	22	257	standard	standard	ADJ
ajlm-1255	22	258	method	method	NOUN
ajlm-1255	22	259	of	of	ADP
ajlm-1255	22	260	confirming	confirm	VERB
ajlm-1255	22	261	covid-19	covid-19	PROPN
ajlm-1255	22	262	diagnosis	diagnosis	NOUN
ajlm-1255	22	263	in	in	ADP
ajlm-1255	22	264	suspected	suspect	VERB
ajlm-1255	22	265	cases	case	NOUN
ajlm-1255	22	266	globally	globally	ADV
ajlm-1255	22	267	.	.	PUNCT
ajlm-1255	23	1	for	for	ADP
ajlm-1255	23	2	epidemiological	epidemiological	ADJ
ajlm-1255	23	3	investigation	investigation	NOUN
ajlm-1255	23	4	,	,	PUNCT
ajlm-1255	23	5	public	public	ADJ
ajlm-1255	23	6	health	health	NOUN
ajlm-1255	23	7	and	and	CCONJ
ajlm-1255	23	8	clinical	clinical	ADJ
ajlm-1255	23	9	actions	action	NOUN
ajlm-1255	23	10	,	,	PUNCT
ajlm-1255	23	11	rt	rt	PROPN
ajlm-1255	23	12	-	-	PUNCT
ajlm-1255	23	13	pcr	pcr	PROPN
ajlm-1255	23	14	has	have	AUX
ajlm-1255	23	15	been	be	AUX
ajlm-1255	23	16	shown	show	VERB
ajlm-1255	23	17	to	to	PART
ajlm-1255	23	18	be	be	AUX
ajlm-1255	23	19	very	very	ADV
ajlm-1255	23	20	reliable	reliable	ADJ
ajlm-1255	23	21	at	at	ADP
ajlm-1255	23	22	screening	screen	VERB
ajlm-1255	23	23	and	and	CCONJ
ajlm-1255	23	24	confirming	confirm	VERB
ajlm-1255	23	25	the	the	DET
ajlm-1255	23	26	diagnosis	diagnosis	NOUN
ajlm-1255	23	27	of	of	ADP
ajlm-1255	23	28	covid-19	covid-19	PROPN
ajlm-1255	23	29	using	use	VERB
ajlm-1255	23	30	upper	upper	ADJ
ajlm-1255	23	31	respiratory	respiratory	NOUN
ajlm-1255	23	32	(	(	PUNCT
ajlm-1255	23	33	e.g.	e.g.	ADV
ajlm-1255	23	34	nasopharyngeal	nasopharyngeal	ADJ
ajlm-1255	23	35	swab	swab	NOUN
ajlm-1255	23	36	,	,	PUNCT
ajlm-1255	23	37	oropharyngeal	oropharyngeal	NOUN
ajlm-1255	23	38	swab	swab	NOUN
ajlm-1255	23	39	,	,	PUNCT
ajlm-1255	23	40	throat	throat	NOUN
ajlm-1255	23	41	swab	swab	PROPN
ajlm-1255	23	42	and	and	CCONJ
ajlm-1255	23	43	nasal	nasal	PROPN
ajlm-1255	23	44	swab	swab	PROPN
ajlm-1255	23	45	)	)	PUNCT
ajlm-1255	23	46	and	and	CCONJ
ajlm-1255	23	47	lower	low	ADJ
ajlm-1255	23	48	respiratory	respiratory	ADJ
ajlm-1255	23	49	(	(	PUNCT
ajlm-1255	23	50	e.g.	e.g.	ADV
ajlm-1255	23	51	sputum	sputum	NOUN
ajlm-1255	23	52	and	and	CCONJ
ajlm-1255	23	53	bronchioalveolar	bronchioalveolar	ADJ
ajlm-1255	23	54	lavage	lavage	NOUN
ajlm-1255	23	55	)	)	PUNCT
ajlm-1255	23	56	samples.7,8	samples.7,8	VERB
ajlm-1255	23	57	real	real	ADJ
ajlm-1255	23	58	-	-	PUNCT
ajlm-1255	23	59	time	time	NOUN
ajlm-1255	23	60	pcr	pcr	NOUN
ajlm-1255	23	61	has	have	AUX
ajlm-1255	23	62	also	also	ADV
ajlm-1255	23	63	been	be	AUX
ajlm-1255	23	64	useful	useful	ADJ
ajlm-1255	23	65	for	for	ADP
ajlm-1255	23	66	monitoring	monitor	VERB
ajlm-1255	23	67	viral	viral	ADJ
ajlm-1255	23	68	rna	rna	NOUN
ajlm-1255	23	69	shedding	shedding	NOUN
ajlm-1255	23	70	dynamics	dynamic	NOUN
ajlm-1255	23	71	during	during	ADP
ajlm-1255	23	72	the	the	DET
ajlm-1255	23	73	acute	acute	ADJ
ajlm-1255	23	74	phase	phase	NOUN
ajlm-1255	23	75	of	of	ADP
ajlm-1255	23	76	the	the	DET
ajlm-1255	23	77	disease	disease	NOUN
ajlm-1255	23	78	and	and	CCONJ
ajlm-1255	23	79	viral	viral	ADJ
ajlm-1255	23	80	rna	rna	NOUN
ajlm-1255	23	81	decay	decay	NOUN
ajlm-1255	23	82	and	and	CCONJ
ajlm-1255	23	83	disappearance	disappearance	NOUN
ajlm-1255	23	84	during	during	ADP
ajlm-1255	23	85	the	the	DET
ajlm-1255	23	86	convalescence	convalescence	NOUN
ajlm-1255	23	87	stage	stage	NOUN
ajlm-1255	23	88	of	of	ADP
ajlm-1255	23	89	the	the	DET
ajlm-1255	23	90	disease	disease	NOUN
ajlm-1255	23	91	among	among	ADP
ajlm-1255	23	92	survivors.9,10	survivors.9,10	NOUN
ajlm-1255	23	93	however	however	ADV
ajlm-1255	23	94	,	,	PUNCT
ajlm-1255	23	95	in	in	ADP
ajlm-1255	23	96	spite	spite	NOUN
ajlm-1255	23	97	of	of	ADP
ajlm-1255	23	98	its	its	PRON
ajlm-1255	23	99	high	high	ADJ
ajlm-1255	23	100	analytical	analytical	ADJ
ajlm-1255	23	101	sensitivity	sensitivity	NOUN
ajlm-1255	23	102	its	its	PRON
ajlm-1255	23	103	detection	detection	NOUN
ajlm-1255	23	104	range	range	NOUN
ajlm-1255	23	105	is	be	AUX
ajlm-1255	23	106	limited	limit	VERB
ajlm-1255	23	107	to	to	ADP
ajlm-1255	23	108	3.2	3.2	NUM
ajlm-1255	23	109	–	–	PUNCT
ajlm-1255	23	110	<	<	X
ajlm-1255	23	111	10.0	10.0	NUM
ajlm-1255	23	112	rna	rna	NOUN
ajlm-1255	23	113	copies	copy	NOUN
ajlm-1255	23	114	per	per	ADP
ajlm-1255	23	115	reaction.6,7,8	reaction.6,7,8	NOUN
ajlm-1255	23	116	the	the	DET
ajlm-1255	23	117	rt	rt	ADJ
ajlm-1255	23	118	-	-	PUNCT
ajlm-1255	23	119	pcr	pcr	ADJ
ajlm-1255	23	120	method	method	NOUN
ajlm-1255	23	121	has	have	AUX
ajlm-1255	23	122	been	be	AUX
ajlm-1255	23	123	reported	report	VERB
ajlm-1255	23	124	from	from	ADP
ajlm-1255	23	125	studies	study	NOUN
ajlm-1255	23	126	done	do	VERB
ajlm-1255	23	127	inside	inside	ADP
ajlm-1255	23	128	and	and	CCONJ
ajlm-1255	23	129	outside	outside	ADP
ajlm-1255	23	130	china	china	PROPN
ajlm-1255	23	131	to	to	PART
ajlm-1255	23	132	also	also	ADV
ajlm-1255	23	133	be	be	AUX
ajlm-1255	23	134	prone	prone	ADJ
ajlm-1255	23	135	to	to	ADP
ajlm-1255	23	136	giving	give	VERB
ajlm-1255	23	137	false	false	ADJ
ajlm-1255	23	138	negative	negative	ADJ
ajlm-1255	23	139	results	result	NOUN
ajlm-1255	23	140	under	under	ADP
ajlm-1255	23	141	certain	certain	ADJ
ajlm-1255	23	142	conditions	condition	NOUN
ajlm-1255	23	143	,	,	PUNCT
ajlm-1255	23	144	thereby	thereby	ADV
ajlm-1255	23	145	missing	miss	VERB
ajlm-1255	23	146	some	some	DET
ajlm-1255	23	147	covid-19	covid-19	PROPN
ajlm-1255	23	148	cases	case	NOUN
ajlm-1255	23	149	.	.	PUNCT
ajlm-1255	24	1	these	these	DET
ajlm-1255	24	2	missed	miss	VERB
ajlm-1255	24	3	cases	case	NOUN
ajlm-1255	24	4	are	be	AUX
ajlm-1255	24	5	therefore	therefore	ADV
ajlm-1255	24	6	not	not	PART
ajlm-1255	24	7	isolated	isolated	ADJ
ajlm-1255	24	8	increasing	increase	VERB
ajlm-1255	24	9	community	community	NOUN
ajlm-1255	24	10	transmission.8,9,10	transmission.8,9,10	NOUN
ajlm-1255	24	11	these	these	DET
ajlm-1255	24	12	conditions	condition	NOUN
ajlm-1255	24	13	include	include	VERB
ajlm-1255	24	14	insufficient	insufficient	ADJ
ajlm-1255	24	15	or	or	CCONJ
ajlm-1255	24	16	inappropriate	inappropriate	ADJ
ajlm-1255	24	17	sample	sample	NOUN
ajlm-1255	24	18	for	for	ADP
ajlm-1255	24	19	viral	viral	ADJ
ajlm-1255	24	20	rna	rna	NOUN
ajlm-1255	24	21	isolation	isolation	NOUN
ajlm-1255	24	22	,	,	PUNCT
ajlm-1255	24	23	poor	poor	ADJ
ajlm-1255	24	24	sample	sample	NOUN
ajlm-1255	24	25	transportation	transportation	NOUN
ajlm-1255	24	26	to	to	ADP
ajlm-1255	24	27	the	the	DET
ajlm-1255	24	28	laboratory	laboratory	NOUN
ajlm-1255	24	29	,	,	PUNCT
ajlm-1255	24	30	poor	poor	ADJ
ajlm-1255	24	31	storage	storage	NOUN
ajlm-1255	24	32	of	of	ADP
ajlm-1255	24	33	the	the	DET
ajlm-1255	24	34	isolated	isolated	ADJ
ajlm-1255	24	35	rna	rna	NOUN
ajlm-1255	24	36	samples	sample	NOUN
ajlm-1255	24	37	,	,	PUNCT
ajlm-1255	24	38	poor	poor	ADJ
ajlm-1255	24	39	quality	quality	NOUN
ajlm-1255	24	40	of	of	ADP
ajlm-1255	24	41	the	the	DET
ajlm-1255	24	42	rt	rt	PROPN
ajlm-1255	24	43	-	-	PUNCT
ajlm-1255	24	44	pcr	pcr	NOUN
ajlm-1255	24	45	assay	assay	NOUN
ajlm-1255	24	46	and	and	CCONJ
ajlm-1255	24	47	poor	poor	ADJ
ajlm-1255	24	48	timing	timing	NOUN
ajlm-1255	24	49	for	for	ADP
ajlm-1255	24	50	sample	sample	NOUN
ajlm-1255	24	51	collection	collection	NOUN
ajlm-1255	24	52	.	.	PUNCT
ajlm-1255	25	1	the	the	DET
ajlm-1255	25	2	asymptomatic	asymptomatic	ADJ
ajlm-1255	25	3	phase	phase	NOUN
ajlm-1255	25	4	of	of	ADP
ajlm-1255	25	5	sars	sar	NOUN
ajlm-1255	25	6	-	-	PUNCT
ajlm-1255	25	7	cov-2	cov-2	PART
ajlm-1255	25	8	infection	infection	NOUN
ajlm-1255	25	9	–	–	PUNCT
ajlm-1255	25	10	the	the	DET
ajlm-1255	25	11	first	first	ADJ
ajlm-1255	25	12	few	few	ADJ
ajlm-1255	25	13	days	day	NOUN
ajlm-1255	25	14	post	post	VERB
ajlm-1255	25	15	infection	infection	NOUN
ajlm-1255	25	16	onset	onset	NOUN
ajlm-1255	25	17	and	and	CCONJ
ajlm-1255	25	18	the	the	DET
ajlm-1255	25	19	convalescence	convalescence	NOUN
ajlm-1255	25	20	phase	phase	NOUN
ajlm-1255	25	21	≥	≥	NUM
ajlm-1255	25	22	14	14	NUM
ajlm-1255	25	23	days	day	NOUN
ajlm-1255	25	24	post	post	NOUN
ajlm-1255	25	25	infection	infection	NOUN
ajlm-1255	25	26	onset	onset	NOUN
ajlm-1255	25	27	,	,	PUNCT
ajlm-1255	25	28	especially	especially	ADV
ajlm-1255	25	29	in	in	ADP
ajlm-1255	25	30	a	a	DET
ajlm-1255	25	31	missed	miss	VERB
ajlm-1255	25	32	infection	infection	NOUN
ajlm-1255	25	33	,	,	PUNCT
ajlm-1255	25	34	have	have	AUX
ajlm-1255	25	35	been	be	AUX
ajlm-1255	25	36	indicated	indicate	VERB
ajlm-1255	25	37	as	as	ADP
ajlm-1255	25	38	times	time	NOUN
ajlm-1255	25	39	when	when	SCONJ
ajlm-1255	25	40	cases	case	NOUN
ajlm-1255	25	41	can	can	AUX
ajlm-1255	25	42	be	be	AUX
ajlm-1255	25	43	missed.7,8,9,10	missed.7,8,9,10	NOUN
ajlm-1255	25	44	poor	poor	ADJ
ajlm-1255	25	45	quality	quality	NOUN
ajlm-1255	25	46	rt	rt	PROPN
ajlm-1255	25	47	-	-	PUNCT
ajlm-1255	25	48	pcr	pcr	ADJ
ajlm-1255	25	49	assay	assay	NOUN
ajlm-1255	25	50	is	be	AUX
ajlm-1255	25	51	characterised	characterise	VERB
ajlm-1255	25	52	by	by	ADP
ajlm-1255	25	53	an	an	DET
ajlm-1255	25	54	inconsistent	inconsistent	ADJ
ajlm-1255	25	55	cycle	cycle	NOUN
ajlm-1255	25	56	threshold	threshold	NOUN
ajlm-1255	25	57	value	value	NOUN
ajlm-1255	25	58	and/or	and/or	CCONJ
ajlm-1255	25	59	lack	lack	NOUN
ajlm-1255	25	60	of	of	ADP
ajlm-1255	25	61	amplification	amplification	NOUN
ajlm-1255	25	62	signal	signal	NOUN
ajlm-1255	25	63	for	for	ADP
ajlm-1255	25	64	one	one	NUM
ajlm-1255	25	65	or	or	CCONJ
ajlm-1255	25	66	two	two	NUM
ajlm-1255	25	67	targeted	target	VERB
ajlm-1255	25	68	genes	gene	NOUN
ajlm-1255	25	69	.	.	PUNCT
ajlm-1255	26	1	these	these	DET
ajlm-1255	26	2	missed	miss	VERB
ajlm-1255	26	3	cases	case	NOUN
ajlm-1255	26	4	are	be	AUX
ajlm-1255	26	5	therefore	therefore	ADV
ajlm-1255	26	6	not	not	PART
ajlm-1255	26	7	isolated	isolate	VERB
ajlm-1255	26	8	increasing	increase	VERB
ajlm-1255	26	9	for	for	ADP
ajlm-1255	26	10	sar	sar	NOUN
ajlm-1255	26	11	-	-	PUNCT
ajlm-1255	26	12	cov-2	cov-2	PART
ajlm-1255	26	13	detection.6,7,8	detection.6,7,8	NOUN
ajlm-1255	26	14	also	also	ADV
ajlm-1255	26	15	,	,	PUNCT
ajlm-1255	26	16	due	due	ADP
ajlm-1255	26	17	to	to	ADP
ajlm-1255	26	18	limited	limited	ADJ
ajlm-1255	26	19	financial	financial	ADJ
ajlm-1255	26	20	resources	resource	NOUN
ajlm-1255	26	21	,	,	PUNCT
ajlm-1255	26	22	the	the	DET
ajlm-1255	26	23	limited	limited	ADJ
ajlm-1255	26	24	number	number	NOUN
ajlm-1255	26	25	of	of	ADP
ajlm-1255	26	26	accredited	accredit	VERB
ajlm-1255	26	27	molecular	molecular	ADJ
ajlm-1255	26	28	laboratories	laboratory	NOUN
ajlm-1255	26	29	of	of	ADP
ajlm-1255	26	30	biosafety	biosafety	NOUN
ajlm-1255	26	31	level	level	NOUN
ajlm-1255	26	32	2/3	2/3	NUM
ajlm-1255	26	33	and	and	CCONJ
ajlm-1255	26	34	limited	limited	ADJ
ajlm-1255	26	35	number	number	NOUN
ajlm-1255	26	36	of	of	ADP
ajlm-1255	26	37	technical	technical	ADJ
ajlm-1255	26	38	experts	expert	NOUN
ajlm-1255	26	39	,	,	PUNCT
ajlm-1255	26	40	the	the	DET
ajlm-1255	26	41	scaling	scaling	NOUN
ajlm-1255	26	42	up	up	ADP
ajlm-1255	26	43	of	of	ADP
ajlm-1255	26	44	rt	rt	NOUN
ajlm-1255	26	45	-	-	PUNCT
ajlm-1255	26	46	pcr	pcr	PROPN
ajlm-1255	26	47	for	for	ADP
ajlm-1255	26	48	covid-19	covid-19	PROPN
ajlm-1255	26	49	diagnosis	diagnosis	NOUN
ajlm-1255	26	50	is	be	AUX
ajlm-1255	26	51	limited	limit	VERB
ajlm-1255	26	52	in	in	ADP
ajlm-1255	26	53	lmics.7,8,9,10	lmics.7,8,9,10	NOUN
ajlm-1255	26	54	taken	take	VERB
ajlm-1255	26	55	together	together	ADV
ajlm-1255	26	56	,	,	PUNCT
ajlm-1255	26	57	the	the	DET
ajlm-1255	26	58	above	above	ADJ
ajlm-1255	26	59	challenges	challenge	NOUN
ajlm-1255	26	60	of	of	ADP
ajlm-1255	26	61	rt	rt	NOUN
ajlm-1255	26	62	-	-	PUNCT
ajlm-1255	26	63	pcr	pcr	PROPN
ajlm-1255	26	64	have	have	AUX
ajlm-1255	26	65	necessitated	necessitate	VERB
ajlm-1255	26	66	the	the	DET
ajlm-1255	26	67	deployment	deployment	NOUN
ajlm-1255	26	68	of	of	ADP
ajlm-1255	26	69	serological	serological	ADJ
ajlm-1255	26	70	rapid	rapid	ADJ
ajlm-1255	26	71	diagnostic	diagnostic	ADJ
ajlm-1255	26	72	tests	test	NOUN
ajlm-1255	26	73	(	(	PUNCT
ajlm-1255	26	74	rdts	rdts	ADJ
ajlm-1255	26	75	)	)	PUNCT
ajlm-1255	26	76	for	for	ADP
ajlm-1255	26	77	covid-19	covid-19	PROPN
ajlm-1255	26	78	diagnosis	diagnosis	NOUN
ajlm-1255	26	79	,	,	PUNCT
ajlm-1255	26	80	which	which	PRON
ajlm-1255	26	81	could	could	AUX
ajlm-1255	26	82	identify	identify	VERB
ajlm-1255	26	83	asymptomatic	asymptomatic	ADJ
ajlm-1255	26	84	and	and	CCONJ
ajlm-1255	26	85	convalescent	convalescent	NOUN
ajlm-1255	26	86	covid-19	covid-19	PROPN
ajlm-1255	26	87	cases	case	NOUN
ajlm-1255	26	88	undiagnosed	undiagnose	VERB
ajlm-1255	26	89	by	by	ADP
ajlm-1255	26	90	rt	rt	NOUN
ajlm-1255	26	91	-	-	PUNCT
ajlm-1255	26	92	pcr	pcr	NOUN
ajlm-1255	26	93	.	.	PUNCT
ajlm-1255	27	1	covid-19	covid-19	PROPN
ajlm-1255	27	2	serological	serological	ADJ
ajlm-1255	27	3	rdts	rdts	NOUN
ajlm-1255	27	4	are	be	AUX
ajlm-1255	27	5	antigen	antigen	NOUN
ajlm-1255	27	6	-	-	PUNCT
ajlm-1255	27	7	antibody	antibody	NOUN
ajlm-1255	27	8	based	base	VERB
ajlm-1255	27	9	tests	test	NOUN
ajlm-1255	27	10	that	that	PRON
ajlm-1255	27	11	detects	detect	VERB
ajlm-1255	27	12	sars	sar	NOUN
ajlm-1255	27	13	-	-	PUNCT
ajlm-1255	27	14	cov-2	cov-2	NOUN
ajlm-1255	27	15	igm	igm	PROPN
ajlm-1255	27	16	and/or	and/or	CCONJ
ajlm-1255	27	17	igg	igg	PROPN
ajlm-1255	27	18	in	in	ADP
ajlm-1255	27	19	human	human	ADJ
ajlm-1255	27	20	blood	blood	NOUN
ajlm-1255	27	21	samples	sample	NOUN
ajlm-1255	27	22	or	or	CCONJ
ajlm-1255	27	23	sars	sar	NOUN
ajlm-1255	27	24	-	-	PUNCT
ajlm-1255	27	25	cov-2	cov-2	NOUN
ajlm-1255	27	26	viral	viral	ADJ
ajlm-1255	27	27	antigen	antigen	NOUN
ajlm-1255	27	28	from	from	ADP
ajlm-1255	27	29	respiratory	respiratory	ADJ
ajlm-1255	27	30	samples	sample	NOUN
ajlm-1255	27	31	within	within	ADP
ajlm-1255	27	32	15	15	NUM
ajlm-1255	27	33	min.8,11,12	min.8,11,12	NOUN
ajlm-1255	27	34	unlike	unlike	ADP
ajlm-1255	27	35	the	the	DET
ajlm-1255	27	36	rt	rt	ADJ
ajlm-1255	27	37	-	-	PUNCT
ajlm-1255	27	38	pcr	pcr	ADJ
ajlm-1255	27	39	protocols	protocol	NOUN
ajlm-1255	27	40	,	,	PUNCT
ajlm-1255	27	41	serological	serological	ADJ
ajlm-1255	27	42	tests	test	NOUN
ajlm-1255	27	43	require	require	VERB
ajlm-1255	27	44	less	less	ADV
ajlm-1255	27	45	expensive	expensive	ADJ
ajlm-1255	27	46	equipment	equipment	NOUN
ajlm-1255	27	47	,	,	PUNCT
ajlm-1255	27	48	no	no	DET
ajlm-1255	27	49	technical	technical	ADJ
ajlm-1255	27	50	expertise	expertise	NOUN
ajlm-1255	27	51	or	or	CCONJ
ajlm-1255	27	52	electricity	electricity	NOUN
ajlm-1255	27	53	to	to	PART
ajlm-1255	27	54	run	run	VERB
ajlm-1255	27	55	and	and	CCONJ
ajlm-1255	27	56	very	very	ADV
ajlm-1255	27	57	minimal	minimal	ADJ
ajlm-1255	27	58	biosafety	biosafety	NOUN
ajlm-1255	27	59	requirements	requirement	NOUN
ajlm-1255	27	60	.	.	PUNCT
ajlm-1255	28	1	also	also	ADV
ajlm-1255	28	2	,	,	PUNCT
ajlm-1255	28	3	unlike	unlike	ADP
ajlm-1255	28	4	rdts	rdts	NOUN
ajlm-1255	28	5	that	that	PRON
ajlm-1255	28	6	use	use	VERB
ajlm-1255	28	7	small	small	ADJ
ajlm-1255	28	8	amounts	amount	NOUN
ajlm-1255	28	9	of	of	ADP
ajlm-1255	28	10	biological	biological	ADJ
ajlm-1255	28	11	sample	sample	NOUN
ajlm-1255	28	12	(	(	PUNCT
ajlm-1255	28	13	10	10	NUM
ajlm-1255	28	14	ul	ul	INTJ
ajlm-1255	28	15	–	–	PUNCT
ajlm-1255	28	16	20	20	NUM
ajlm-1255	28	17	ul	ul	NOUN
ajlm-1255	28	18	)	)	PUNCT
ajlm-1255	28	19	and	and	CCONJ
ajlm-1255	28	20	have	have	VERB
ajlm-1255	28	21	an	an	DET
ajlm-1255	28	22	average	average	ADJ
ajlm-1255	28	23	run	run	NOUN
ajlm-1255	28	24	time	time	NOUN
ajlm-1255	28	25	of	of	ADP
ajlm-1255	28	26	15	15	NUM
ajlm-1255	28	27	minutes	minute	NOUN
ajlm-1255	28	28	,	,	PUNCT
ajlm-1255	28	29	the	the	DET
ajlm-1255	28	30	rt	rt	ADJ
ajlm-1255	28	31	-	-	PUNCT
ajlm-1255	28	32	pcr	pcr	ADJ
ajlm-1255	28	33	protocols	protocol	NOUN
ajlm-1255	28	34	use	use	VERB
ajlm-1255	28	35	large	large	ADJ
ajlm-1255	28	36	amounts	amount	NOUN
ajlm-1255	28	37	of	of	ADP
ajlm-1255	28	38	samples	sample	NOUN
ajlm-1255	28	39	(	(	PUNCT
ajlm-1255	28	40	150	150	NUM
ajlm-1255	28	41	ul	ul	INTJ
ajlm-1255	28	42	–	–	PUNCT
ajlm-1255	28	43	200	200	NUM
ajlm-1255	28	44	ul	ul	NOUN
ajlm-1255	28	45	)	)	PUNCT
ajlm-1255	28	46	and	and	CCONJ
ajlm-1255	28	47	have	have	VERB
ajlm-1255	28	48	an	an	DET
ajlm-1255	28	49	average	average	ADJ
ajlm-1255	28	50	run	run	NOUN
ajlm-1255	28	51	time	time	NOUN
ajlm-1255	28	52	of	of	ADP
ajlm-1255	28	53	about	about	ADV
ajlm-1255	28	54	90	90	NUM
ajlm-1255	28	55	minutes.6,7,8	minutes.6,7,8	NOUN
ajlm-1255	28	56	these	these	DET
ajlm-1255	28	57	advantages	advantage	NOUN
ajlm-1255	28	58	of	of	ADP
ajlm-1255	28	59	serological	serological	ADJ
ajlm-1255	28	60	rdts	rdts	NOUN
ajlm-1255	28	61	have	have	AUX
ajlm-1255	28	62	attracted	attract	VERB
ajlm-1255	28	63	serious	serious	ADJ
ajlm-1255	28	64	attention	attention	NOUN
ajlm-1255	28	65	for	for	ADP
ajlm-1255	28	66	their	their	PRON
ajlm-1255	28	67	use	use	NOUN
ajlm-1255	28	68	in	in	ADP
ajlm-1255	28	69	large	large	ADJ
ajlm-1255	28	70	-	-	PUNCT
ajlm-1255	28	71	scale	scale	NOUN
ajlm-1255	28	72	covid-19	covid-19	PROPN
ajlm-1255	28	73	serological	serological	ADJ
ajlm-1255	28	74	rdts	rdts	NOUN
ajlm-1255	28	75	are	be	AUX
ajlm-1255	28	76	antigen	antigen	NOUN
ajlm-1255	28	77	-	-	PUNCT
ajlm-1255	28	78	antibody	antibody	NOUN
ajlm-1255	28	79	based	base	VERB
ajlm-1255	28	80	tests	test	NOUN
ajlm-1255	28	81	that	that	PRON
ajlm-1255	28	82	detects	detect	VERB
ajlm-1255	28	83	sars	sar	NOUN
ajlm-1255	28	84	-	-	PUNCT
ajlm-1255	28	85	cov-2	cov-2	NOUN
ajlm-1255	28	86	igm	igm	PROPN
ajlm-1255	28	87	and/or	and/or	CCONJ
ajlm-1255	28	88	igg	igg	PROPN
ajlm-1255	28	89	in	in	ADP
ajlm-1255	28	90	human	human	ADJ
ajlm-1255	28	91	blood	blood	NOUN
ajlm-1255	28	92	samples	sample	NOUN
ajlm-1255	28	93	or	or	CCONJ
ajlm-1255	28	94	sars	sar	NOUN
ajlm-1255	28	95	-	-	PUNCT
ajlm-1255	28	96	cov-2	cov-2	NOUN
ajlm-1255	28	97	viral	viral	ADJ
ajlm-1255	28	98	antigen	antigen	NOUN
ajlm-1255	28	99	from	from	ADP
ajlm-1255	28	100	respiratory	respiratory	ADJ
ajlm-1255	28	101	samples	sample	NOUN
ajlm-1255	28	102	within	within	ADP
ajlm-1255	28	103	15	15	NUM
ajlm-1255	28	104	min	min	NOUN
ajlm-1255	28	105	testing	testing	NOUN
ajlm-1255	28	106	especially	especially	ADV
ajlm-1255	28	107	at	at	ADP
ajlm-1255	28	108	the	the	DET
ajlm-1255	28	109	peripheral	peripheral	ADJ
ajlm-1255	28	110	level	level	NOUN
ajlm-1255	28	111	of	of	ADP
ajlm-1255	28	112	the	the	DET
ajlm-1255	28	113	health	health	NOUN
ajlm-1255	28	114	system	system	NOUN
ajlm-1255	28	115	and	and	CCONJ
ajlm-1255	28	116	outside	outside	ADJ
ajlm-1255	28	117	hospital	hospital	NOUN
ajlm-1255	28	118	settings	setting	NOUN
ajlm-1255	28	119	in	in	ADP
ajlm-1255	28	120	lmics	lmic	NOUN
ajlm-1255	28	121	.	.	PUNCT
ajlm-1255	29	1	data	datum	NOUN
ajlm-1255	29	2	from	from	ADP
ajlm-1255	29	3	worldmeters	worldmeter	NOUN
ajlm-1255	29	4	show	show	VERB
ajlm-1255	29	5	that	that	SCONJ
ajlm-1255	29	6	african	african	ADJ
ajlm-1255	29	7	countries	country	NOUN
ajlm-1255	29	8	compared	compare	VERB
ajlm-1255	29	9	to	to	ADP
ajlm-1255	29	10	other	other	ADJ
ajlm-1255	29	11	countries	country	NOUN
ajlm-1255	29	12	conducted	conduct	VERB
ajlm-1255	29	13	fewer	few	ADJ
ajlm-1255	29	14	tests	test	NOUN
ajlm-1255	29	15	per	per	ADP
ajlm-1255	29	16	population	population	NOUN
ajlm-1255	29	17	(	(	PUNCT
ajlm-1255	29	18	figure	figure	NOUN
ajlm-1255	29	19	1	1	NUM
ajlm-1255	29	20	)	)	PUNCT
ajlm-1255	29	21	.	.	PUNCT
ajlm-1255	30	1	this	this	DET
ajlm-1255	30	2	lower	low	ADJ
ajlm-1255	30	3	testing	testing	NOUN
ajlm-1255	30	4	power	power	NOUN
ajlm-1255	30	5	means	mean	VERB
ajlm-1255	30	6	relatively	relatively	ADV
ajlm-1255	30	7	fewer	few	ADJ
ajlm-1255	30	8	cases	case	NOUN
ajlm-1255	30	9	can	can	AUX
ajlm-1255	30	10	be	be	AUX
ajlm-1255	30	11	detected	detect	VERB
ajlm-1255	30	12	.	.	PUNCT
ajlm-1255	31	1	thus	thus	ADV
ajlm-1255	31	2	,	,	PUNCT
ajlm-1255	31	3	the	the	DET
ajlm-1255	31	4	rollout	rollout	NOUN
ajlm-1255	31	5	of	of	ADP
ajlm-1255	31	6	various	various	ADJ
ajlm-1255	31	7	rdt	rdt	PROPN
ajlm-1255	31	8	kits	kit	NOUN
ajlm-1255	31	9	by	by	ADP
ajlm-1255	31	10	different	different	ADJ
ajlm-1255	31	11	manufacturers	manufacturer	NOUN
ajlm-1255	31	12	could	could	AUX
ajlm-1255	31	13	be	be	AUX
ajlm-1255	31	14	a	a	DET
ajlm-1255	31	15	favourable	favourable	ADJ
ajlm-1255	31	16	development	development	NOUN
ajlm-1255	31	17	particularly	particularly	ADV
ajlm-1255	31	18	for	for	ADP
ajlm-1255	31	19	lmics	lmic	NOUN
ajlm-1255	31	20	as	as	ADP
ajlm-1255	31	21	rdts	rdts	ADJ
ajlm-1255	31	22	can	can	AUX
ajlm-1255	31	23	be	be	AUX
ajlm-1255	31	24	easily	easily	ADV
ajlm-1255	31	25	scaled	scale	VERB
ajlm-1255	31	26	up	up	ADP
ajlm-1255	31	27	for	for	ADP
ajlm-1255	31	28	rapid	rapid	ADJ
ajlm-1255	31	29	covid-19	covid-19	PROPN
ajlm-1255	31	30	diagnosis.11,12	diagnosis.11,12	NOUN
ajlm-1255	31	31	besides	besides	SCONJ
ajlm-1255	31	32	,	,	PUNCT
ajlm-1255	31	33	rdts	rdts	PROPN
ajlm-1255	31	34	can	can	AUX
ajlm-1255	31	35	provide	provide	VERB
ajlm-1255	31	36	additional	additional	ADJ
ajlm-1255	31	37	sero	sero	ADJ
ajlm-1255	31	38	-	-	PUNCT
ajlm-1255	31	39	epidemiological	epidemiological	ADJ
ajlm-1255	31	40	data	datum	NOUN
ajlm-1255	31	41	that	that	PRON
ajlm-1255	31	42	will	will	AUX
ajlm-1255	31	43	be	be	AUX
ajlm-1255	31	44	used	use	VERB
ajlm-1255	31	45	to	to	PART
ajlm-1255	31	46	determine	determine	VERB
ajlm-1255	31	47	the	the	DET
ajlm-1255	31	48	magnitude	magnitude	NOUN
ajlm-1255	31	49	of	of	ADP
ajlm-1255	31	50	covid-19	covid-19	PROPN
ajlm-1255	31	51	spread	spread	VERB
ajlm-1255	31	52	within	within	ADP
ajlm-1255	31	53	a	a	DET
ajlm-1255	31	54	population	population	NOUN
ajlm-1255	31	55	.	.	PUNCT
ajlm-1255	32	1	rdts	rdts	PROPN
ajlm-1255	32	2	achieve	achieve	VERB
ajlm-1255	32	3	this	this	PRON
ajlm-1255	32	4	by	by	ADP
ajlm-1255	32	5	identifying	identify	VERB
ajlm-1255	32	6	active	active	ADJ
ajlm-1255	32	7	and	and	CCONJ
ajlm-1255	32	8	previous	previous	ADJ
ajlm-1255	32	9	symptomatic	symptomatic	ADJ
ajlm-1255	32	10	or	or	CCONJ
ajlm-1255	32	11	asymptomatic	asymptomatic	ADJ
ajlm-1255	32	12	cases	case	NOUN
ajlm-1255	32	13	;	;	PUNCT
ajlm-1255	32	14	these	these	DET
ajlm-1255	32	15	data	datum	NOUN
ajlm-1255	32	16	are	be	AUX
ajlm-1255	32	17	then	then	ADV
ajlm-1255	32	18	used	use	VERB
ajlm-1255	32	19	to	to	PART
ajlm-1255	32	20	calculate	calculate	VERB
ajlm-1255	32	21	case	case	NOUN
ajlm-1255	32	22	-	-	PUNCT
ajlm-1255	32	23	fatality	fatality	NOUN
ajlm-1255	32	24	rate	rate	NOUN
ajlm-1255	32	25	and	and	CCONJ
ajlm-1255	32	26	determine	determine	VERB
ajlm-1255	32	27	the	the	DET
ajlm-1255	32	28	anti	anti	ADJ
ajlm-1255	32	29	-	-	ADJ
ajlm-1255	32	30	sars	sar	NOUN
ajlm-1255	32	31	-	-	PUNCT
ajlm-1255	32	32	cov-2	cov-2	NOUN
ajlm-1255	32	33	immunity	immunity	NOUN
ajlm-1255	32	34	level	level	NOUN
ajlm-1255	32	35	of	of	ADP
ajlm-1255	32	36	a	a	DET
ajlm-1255	32	37	community.11,12	community.11,12	NOUN
ajlm-1255	32	38	however	however	ADV
ajlm-1255	32	39	,	,	PUNCT
ajlm-1255	32	40	to	to	PART
ajlm-1255	32	41	harness	harness	VERB
ajlm-1255	32	42	the	the	DET
ajlm-1255	32	43	various	various	ADJ
ajlm-1255	32	44	epidemiological	epidemiological	ADJ
ajlm-1255	32	45	and	and	CCONJ
ajlm-1255	32	46	clinical	clinical	ADJ
ajlm-1255	32	47	usefulness	usefulness	NOUN
ajlm-1255	32	48	of	of	ADP
ajlm-1255	32	49	currently	currently	ADV
ajlm-1255	32	50	available	available	ADJ
ajlm-1255	32	51	covid-19	covid-19	PROPN
ajlm-1255	32	52	serological	serological	ADJ
ajlm-1255	32	53	rdts	rdts	NOUN
ajlm-1255	32	54	,	,	PUNCT
ajlm-1255	32	55	it	it	PRON
ajlm-1255	32	56	is	be	AUX
ajlm-1255	32	57	important	important	ADJ
ajlm-1255	32	58	to	to	PART
ajlm-1255	32	59	determine	determine	VERB
ajlm-1255	32	60	and/or	and/or	CCONJ
ajlm-1255	32	61	validate	validate	VERB
ajlm-1255	32	62	their	their	PRON
ajlm-1255	32	63	performance	performance	NOUN
ajlm-1255	32	64	levels	level	NOUN
ajlm-1255	32	65	.	.	PUNCT
ajlm-1255	33	1	in	in	ADP
ajlm-1255	33	2	the	the	DET
ajlm-1255	33	3	present	present	ADJ
ajlm-1255	33	4	scoping	scoping	NOUN
ajlm-1255	33	5	review	review	NOUN
ajlm-1255	33	6	,	,	PUNCT
ajlm-1255	33	7	the	the	DET
ajlm-1255	33	8	following	follow	VERB
ajlm-1255	33	9	research	research	NOUN
ajlm-1255	33	10	questions	question	NOUN
ajlm-1255	33	11	will	will	AUX
ajlm-1255	33	12	be	be	AUX
ajlm-1255	33	13	answered	answer	VERB
ajlm-1255	33	14	:	:	PUNCT
ajlm-1255	33	15	(	(	PUNCT
ajlm-1255	33	16	1	1	X
ajlm-1255	33	17	)	)	PUNCT
ajlm-1255	33	18	what	what	PRON
ajlm-1255	33	19	are	be	AUX
ajlm-1255	33	20	the	the	DET
ajlm-1255	33	21	currently	currently	ADV
ajlm-1255	33	22	available	available	ADJ
ajlm-1255	33	23	serological	serological	ADJ
ajlm-1255	33	24	rdts	rdts	NOUN
ajlm-1255	33	25	for	for	ADP
ajlm-1255	33	26	testing	testing	NOUN
ajlm-1255	33	27	,	,	PUNCT
ajlm-1255	33	28	(	(	PUNCT
ajlm-1255	33	29	2	2	X
ajlm-1255	33	30	)	)	PUNCT
ajlm-1255	33	31	to	to	ADP
ajlm-1255	33	32	what	what	DET
ajlm-1255	33	33	extent	extent	NOUN
ajlm-1255	33	34	have	have	VERB
ajlm-1255	33	35	these	these	DET
ajlm-1255	33	36	serological	serological	ADJ
ajlm-1255	33	37	rdts	rdts	NOUN
ajlm-1255	33	38	been	be	AUX
ajlm-1255	33	39	validated	validate	VERB
ajlm-1255	33	40	by	by	ADP
ajlm-1255	33	41	their	their	PRON
ajlm-1255	33	42	manufacturers	manufacturer	NOUN
ajlm-1255	33	43	and	and	CCONJ
ajlm-1255	33	44	(	(	PUNCT
ajlm-1255	33	45	3	3	X
ajlm-1255	33	46	)	)	PUNCT
ajlm-1255	33	47	what	what	PRON
ajlm-1255	33	48	is	be	AUX
ajlm-1255	33	49	the	the	DET
ajlm-1255	33	50	level	level	NOUN
ajlm-1255	33	51	of	of	ADP
ajlm-1255	33	52	performance	performance	NOUN
ajlm-1255	33	53	characteristics	characteristic	NOUN
ajlm-1255	33	54	of	of	ADP
ajlm-1255	33	55	these	these	DET
ajlm-1255	33	56	serological	serological	ADJ
ajlm-1255	33	57	rdts	rdts	NOUN
ajlm-1255	33	58	?	?	PUNCT
ajlm-1255	34	1	presently	presently	ADV
ajlm-1255	34	2	,	,	PUNCT
ajlm-1255	34	3	the	the	DET
ajlm-1255	34	4	level	level	NOUN
ajlm-1255	34	5	of	of	ADP
ajlm-1255	34	6	accuracy	accuracy	NOUN
ajlm-1255	34	7	of	of	ADP
ajlm-1255	34	8	many	many	ADJ
ajlm-1255	34	9	serological	serological	ADJ
ajlm-1255	34	10	rdts	rdts	NOUN
ajlm-1255	34	11	available	available	ADJ
ajlm-1255	34	12	for	for	ADP
ajlm-1255	34	13	use	use	NOUN
ajlm-1255	34	14	in	in	ADP
ajlm-1255	34	15	lmics	lmic	NOUN
ajlm-1255	34	16	remains	remain	VERB
ajlm-1255	34	17	unclear	unclear	ADJ
ajlm-1255	34	18	,	,	PUNCT
ajlm-1255	34	19	coupled	couple	VERB
ajlm-1255	34	20	with	with	ADP
ajlm-1255	34	21	insufficient	insufficient	ADJ
ajlm-1255	34	22	information	information	NOUN
ajlm-1255	34	23	about	about	ADP
ajlm-1255	34	24	their	their	PRON
ajlm-1255	34	25	strengths	strength	NOUN
ajlm-1255	34	26	and	and	CCONJ
ajlm-1255	34	27	limitations	limitation	NOUN
ajlm-1255	34	28	.	.	PUNCT
ajlm-1255	35	1	this	this	DET
ajlm-1255	35	2	review	review	NOUN
ajlm-1255	35	3	will	will	AUX
ajlm-1255	35	4	provide	provide	VERB
ajlm-1255	35	5	insight	insight	NOUN
ajlm-1255	35	6	into	into	ADP
ajlm-1255	35	7	the	the	DET
ajlm-1255	35	8	performance	performance	NOUN
ajlm-1255	35	9	characteristics	characteristic	NOUN
ajlm-1255	35	10	of	of	ADP
ajlm-1255	35	11	these	these	DET
ajlm-1255	35	12	kits	kit	NOUN
ajlm-1255	35	13	and	and	CCONJ
ajlm-1255	35	14	enable	enable	VERB
ajlm-1255	35	15	evidenced	evidence	VERB
ajlm-1255	35	16	-	-	PUNCT
ajlm-1255	35	17	based	base	VERB
ajlm-1255	35	18	decisions	decision	NOUN
ajlm-1255	35	19	for	for	ADP
ajlm-1255	35	20	their	their	PRON
ajlm-1255	35	21	possible	possible	ADJ
ajlm-1255	35	22	use	use	NOUN
ajlm-1255	35	23	in	in	ADP
ajlm-1255	35	24	large	large	ADJ
ajlm-1255	35	25	-	-	PUNCT
ajlm-1255	35	26	scale	scale	NOUN
ajlm-1255	35	27	covid-19	covid-19	PROPN
ajlm-1255	35	28	testing	testing	NOUN
ajlm-1255	35	29	and	and	CCONJ
ajlm-1255	35	30	containment	containment	NOUN
ajlm-1255	35	31	strategies	strategy	NOUN
ajlm-1255	35	32	in	in	ADP
ajlm-1255	35	33	lmics	lmic	NOUN
ajlm-1255	35	34	.	.	PUNCT
ajlm-1255	36	1	figure	figure	VERB
ajlm-1255	36	2	1	1	NUM
ajlm-1255	36	3	:	:	PUNCT
ajlm-1255	36	4	distribution	distribution	NOUN
ajlm-1255	36	5	of	of	ADP
ajlm-1255	36	6	severe	severe	ADJ
ajlm-1255	36	7	acute	acute	ADJ
ajlm-1255	36	8	respiratory	respiratory	ADJ
ajlm-1255	36	9	syndrome	syndrome	NOUN
ajlm-1255	36	10	coronavirus-2	coronavirus-2	NUM
ajlm-1255	36	11	burden	burden	NOUN
ajlm-1255	36	12	and	and	CCONJ
ajlm-1255	36	13	test	test	NOUN
ajlm-1255	36	14	per	per	ADP
ajlm-1255	36	15	population	population	NOUN
ajlm-1255	36	16	in	in	ADP
ajlm-1255	36	17	selected	select	VERB
ajlm-1255	36	18	african	african	ADJ
ajlm-1255	36	19	countries	country	NOUN
ajlm-1255	36	20	.	.	PUNCT
ajlm-1255	37	1	methodology	methodology	NOUN
ajlm-1255	37	2	and	and	CCONJ
ajlm-1255	37	3	data	datum	NOUN
ajlm-1255	37	4	analysis	analysis	NOUN
ajlm-1255	37	5	a	a	DET
ajlm-1255	37	6	scoping	scope	VERB
ajlm-1255	37	7	review	review	NOUN
ajlm-1255	37	8	was	be	AUX
ajlm-1255	37	9	conducted	conduct	VERB
ajlm-1255	37	10	using	use	VERB
ajlm-1255	37	11	a	a	DET
ajlm-1255	37	12	methodology	methodology	NOUN
ajlm-1255	37	13	framework	framework	NOUN
ajlm-1255	37	14	by	by	ADP
ajlm-1255	37	15	arksey13	arksey13	NOUN
ajlm-1255	37	16	with	with	ADP
ajlm-1255	37	17	modification	modification	NOUN
ajlm-1255	37	18	as	as	SCONJ
ajlm-1255	37	19	described	describe	VERB
ajlm-1255	37	20	by	by	ADP
ajlm-1255	37	21	adhikari	adhikari	PROPN
ajlm-1255	37	22	et	et	PROPN
ajlm-1255	37	23	al.14	al.14	NOUN
ajlm-1255	37	24	this	this	PRON
ajlm-1255	37	25	includes	include	VERB
ajlm-1255	37	26	:	:	PUNCT
ajlm-1255	37	27	(	(	PUNCT
ajlm-1255	37	28	1	1	X
ajlm-1255	37	29	)	)	PUNCT
ajlm-1255	37	30	identifying	identify	VERB
ajlm-1255	37	31	a	a	DET
ajlm-1255	37	32	clear	clear	ADJ
ajlm-1255	37	33	research	research	NOUN
ajlm-1255	37	34	objective	objective	NOUN
ajlm-1255	37	35	and	and	CCONJ
ajlm-1255	37	36	search	search	NOUN
ajlm-1255	37	37	strategies	strategy	NOUN
ajlm-1255	37	38	,	,	PUNCT
ajlm-1255	37	39	(	(	PUNCT
ajlm-1255	37	40	2	2	X
ajlm-1255	37	41	)	)	PUNCT
ajlm-1255	37	42	identifying	identify	VERB
ajlm-1255	37	43	relevant	relevant	ADJ
ajlm-1255	37	44	research	research	NOUN
ajlm-1255	37	45	articles	article	NOUN
ajlm-1255	37	46	,	,	PUNCT
ajlm-1255	37	47	(	(	PUNCT
ajlm-1255	37	48	3	3	X
ajlm-1255	37	49	)	)	PUNCT
ajlm-1255	37	50	selecting	select	VERB
ajlm-1255	37	51	research	research	NOUN
ajlm-1255	37	52	articles	article	NOUN
ajlm-1255	37	53	,	,	PUNCT
ajlm-1255	37	54	(	(	PUNCT
ajlm-1255	37	55	4	4	X
ajlm-1255	37	56	)	)	PUNCT
ajlm-1255	37	57	extracting	extract	VERB
ajlm-1255	37	58	and	and	CCONJ
ajlm-1255	37	59	charting	charting	NOUN
ajlm-1255	37	60	of	of	ADP
ajlm-1255	37	61	data	datum	NOUN
ajlm-1255	37	62	,	,	PUNCT
ajlm-1255	37	63	and	and	CCONJ
ajlm-1255	37	64	(	(	PUNCT
ajlm-1255	37	65	5	5	X
ajlm-1255	37	66	)	)	PUNCT
ajlm-1255	37	67	summarising	summarising	NOUN
ajlm-1255	37	68	,	,	PUNCT
ajlm-1255	37	69	discussing	discussing	NOUN
ajlm-1255	37	70	,	,	PUNCT
ajlm-1255	37	71	analysing	analyse	VERB
ajlm-1255	37	72	and	and	CCONJ
ajlm-1255	37	73	reporting	report	VERB
ajlm-1255	37	74	the	the	DET
ajlm-1255	37	75	results	result	NOUN
ajlm-1255	37	76	.	.	PUNCT
ajlm-1255	38	1	the	the	DET
ajlm-1255	38	2	online	online	ADJ
ajlm-1255	38	3	databases	database	NOUN
ajlm-1255	38	4	searched	search	VERB
ajlm-1255	38	5	included	include	VERB
ajlm-1255	38	6	google	google	NOUN
ajlm-1255	38	7	scholar	scholar	NOUN
ajlm-1255	38	8	,	,	PUNCT
ajlm-1255	38	9	medrxiv	medrxiv	NOUN
ajlm-1255	38	10	,	,	PUNCT
ajlm-1255	38	11	biorxiv	biorxiv	PROPN
ajlm-1255	38	12	and	and	CCONJ
ajlm-1255	38	13	pubmed	pubmed	PROPN
ajlm-1255	38	14	,	,	PUNCT
ajlm-1255	38	15	as	as	ADV
ajlm-1255	38	16	well	well	ADV
ajlm-1255	38	17	as	as	ADP
ajlm-1255	38	18	documentary	documentary	ADJ
ajlm-1255	38	19	reports	report	NOUN
ajlm-1255	38	20	and	and	CCONJ
ajlm-1255	38	21	white	white	ADJ
ajlm-1255	38	22	paper	paper	NOUN
ajlm-1255	38	23	publications	publication	NOUN
ajlm-1255	38	24	from	from	ADP
ajlm-1255	38	25	relevant	relevant	ADJ
ajlm-1255	38	26	online	online	ADJ
ajlm-1255	38	27	websites	website	NOUN
ajlm-1255	38	28	including	include	VERB
ajlm-1255	38	29	who	who	PRON
ajlm-1255	38	30	,	,	PUNCT
ajlm-1255	38	31	the	the	DET
ajlm-1255	38	32	united	united	PROPN
ajlm-1255	38	33	states	states	PROPN
ajlm-1255	38	34	centers	center	NOUN
ajlm-1255	38	35	for	for	ADP
ajlm-1255	38	36	disease	disease	NOUN
ajlm-1255	38	37	control	control	NOUN
ajlm-1255	38	38	and	and	CCONJ
ajlm-1255	38	39	prevention	prevention	NOUN
ajlm-1255	38	40	(	(	PUNCT
ajlm-1255	38	41	cdc	cdc	PROPN
ajlm-1255	38	42	)	)	PUNCT
ajlm-1255	38	43	and	and	CCONJ
ajlm-1255	38	44	the	the	DET
ajlm-1255	38	45	nigeria	nigeria	PROPN
ajlm-1255	38	46	centre	centre	PROPN
ajlm-1255	38	47	for	for	ADP
ajlm-1255	38	48	disease	disease	NOUN
ajlm-1255	38	49	control	control	NOUN
ajlm-1255	38	50	(	(	PUNCT
ajlm-1255	38	51	ncdc	ncdc	PROPN
ajlm-1255	38	52	)	)	PUNCT
ajlm-1255	38	53	for	for	ADP
ajlm-1255	38	54	information	information	NOUN
ajlm-1255	38	55	on	on	ADP
ajlm-1255	38	56	new	new	ADJ
ajlm-1255	38	57	rdts	rdts	NOUN
ajlm-1255	38	58	for	for	ADP
ajlm-1255	38	59	covid-19	covid-19	PROPN
ajlm-1255	38	60	published	publish	VERB
ajlm-1255	38	61	up	up	ADP
ajlm-1255	38	62	to	to	ADP
ajlm-1255	38	63	22	22	NUM
ajlm-1255	38	64	april	april	PROPN
ajlm-1255	38	65	2020	2020	NUM
ajlm-1255	38	66	.	.	PUNCT
ajlm-1255	39	1	the	the	DET
ajlm-1255	39	2	search	search	NOUN
ajlm-1255	39	3	terms	term	NOUN
ajlm-1255	39	4	used	use	VERB
ajlm-1255	39	5	include	include	VERB
ajlm-1255	39	6	‘	'	PUNCT
ajlm-1255	39	7	sars	sar	NOUN
ajlm-1255	39	8	-	-	PUNCT
ajlm-1255	39	9	cov-2	cov-2	NOUN
ajlm-1255	39	10	and	and	CCONJ
ajlm-1255	39	11	testing	testing	NOUN
ajlm-1255	39	12	’	'	PUNCT
ajlm-1255	39	13	,	,	PUNCT
ajlm-1255	39	14	‘	'	PUNCT
ajlm-1255	39	15	covid-19	covid-19	PROPN
ajlm-1255	39	16	and	and	CCONJ
ajlm-1255	39	17	rapid	rapid	ADJ
ajlm-1255	39	18	test	test	NOUN
ajlm-1255	39	19	’	'	PUNCT
ajlm-1255	39	20	and	and	CCONJ
ajlm-1255	39	21	‘	'	PUNCT
ajlm-1255	39	22	covid-19	covid-19	PROPN
ajlm-1255	39	23	and	and	CCONJ
ajlm-1255	39	24	diagnostic	diagnostic	ADJ
ajlm-1255	39	25	kits	kit	NOUN
ajlm-1255	39	26	’	'	PUNCT
ajlm-1255	39	27	.	.	PUNCT
ajlm-1255	40	1	diagnostic	diagnostic	ADJ
ajlm-1255	40	2	kits	kit	NOUN
ajlm-1255	40	3	published	publish	VERB
ajlm-1255	40	4	for	for	ADP
ajlm-1255	40	5	the	the	DET
ajlm-1255	40	6	confirmation	confirmation	NOUN
ajlm-1255	40	7	of	of	ADP
ajlm-1255	40	8	other	other	ADJ
ajlm-1255	40	9	coronaviruses	coronaviruse	NOUN
ajlm-1255	40	10	,	,	PUNCT
ajlm-1255	40	11	such	such	ADJ
ajlm-1255	40	12	as	as	ADP
ajlm-1255	40	13	the	the	DET
ajlm-1255	40	14	coronavirus	coronavirus	NOUN
ajlm-1255	40	15	associated	associate	VERB
ajlm-1255	40	16	with	with	ADP
ajlm-1255	40	17	the	the	DET
ajlm-1255	40	18	2003	2003	NUM
ajlm-1255	40	19	sars	sar	NOUN
ajlm-1255	40	20	outbreak	outbreak	NOUN
ajlm-1255	40	21	in	in	ADP
ajlm-1255	40	22	asia	asia	PROPN
ajlm-1255	40	23	and	and	CCONJ
ajlm-1255	40	24	middle	middle	PROPN
ajlm-1255	40	25	east	east	PROPN
ajlm-1255	40	26	respiratory	respiratory	ADJ
ajlm-1255	40	27	syndrome	syndrome	NOUN
ajlm-1255	40	28	-	-	PUNCT
ajlm-1255	40	29	coronavirus	coronavirus	NOUN
ajlm-1255	40	30	,	,	PUNCT
ajlm-1255	40	31	were	be	AUX
ajlm-1255	40	32	excluded	exclude	VERB
ajlm-1255	40	33	.	.	PUNCT
ajlm-1255	41	1	all	all	DET
ajlm-1255	41	2	the	the	DET
ajlm-1255	41	3	members	member	NOUN
ajlm-1255	41	4	of	of	ADP
ajlm-1255	41	5	the	the	DET
ajlm-1255	41	6	review	review	NOUN
ajlm-1255	41	7	teams	team	NOUN
ajlm-1255	41	8	were	be	AUX
ajlm-1255	41	9	involved	involve	VERB
ajlm-1255	41	10	in	in	ADP
ajlm-1255	41	11	paper	paper	NOUN
ajlm-1255	41	12	search	search	NOUN
ajlm-1255	41	13	and	and	CCONJ
ajlm-1255	41	14	selection	selection	NOUN
ajlm-1255	41	15	and	and	CCONJ
ajlm-1255	41	16	a	a	DET
ajlm-1255	41	17	consensus	consensus	NOUN
ajlm-1255	41	18	was	be	AUX
ajlm-1255	41	19	reached	reach	VERB
ajlm-1255	41	20	through	through	ADP
ajlm-1255	41	21	peer	peer	NOUN
ajlm-1255	41	22	review	review	NOUN
ajlm-1255	41	23	.	.	PUNCT
ajlm-1255	42	1	duplicated	duplicate	VERB
ajlm-1255	42	2	publications	publication	NOUN
ajlm-1255	42	3	and	and	CCONJ
ajlm-1255	42	4	those	those	PRON
ajlm-1255	42	5	with	with	ADP
ajlm-1255	42	6	insufficient	insufficient	ADJ
ajlm-1255	42	7	information	information	NOUN
ajlm-1255	42	8	were	be	AUX
ajlm-1255	42	9	removed	remove	VERB
ajlm-1255	42	10	.	.	PUNCT
ajlm-1255	43	1	the	the	DET
ajlm-1255	43	2	extracted	extract	VERB
ajlm-1255	43	3	data	datum	NOUN
ajlm-1255	43	4	included	include	VERB
ajlm-1255	43	5	the	the	DET
ajlm-1255	43	6	name	name	NOUN
ajlm-1255	43	7	of	of	ADP
ajlm-1255	43	8	the	the	DET
ajlm-1255	43	9	diagnostic	diagnostic	ADJ
ajlm-1255	43	10	kit	kit	NOUN
ajlm-1255	43	11	,	,	PUNCT
ajlm-1255	43	12	manufacturer	manufacturer	NOUN
ajlm-1255	43	13	,	,	PUNCT
ajlm-1255	43	14	test	test	NOUN
ajlm-1255	43	15	performance	performance	NOUN
ajlm-1255	43	16	based	base	VERB
ajlm-1255	43	17	on	on	ADP
ajlm-1255	43	18	sensitivity	sensitivity	NOUN
ajlm-1255	43	19	,	,	PUNCT
ajlm-1255	43	20	specificity	specificity	NOUN
ajlm-1255	43	21	,	,	PUNCT
ajlm-1255	43	22	predictive	predictive	ADJ
ajlm-1255	43	23	positive	positive	ADJ
ajlm-1255	43	24	and	and	CCONJ
ajlm-1255	43	25	negative	negative	ADJ
ajlm-1255	43	26	values	value	NOUN
ajlm-1255	43	27	,	,	PUNCT
ajlm-1255	43	28	test	test	NOUN
ajlm-1255	43	29	principles	principle	NOUN
ajlm-1255	43	30	and	and	CCONJ
ajlm-1255	43	31	special	special	ADJ
ajlm-1255	43	32	characteristics	characteristic	NOUN
ajlm-1255	43	33	and	and	CCONJ
ajlm-1255	43	34	testing	testing	NOUN
ajlm-1255	43	35	time	time	NOUN
ajlm-1255	43	36	.	.	PUNCT
ajlm-1255	44	1	the	the	DET
ajlm-1255	44	2	data	datum	NOUN
ajlm-1255	44	3	were	be	AUX
ajlm-1255	44	4	entered	enter	VERB
ajlm-1255	44	5	into	into	ADP
ajlm-1255	44	6	excel	excel	PROPN
ajlm-1255	44	7	(	(	PUNCT
ajlm-1255	44	8	microsoft	microsoft	PROPN
ajlm-1255	44	9	,	,	PUNCT
ajlm-1255	44	10	redmond	redmond	PROPN
ajlm-1255	44	11	,	,	PUNCT
ajlm-1255	44	12	washington	washington	PROPN
ajlm-1255	44	13	,	,	PUNCT
ajlm-1255	44	14	united	united	PROPN
ajlm-1255	44	15	states	states	PROPN
ajlm-1255	44	16	)	)	PUNCT
ajlm-1255	44	17	and	and	CCONJ
ajlm-1255	44	18	exported	export	VERB
ajlm-1255	44	19	to	to	ADP
ajlm-1255	44	20	statistical	statistical	ADJ
ajlm-1255	44	21	product	product	NOUN
ajlm-1255	44	22	and	and	CCONJ
ajlm-1255	44	23	service	service	NOUN
ajlm-1255	44	24	solution	solution	NOUN
ajlm-1255	44	25	version	version	NOUN
ajlm-1255	44	26	23	23	NUM
ajlm-1255	44	27	(	(	PUNCT
ajlm-1255	44	28	ibm	ibm	PROPN
ajlm-1255	44	29	spss	spss	PROPN
ajlm-1255	44	30	inc	inc	PROPN
ajlm-1255	44	31	.	.	PROPN
ajlm-1255	44	32	,	,	PUNCT
ajlm-1255	44	33	chicago	chicago	PROPN
ajlm-1255	44	34	,	,	PUNCT
ajlm-1255	44	35	illinois	illinois	PROPN
ajlm-1255	44	36	,	,	PUNCT
ajlm-1255	44	37	united	united	PROPN
ajlm-1255	44	38	states	states	PROPN
ajlm-1255	44	39	)	)	PUNCT
ajlm-1255	44	40	for	for	ADP
ajlm-1255	44	41	cleaning	cleaning	NOUN
ajlm-1255	44	42	and	and	CCONJ
ajlm-1255	44	43	analysis	analysis	NOUN
ajlm-1255	44	44	.	.	PUNCT
ajlm-1255	45	1	review	review	NOUN
ajlm-1255	45	2	findings	finding	NOUN
ajlm-1255	45	3	overall	overall	ADV
ajlm-1255	45	4	,	,	PUNCT
ajlm-1255	45	5	28	28	NUM
ajlm-1255	45	6	publications	publication	NOUN
ajlm-1255	45	7	on	on	ADP
ajlm-1255	45	8	coronavirus	coronavirus	NOUN
ajlm-1255	45	9	-	-	PUNCT
ajlm-1255	45	10	based	base	VERB
ajlm-1255	45	11	diagnostic	diagnostic	ADJ
ajlm-1255	45	12	kits	kit	NOUN
ajlm-1255	45	13	that	that	PRON
ajlm-1255	45	14	matched	match	VERB
ajlm-1255	45	15	the	the	DET
ajlm-1255	45	16	goal	goal	NOUN
ajlm-1255	45	17	of	of	ADP
ajlm-1255	45	18	this	this	DET
ajlm-1255	45	19	publication	publication	NOUN
ajlm-1255	45	20	were	be	AUX
ajlm-1255	45	21	included	include	VERB
ajlm-1255	45	22	in	in	ADP
ajlm-1255	45	23	this	this	DET
ajlm-1255	45	24	study	study	NOUN
ajlm-1255	45	25	(	(	PUNCT
ajlm-1255	45	26	figure	figure	NOUN
ajlm-1255	45	27	2	2	NUM
ajlm-1255	45	28	)	)	PUNCT
ajlm-1255	45	29	.	.	PUNCT
ajlm-1255	46	1	articles	article	NOUN
ajlm-1255	46	2	were	be	AUX
ajlm-1255	46	3	excluded	exclude	VERB
ajlm-1255	46	4	based	base	VERB
ajlm-1255	46	5	on	on	ADP
ajlm-1255	46	6	duplication	duplication	NOUN
ajlm-1255	46	7	and	and	CCONJ
ajlm-1255	46	8	lack	lack	NOUN
ajlm-1255	46	9	of	of	ADP
ajlm-1255	46	10	information	information	NOUN
ajlm-1255	46	11	on	on	ADP
ajlm-1255	46	12	detection	detection	NOUN
ajlm-1255	46	13	principle	principle	NOUN
ajlm-1255	46	14	,	,	PUNCT
ajlm-1255	46	15	type	type	NOUN
ajlm-1255	46	16	of	of	ADP
ajlm-1255	46	17	kit	kit	NOUN
ajlm-1255	46	18	,	,	PUNCT
ajlm-1255	46	19	performance	performance	NOUN
ajlm-1255	46	20	characteristics	characteristic	NOUN
ajlm-1255	46	21	and	and	CCONJ
ajlm-1255	46	22	manufacturers	manufacturer	NOUN
ajlm-1255	46	23	’	’	PART
ajlm-1255	46	24	details	detail	NOUN
ajlm-1255	46	25	.	.	PUNCT
ajlm-1255	47	1	all	all	DET
ajlm-1255	47	2	eligible	eligible	ADJ
ajlm-1255	47	3	publications	publication	NOUN
ajlm-1255	47	4	on	on	ADP
ajlm-1255	47	5	covid-19	covid-19	PROPN
ajlm-1255	47	6	diagnostic	diagnostic	ADJ
ajlm-1255	47	7	kits	kit	NOUN
ajlm-1255	47	8	by	by	ADP
ajlm-1255	47	9	country	country	NOUN
ajlm-1255	47	10	and	and	CCONJ
ajlm-1255	47	11	performance	performance	NOUN
ajlm-1255	47	12	as	as	ADP
ajlm-1255	47	13	of	of	ADP
ajlm-1255	47	14	22	22	NUM
ajlm-1255	47	15	april	april	PROPN
ajlm-1255	47	16	2020	2020	NUM
ajlm-1255	47	17	were	be	AUX
ajlm-1255	47	18	summarised	summarise	VERB
ajlm-1255	47	19	in	in	ADP
ajlm-1255	47	20	numbers	number	NOUN
ajlm-1255	47	21	and	and	CCONJ
ajlm-1255	47	22	percentages	percentage	NOUN
ajlm-1255	47	23	using	use	VERB
ajlm-1255	47	24	descriptive	descriptive	ADJ
ajlm-1255	47	25	analysis	analysis	NOUN
ajlm-1255	47	26	.	.	PUNCT
ajlm-1255	48	1	on	on	ADP
ajlm-1255	48	2	the	the	DET
ajlm-1255	48	3	whole	whole	NOUN
ajlm-1255	48	4	,	,	PUNCT
ajlm-1255	48	5	a	a	DET
ajlm-1255	48	6	total	total	NOUN
ajlm-1255	48	7	of	of	ADP
ajlm-1255	48	8	18	18	NUM
ajlm-1255	48	9	serological	serological	ADJ
ajlm-1255	48	10	rdt	rdt	PROPN
ajlm-1255	48	11	kits	kit	NOUN
ajlm-1255	48	12	were	be	AUX
ajlm-1255	48	13	included	include	VERB
ajlm-1255	48	14	for	for	ADP
ajlm-1255	48	15	analysis	analysis	NOUN
ajlm-1255	48	16	.	.	PUNCT
ajlm-1255	49	1	of	of	ADP
ajlm-1255	49	2	these	these	PRON
ajlm-1255	49	3	,	,	PUNCT
ajlm-1255	49	4	four	four	NUM
ajlm-1255	49	5	were	be	AUX
ajlm-1255	49	6	antigen	antigen	ADV
ajlm-1255	49	7	rdts	rdts	ADJ
ajlm-1255	49	8	(	(	PUNCT
ajlm-1255	49	9	22.2	22.2	NUM
ajlm-1255	49	10	%	%	NOUN
ajlm-1255	49	11	)	)	PUNCT
ajlm-1255	49	12	,	,	PUNCT
ajlm-1255	49	13	nine	nine	NUM
ajlm-1255	49	14	were	be	AUX
ajlm-1255	49	15	total	total	ADJ
ajlm-1255	49	16	immunoglobulin	immunoglobulin	NOUN
ajlm-1255	49	17	rdts	rdts	NOUN
ajlm-1255	49	18	(	(	PUNCT
ajlm-1255	49	19	50	50	NUM
ajlm-1255	49	20	%	%	NOUN
ajlm-1255	49	21	)	)	PUNCT
ajlm-1255	49	22	and	and	CCONJ
ajlm-1255	49	23	five	five	NUM
ajlm-1255	49	24	were	be	AUX
ajlm-1255	49	25	igm	igm	PROPN
ajlm-1255	49	26	/	/	SYM
ajlm-1255	49	27	igg	igg	PROPN
ajlm-1255	49	28	serological	serological	ADJ
ajlm-1255	49	29	rdts	rdts	NOUN
ajlm-1255	49	30	(	(	PUNCT
ajlm-1255	49	31	27.8	27.8	NUM
ajlm-1255	49	32	%	%	NOUN
ajlm-1255	49	33	)	)	PUNCT
ajlm-1255	49	34	(	(	PUNCT
ajlm-1255	49	35	figure	figure	NOUN
ajlm-1255	49	36	3	3	NUM
ajlm-1255	49	37	)	)	PUNCT
ajlm-1255	49	38	.	.	PUNCT
ajlm-1255	50	1	these	these	DET
ajlm-1255	50	2	kits	kit	NOUN
ajlm-1255	50	3	were	be	AUX
ajlm-1255	50	4	produced	produce	VERB
ajlm-1255	50	5	in	in	ADP
ajlm-1255	50	6	eight	eight	NUM
ajlm-1255	50	7	countries	country	NOUN
ajlm-1255	50	8	,	,	PUNCT
ajlm-1255	50	9	namely	namely	ADV
ajlm-1255	50	10	china	china	PROPN
ajlm-1255	50	11	(	(	PUNCT
ajlm-1255	50	12	6	6	NUM
ajlm-1255	50	13	;	;	PUNCT
ajlm-1255	50	14	33.33	33.33	NUM
ajlm-1255	50	15	%	%	NOUN
ajlm-1255	50	16	)	)	PUNCT
ajlm-1255	50	17	,	,	PUNCT
ajlm-1255	50	18	the	the	DET
ajlm-1255	50	19	united	united	PROPN
ajlm-1255	50	20	states	states	PROPN
ajlm-1255	50	21	(	(	PUNCT
ajlm-1255	50	22	4	4	NUM
ajlm-1255	50	23	;	;	PUNCT
ajlm-1255	50	24	22.22	22.22	NUM
ajlm-1255	50	25	%	%	NOUN
ajlm-1255	50	26	)	)	PUNCT
ajlm-1255	50	27	,	,	PUNCT
ajlm-1255	50	28	germany	germany	PROPN
ajlm-1255	50	29	(	(	PUNCT
ajlm-1255	50	30	2	2	NUM
ajlm-1255	50	31	;	;	PUNCT
ajlm-1255	50	32	11.11	11.11	NUM
ajlm-1255	50	33	%	%	NOUN
ajlm-1255	50	34	)	)	PUNCT
ajlm-1255	50	35	,	,	PUNCT
ajlm-1255	50	36	singapore	singapore	PROPN
ajlm-1255	50	37	(	(	PUNCT
ajlm-1255	50	38	2	2	NUM
ajlm-1255	50	39	;	;	PUNCT
ajlm-1255	50	40	11.11	11.11	NUM
ajlm-1255	50	41	%	%	NOUN
ajlm-1255	50	42	)	)	PUNCT
ajlm-1255	50	43	and	and	CCONJ
ajlm-1255	50	44	kenya	kenya	PROPN
ajlm-1255	50	45	,	,	PUNCT
ajlm-1255	50	46	canada	canada	PROPN
ajlm-1255	50	47	,	,	PUNCT
ajlm-1255	50	48	korea	korea	PROPN
ajlm-1255	50	49	and	and	CCONJ
ajlm-1255	50	50	belgium	belgium	PROPN
ajlm-1255	50	51	(	(	PUNCT
ajlm-1255	50	52	1	1	NUM
ajlm-1255	50	53	each	each	DET
ajlm-1255	50	54	;	;	PUNCT
ajlm-1255	50	55	6.56	6.56	NUM
ajlm-1255	50	56	%	%	NOUN
ajlm-1255	50	57	)	)	PUNCT
ajlm-1255	50	58	(	(	PUNCT
ajlm-1255	50	59	table	table	NOUN
ajlm-1255	50	60	1	1	NUM
ajlm-1255	50	61	)	)	PUNCT
ajlm-1255	50	62	.	.	PUNCT
ajlm-1255	51	1	fourteen	fourteen	NUM
ajlm-1255	51	2	of	of	ADP
ajlm-1255	51	3	the	the	DET
ajlm-1255	51	4	rdt	rdt	PROPN
ajlm-1255	51	5	kits	kit	NOUN
ajlm-1255	51	6	are	be	AUX
ajlm-1255	51	7	antibody	antibody	NOUN
ajlm-1255	51	8	-	-	PUNCT
ajlm-1255	51	9	detection	detection	NOUN
ajlm-1255	51	10	kits	kit	NOUN
ajlm-1255	51	11	for	for	ADP
ajlm-1255	51	12	use	use	NOUN
ajlm-1255	51	13	with	with	ADP
ajlm-1255	51	14	blood	blood	NOUN
ajlm-1255	51	15	,	,	PUNCT
ajlm-1255	51	16	plasma	plasma	NOUN
ajlm-1255	51	17	or	or	CCONJ
ajlm-1255	51	18	serum	serum	NOUN
ajlm-1255	51	19	(	(	PUNCT
ajlm-1255	51	20	77.8	77.8	NUM
ajlm-1255	51	21	%	%	NOUN
ajlm-1255	51	22	)	)	PUNCT
ajlm-1255	51	23	,	,	PUNCT
ajlm-1255	51	24	and	and	CCONJ
ajlm-1255	51	25	four	four	NUM
ajlm-1255	51	26	were	be	AUX
ajlm-1255	51	27	antigen	antigen	NOUN
ajlm-1255	51	28	-	-	PUNCT
ajlm-1255	51	29	detection	detection	NOUN
ajlm-1255	51	30	kits	kit	NOUN
ajlm-1255	51	31	for	for	ADP
ajlm-1255	51	32	use	use	NOUN
ajlm-1255	51	33	with	with	ADP
ajlm-1255	51	34	swab	swab	NOUN
ajlm-1255	51	35	,	,	PUNCT
ajlm-1255	51	36	sputum	sputum	NOUN
ajlm-1255	51	37	or	or	CCONJ
ajlm-1255	51	38	blood	blood	NOUN
ajlm-1255	51	39	(	(	PUNCT
ajlm-1255	51	40	22.2	22.2	NUM
ajlm-1255	51	41	%	%	NOUN
ajlm-1255	51	42	)	)	PUNCT
ajlm-1255	51	43	.	.	PUNCT
ajlm-1255	52	1	the	the	DET
ajlm-1255	52	2	majority	majority	NOUN
ajlm-1255	52	3	of	of	ADP
ajlm-1255	52	4	these	these	DET
ajlm-1255	52	5	kits	kit	NOUN
ajlm-1255	52	6	(	(	PUNCT
ajlm-1255	52	7	13	13	NUM
ajlm-1255	52	8	;	;	PUNCT
ajlm-1255	52	9	72.22	72.22	NUM
ajlm-1255	52	10	%	%	NOUN
ajlm-1255	52	11	)	)	PUNCT
ajlm-1255	52	12	use	use	VERB
ajlm-1255	52	13	lateral	lateral	ADJ
ajlm-1255	52	14	flow	flow	NOUN
ajlm-1255	52	15	membrane	membrane	NOUN
ajlm-1255	52	16	technology	technology	NOUN
ajlm-1255	52	17	,	,	PUNCT
ajlm-1255	52	18	whereas	whereas	SCONJ
ajlm-1255	52	19	the	the	DET
ajlm-1255	52	20	remaining	remain	VERB
ajlm-1255	52	21	five	five	NUM
ajlm-1255	52	22	(	(	PUNCT
ajlm-1255	52	23	27.78	27.78	NUM
ajlm-1255	52	24	%	%	NOUN
ajlm-1255	52	25	)	)	PUNCT
ajlm-1255	52	26	use	use	NOUN
ajlm-1255	52	27	colloidal	colloidal	NOUN
ajlm-1255	52	28	gold	gold	NOUN
ajlm-1255	52	29	(	(	PUNCT
ajlm-1255	52	30	figure	figure	NOUN
ajlm-1255	52	31	4	4	NUM
ajlm-1255	52	32	)	)	PUNCT
ajlm-1255	52	33	.	.	PUNCT
ajlm-1255	53	1	figure	figure	VERB
ajlm-1255	53	2	2	2	NUM
ajlm-1255	53	3	:	:	PUNCT
ajlm-1255	53	4	prisma	prisma	PROPN
ajlm-1255	53	5	flow	flow	NOUN
ajlm-1255	53	6	diagram	diagram	NOUN
ajlm-1255	53	7	showing	show	VERB
ajlm-1255	53	8	the	the	DET
ajlm-1255	53	9	scoping	scoping	NOUN
ajlm-1255	53	10	review	review	NOUN
ajlm-1255	53	11	process	process	NOUN
ajlm-1255	53	12	.	.	PUNCT
ajlm-1255	54	1	figure	figure	VERB
ajlm-1255	54	2	3	3	NUM
ajlm-1255	54	3	:	:	PUNCT
ajlm-1255	54	4	distribution	distribution	NOUN
ajlm-1255	54	5	of	of	ADP
ajlm-1255	54	6	the	the	DET
ajlm-1255	54	7	serological	serological	ADJ
ajlm-1255	54	8	rapid	rapid	ADJ
ajlm-1255	54	9	diagnostic	diagnostic	ADJ
ajlm-1255	54	10	tests	test	NOUN
ajlm-1255	54	11	by	by	ADP
ajlm-1255	54	12	testing	test	VERB
ajlm-1255	54	13	principle	principle	NOUN
ajlm-1255	54	14	.	.	PUNCT
ajlm-1255	55	1	figure	figure	VERB
ajlm-1255	55	2	4	4	NUM
ajlm-1255	55	3	:	:	PUNCT
ajlm-1255	55	4	distribution	distribution	NOUN
ajlm-1255	55	5	of	of	ADP
ajlm-1255	55	6	the	the	DET
ajlm-1255	55	7	serological	serological	ADJ
ajlm-1255	55	8	rapid	rapid	ADJ
ajlm-1255	55	9	diagnostic	diagnostic	ADJ
ajlm-1255	55	10	tests	test	NOUN
ajlm-1255	55	11	by	by	ADP
ajlm-1255	55	12	testing	test	VERB
ajlm-1255	55	13	platform	platform	NOUN
ajlm-1255	55	14	.	.	PUNCT
ajlm-1255	56	1	table	table	NOUN
ajlm-1255	56	2	1	1	NUM
ajlm-1255	56	3	:	:	PUNCT
ajlm-1255	56	4	 	 	SPACE
ajlm-1255	56	5	performance	performance	NOUN
ajlm-1255	56	6	characteristics	characteristic	NOUN
ajlm-1255	56	7	of	of	ADP
ajlm-1255	56	8	newly	newly	ADV
ajlm-1255	56	9	developed	develop	VERB
ajlm-1255	56	10	severe	severe	ADJ
ajlm-1255	56	11	acute	acute	ADJ
ajlm-1255	56	12	respiratory	respiratory	ADJ
ajlm-1255	56	13	syndrome	syndrome	NOUN
ajlm-1255	56	14	coronavirus	coronavirus	NOUN
ajlm-1255	56	15	rapid	rapid	ADJ
ajlm-1255	56	16	diagnostic	diagnostic	ADJ
ajlm-1255	56	17	kits	kit	NOUN
ajlm-1255	56	18	analysed	analyse	VERB
ajlm-1255	56	19	in	in	ADP
ajlm-1255	56	20	this	this	DET
ajlm-1255	56	21	review	review	NOUN
ajlm-1255	56	22	,	,	PUNCT
ajlm-1255	56	23	22	22	NUM
ajlm-1255	56	24	april	april	PROPN
ajlm-1255	56	25	2020	2020	NUM
ajlm-1255	56	26	.	.	PUNCT
ajlm-1255	57	1	in	in	ADP
ajlm-1255	57	2	general	general	ADJ
ajlm-1255	57	3	,	,	PUNCT
ajlm-1255	57	4	the	the	DET
ajlm-1255	57	5	sensitivity	sensitivity	NOUN
ajlm-1255	57	6	of	of	ADP
ajlm-1255	57	7	the	the	DET
ajlm-1255	57	8	test	test	NOUN
ajlm-1255	57	9	kits	kit	NOUN
ajlm-1255	57	10	irrespective	irrespective	ADV
ajlm-1255	57	11	of	of	ADP
ajlm-1255	57	12	sample	sample	NOUN
ajlm-1255	57	13	specification	specification	NOUN
ajlm-1255	57	14	ranged	range	VERB
ajlm-1255	57	15	from	from	ADP
ajlm-1255	57	16	18.4	18.4	NUM
ajlm-1255	57	17	%	%	NOUN
ajlm-1255	57	18	to	to	PART
ajlm-1255	57	19	100	100	NUM
ajlm-1255	57	20	%	%	NOUN
ajlm-1255	57	21	and	and	CCONJ
ajlm-1255	57	22	their	their	PRON
ajlm-1255	57	23	specificity	specificity	NOUN
ajlm-1255	57	24	ranged	range	VERB
ajlm-1255	57	25	from	from	ADP
ajlm-1255	57	26	90.6	90.6	NUM
ajlm-1255	57	27	%	%	NOUN
ajlm-1255	57	28	to	to	PART
ajlm-1255	57	29	100	100	NUM
ajlm-1255	57	30	%	%	NOUN
ajlm-1255	57	31	.	.	PUNCT
ajlm-1255	58	1	the	the	DET
ajlm-1255	58	2	pooled	pooled	ADJ
ajlm-1255	58	3	analysis	analysis	NOUN
ajlm-1255	58	4	revealed	reveal	VERB
ajlm-1255	58	5	an	an	DET
ajlm-1255	58	6	average	average	ADJ
ajlm-1255	58	7	(	(	PUNCT
ajlm-1255	58	8	range	range	NOUN
ajlm-1255	58	9	)	)	PUNCT
ajlm-1255	58	10	sensitivity	sensitivity	NOUN
ajlm-1255	58	11	of	of	ADP
ajlm-1255	58	12	81.6	81.6	NUM
ajlm-1255	58	13	%	%	NOUN
ajlm-1255	58	14	(	(	PUNCT
ajlm-1255	58	15	72.9	72.9	NUM
ajlm-1255	58	16	%	%	NOUN
ajlm-1255	58	17	–	–	PUNCT
ajlm-1255	58	18	88	88	NUM
ajlm-1255	58	19	%	%	NOUN
ajlm-1255	58	20	)	)	PUNCT
ajlm-1255	58	21	and	and	CCONJ
ajlm-1255	58	22	specificity	specificity	NOUN
ajlm-1255	58	23	of	of	ADP
ajlm-1255	58	24	94.4	94.4	NUM
ajlm-1255	58	25	%	%	NOUN
ajlm-1255	58	26	(	(	PUNCT
ajlm-1255	58	27	88.2	88.2	NUM
ajlm-1255	58	28	%	%	NOUN
ajlm-1255	58	29	–	–	PUNCT
ajlm-1255	58	30	97.5	97.5	NUM
ajlm-1255	58	31	%	%	NOUN
ajlm-1255	58	32	)	)	PUNCT
ajlm-1255	58	33	.	.	PUNCT
ajlm-1255	59	1	the	the	DET
ajlm-1255	59	2	sensitivity	sensitivity	NOUN
ajlm-1255	59	3	and	and	CCONJ
ajlm-1255	59	4	specificity	specificity	NOUN
ajlm-1255	59	5	of	of	ADP
ajlm-1255	59	6	lateral	lateral	ADJ
ajlm-1255	59	7	flow	flow	NOUN
ajlm-1255	59	8	immunoassay	immunoassay	ADJ
ajlm-1255	59	9	membrane	membrane	NOUN
ajlm-1255	59	10	type	type	NOUN
ajlm-1255	59	11	rdt	rdt	PROPN
ajlm-1255	59	12	kits	kit	NOUN
ajlm-1255	59	13	were	be	AUX
ajlm-1255	59	14	in	in	ADP
ajlm-1255	59	15	the	the	DET
ajlm-1255	59	16	range	range	NOUN
ajlm-1255	59	17	(	(	PUNCT
ajlm-1255	59	18	average	average	ADJ
ajlm-1255	59	19	)	)	PUNCT
ajlm-1255	59	20	of	of	ADP
ajlm-1255	59	21	84.4	84.4	NUM
ajlm-1255	59	22	%	%	NOUN
ajlm-1255	59	23	–	–	PUNCT
ajlm-1255	59	24	100	100	NUM
ajlm-1255	59	25	%	%	NOUN
ajlm-1255	59	26	(	(	PUNCT
ajlm-1255	59	27	92.7	92.7	NUM
ajlm-1255	59	28	%	%	NOUN
ajlm-1255	59	29	)	)	PUNCT
ajlm-1255	59	30	and	and	CCONJ
ajlm-1255	59	31	90.6	90.6	NUM
ajlm-1255	59	32	%	%	NOUN
ajlm-1255	59	33	–	–	PUNCT
ajlm-1255	59	34	100	100	NUM
ajlm-1255	59	35	%	%	NOUN
ajlm-1255	59	36	(	(	PUNCT
ajlm-1255	59	37	96	96	NUM
ajlm-1255	59	38	%	%	NOUN
ajlm-1255	59	39	)	)	PUNCT
ajlm-1255	59	40	,	,	PUNCT
ajlm-1255	59	41	respectively	respectively	ADV
ajlm-1255	59	42	,	,	PUNCT
ajlm-1255	59	43	and	and	CCONJ
ajlm-1255	59	44	that	that	PRON
ajlm-1255	59	45	of	of	ADP
ajlm-1255	59	46	lateral	lateral	ADJ
ajlm-1255	59	47	flow	flow	NOUN
ajlm-1255	59	48	immunoassay	immunoassay	ADJ
ajlm-1255	59	49	colloidal	colloidal	NOUN
ajlm-1255	59	50	gold	gold	NOUN
ajlm-1255	59	51	type	type	NOUN
ajlm-1255	59	52	were	be	AUX
ajlm-1255	59	53	18.4	18.4	NUM
ajlm-1255	59	54	–	–	PUNCT
ajlm-1255	59	55	99.1	99.1	NUM
ajlm-1255	59	56	%	%	NOUN
ajlm-1255	59	57	(	(	PUNCT
ajlm-1255	59	58	67.7	67.7	NUM
ajlm-1255	59	59	%	%	NOUN
ajlm-1255	59	60	)	)	PUNCT
ajlm-1255	59	61	and	and	CCONJ
ajlm-1255	59	62	91.7	91.7	NUM
ajlm-1255	59	63	%	%	NOUN
ajlm-1255	59	64	–	–	PUNCT
ajlm-1255	59	65	100	100	NUM
ajlm-1255	59	66	%	%	NOUN
ajlm-1255	59	67	(	(	PUNCT
ajlm-1255	59	68	98.3	98.3	NUM
ajlm-1255	59	69	%	%	NOUN
ajlm-1255	59	70	)	)	PUNCT
ajlm-1255	59	71	,	,	PUNCT
ajlm-1255	59	72	respectively	respectively	ADV
ajlm-1255	59	73	(	(	PUNCT
ajlm-1255	59	74	figure	figure	NOUN
ajlm-1255	59	75	4	4	NUM
ajlm-1255	59	76	)	)	PUNCT
ajlm-1255	59	77	.	.	PUNCT
ajlm-1255	60	1	three	three	NUM
ajlm-1255	60	2	of	of	ADP
ajlm-1255	60	3	these	these	DET
ajlm-1255	60	4	kits	kit	NOUN
ajlm-1255	60	5	,	,	PUNCT
ajlm-1255	60	6	namely	namely	ADV
ajlm-1255	60	7	bodysphere	bodysphere	VERB
ajlm-1255	60	8	rapid	rapid	ADJ
ajlm-1255	60	9	test	test	NOUN
ajlm-1255	60	10	(	(	PUNCT
ajlm-1255	60	11	los	los	PROPN
ajlm-1255	60	12	angeles	angeles	PROPN
ajlm-1255	60	13	,	,	PUNCT
ajlm-1255	60	14	california	california	PROPN
ajlm-1255	60	15	,	,	PUNCT
ajlm-1255	60	16	united	united	PROPN
ajlm-1255	60	17	states	states	PROPN
ajlm-1255	60	18	)	)	PUNCT
ajlm-1255	60	19	,	,	PUNCT
ajlm-1255	60	20	thermogenesis	thermogenesis	NOUN
ajlm-1255	60	21	rapid	rapid	ADJ
ajlm-1255	60	22	covid-19	covid-19	PROPN
ajlm-1255	60	23	test	test	NOUN
ajlm-1255	60	24	kit	kit	NOUN
ajlm-1255	60	25	(	(	PUNCT
ajlm-1255	60	26	rancho	rancho	PROPN
ajlm-1255	60	27	cordova	cordova	PROPN
ajlm-1255	60	28	,	,	PUNCT
ajlm-1255	60	29	california	california	PROPN
ajlm-1255	60	30	,	,	PUNCT
ajlm-1255	60	31	united	united	PROPN
ajlm-1255	60	32	states	states	PROPN
ajlm-1255	60	33	)	)	PUNCT
ajlm-1255	60	34	and	and	CCONJ
ajlm-1255	60	35	nadal	nadal	ADJ
ajlm-1255	60	36	®	®	NOUN
ajlm-1255	60	37	covid-19	covid-19	PROPN
ajlm-1255	60	38	test	test	NOUN
ajlm-1255	60	39	kit	kit	NOUN
ajlm-1255	60	40	(	(	PUNCT
ajlm-1255	60	41	regensburg	regensburg	PROPN
ajlm-1255	60	42	,	,	PUNCT
ajlm-1255	60	43	germany	germany	PROPN
ajlm-1255	60	44	)	)	PUNCT
ajlm-1255	60	45	,	,	PUNCT
ajlm-1255	60	46	had	have	VERB
ajlm-1255	60	47	a	a	DET
ajlm-1255	60	48	sensitivity	sensitivity	NOUN
ajlm-1255	60	49	of	of	ADP
ajlm-1255	60	50	99	99	NUM
ajlm-1255	60	51	%	%	NOUN
ajlm-1255	60	52	–	–	PUNCT
ajlm-1255	60	53	100	100	NUM
ajlm-1255	60	54	%	%	NOUN
ajlm-1255	60	55	.	.	PUNCT
ajlm-1255	61	1	these	these	DET
ajlm-1255	61	2	three	three	NUM
ajlm-1255	61	3	kits	kit	NOUN
ajlm-1255	61	4	also	also	ADV
ajlm-1255	61	5	had	have	VERB
ajlm-1255	61	6	a	a	DET
ajlm-1255	61	7	specificity	specificity	NOUN
ajlm-1255	61	8	range	range	NOUN
ajlm-1255	61	9	of	of	ADP
ajlm-1255	61	10	91	91	NUM
ajlm-1255	61	11	%	%	NOUN
ajlm-1255	61	12	–	–	PUNCT
ajlm-1255	61	13	100	100	NUM
ajlm-1255	61	14	%	%	NOUN
ajlm-1255	61	15	.	.	PUNCT
ajlm-1255	62	1	asides	aside	VERB
ajlm-1255	62	2	their	their	PRON
ajlm-1255	62	3	better	well	ADJ
ajlm-1255	62	4	sensitivity	sensitivity	NOUN
ajlm-1255	62	5	and	and	CCONJ
ajlm-1255	62	6	specificity	specificity	NOUN
ajlm-1255	62	7	compared	compare	VERB
ajlm-1255	62	8	to	to	ADP
ajlm-1255	62	9	other	other	ADJ
ajlm-1255	62	10	rdts	rdts	ADJ
ajlm-1255	62	11	,	,	PUNCT
ajlm-1255	62	12	these	these	DET
ajlm-1255	62	13	kits	kit	NOUN
ajlm-1255	62	14	are	be	AUX
ajlm-1255	62	15	for	for	ADP
ajlm-1255	62	16	use	use	NOUN
ajlm-1255	62	17	with	with	ADP
ajlm-1255	62	18	blood	blood	NOUN
ajlm-1255	62	19	samples	sample	NOUN
ajlm-1255	62	20	only	only	ADV
ajlm-1255	62	21	,	,	PUNCT
ajlm-1255	62	22	detect	detect	VERB
ajlm-1255	62	23	both	both	DET
ajlm-1255	62	24	igg	igg	PROPN
ajlm-1255	62	25	and	and	CCONJ
ajlm-1255	62	26	igm	igm	PROPN
ajlm-1255	62	27	,	,	PUNCT
ajlm-1255	62	28	and	and	CCONJ
ajlm-1255	62	29	have	have	VERB
ajlm-1255	62	30	shorter	short	ADJ
ajlm-1255	62	31	testing	testing	NOUN
ajlm-1255	62	32	time	time	NOUN
ajlm-1255	62	33	of	of	ADP
ajlm-1255	62	34	2	2	NUM
ajlm-1255	62	35	–	–	SYM
ajlm-1255	62	36	10	10	NUM
ajlm-1255	62	37	min	min	NOUN
ajlm-1255	62	38	.	.	PUNCT
ajlm-1255	63	1	the	the	DET
ajlm-1255	63	2	testing	testing	NOUN
ajlm-1255	63	3	time	time	NOUN
ajlm-1255	63	4	for	for	SCONJ
ajlm-1255	63	5	all	all	DET
ajlm-1255	63	6	the	the	DET
ajlm-1255	63	7	identified	identify	VERB
ajlm-1255	63	8	kits	kit	NOUN
ajlm-1255	63	9	ranged	range	VERB
ajlm-1255	63	10	from	from	ADP
ajlm-1255	63	11	2	2	NUM
ajlm-1255	63	12	to	to	PART
ajlm-1255	63	13	30	30	NUM
ajlm-1255	63	14	min	min	NOUN
ajlm-1255	63	15	with	with	ADP
ajlm-1255	63	16	an	an	DET
ajlm-1255	63	17	average	average	ADJ
ajlm-1255	63	18	testing	testing	NOUN
ajlm-1255	63	19	time	time	NOUN
ajlm-1255	63	20	of	of	ADP
ajlm-1255	63	21	13.5	13.5	NUM
ajlm-1255	63	22	min	min	NOUN
ajlm-1255	63	23	(	(	PUNCT
ajlm-1255	63	24	95	95	NUM
ajlm-1255	63	25	%	%	NOUN
ajlm-1255	63	26	confidence	confidence	NOUN
ajlm-1255	63	27	interval	interval	NOUN
ajlm-1255	63	28	=	=	NOUN
ajlm-1255	63	29	10.8	10.8	NUM
ajlm-1255	63	30	min	min	NOUN
ajlm-1255	63	31	–	–	PUNCT
ajlm-1255	63	32	16.1	16.1	NUM
ajlm-1255	63	33	min	min	NOUN
ajlm-1255	63	34	)	)	PUNCT
ajlm-1255	63	35	.	.	PUNCT
ajlm-1255	64	1	only	only	ADV
ajlm-1255	64	2	two	two	NUM
ajlm-1255	64	3	of	of	ADP
ajlm-1255	64	4	the	the	DET
ajlm-1255	64	5	kits	kit	NOUN
ajlm-1255	64	6	provided	provide	VERB
ajlm-1255	64	7	information	information	NOUN
ajlm-1255	64	8	on	on	ADP
ajlm-1255	64	9	positive	positive	ADJ
ajlm-1255	64	10	predicted	predict	VERB
ajlm-1255	64	11	value	value	NOUN
ajlm-1255	64	12	and	and	CCONJ
ajlm-1255	64	13	negative	negative	ADJ
ajlm-1255	64	14	predictive	predictive	ADJ
ajlm-1255	64	15	value	value	NOUN
ajlm-1255	64	16	(	(	PUNCT
ajlm-1255	64	17	range	range	NOUN
ajlm-1255	64	18	=	=	SYM
ajlm-1255	64	19	87.5	87.5	NUM
ajlm-1255	64	20	%	%	NOUN
ajlm-1255	64	21	–	–	PUNCT
ajlm-1255	64	22	100.0	100.0	NUM
ajlm-1255	64	23	%	%	NOUN
ajlm-1255	64	24	to	to	ADP
ajlm-1255	64	25	26.2	26.2	NUM
ajlm-1255	64	26	%	%	NOUN
ajlm-1255	64	27	–	–	PUNCT
ajlm-1255	64	28	96.2	96.2	NUM
ajlm-1255	64	29	%	%	NOUN
ajlm-1255	64	30	)	)	PUNCT
ajlm-1255	64	31	.	.	PUNCT
ajlm-1255	65	1	out	out	ADP
ajlm-1255	65	2	of	of	ADP
ajlm-1255	65	3	the	the	DET
ajlm-1255	65	4	18	18	NUM
ajlm-1255	65	5	rdts	rdts	NOUN
ajlm-1255	65	6	identified	identify	VERB
ajlm-1255	65	7	,	,	PUNCT
ajlm-1255	65	8	6	6	NUM
ajlm-1255	65	9	(	(	PUNCT
ajlm-1255	65	10	33	33	NUM
ajlm-1255	65	11	%	%	NOUN
ajlm-1255	65	12	)	)	PUNCT
ajlm-1255	65	13	were	be	AUX
ajlm-1255	65	14	not	not	PART
ajlm-1255	65	15	subjected	subject	VERB
ajlm-1255	65	16	to	to	ADP
ajlm-1255	65	17	performance	performance	NOUN
ajlm-1255	65	18	validation	validation	NOUN
ajlm-1255	65	19	by	by	ADP
ajlm-1255	65	20	the	the	DET
ajlm-1255	65	21	manufacturers	manufacturer	NOUN
ajlm-1255	65	22	of	of	ADP
ajlm-1255	65	23	the	the	DET
ajlm-1255	65	24	kits	kit	NOUN
ajlm-1255	65	25	.	.	PUNCT
ajlm-1255	66	1	two	two	NUM
ajlm-1255	66	2	of	of	ADP
ajlm-1255	66	3	four	four	NUM
ajlm-1255	66	4	antigen	antigen	ADJ
ajlm-1255	66	5	detection	detection	NOUN
ajlm-1255	66	6	kits	kit	NOUN
ajlm-1255	66	7	,	,	PUNCT
ajlm-1255	66	8	seven	seven	NUM
ajlm-1255	66	9	of	of	ADP
ajlm-1255	66	10	nine	nine	NUM
ajlm-1255	66	11	total	total	ADJ
ajlm-1255	66	12	immunoglobulin	immunoglobulin	NOUN
ajlm-1255	66	13	and	and	CCONJ
ajlm-1255	66	14	three	three	NUM
ajlm-1255	66	15	of	of	ADP
ajlm-1255	66	16	five	five	NUM
ajlm-1255	66	17	igm	igm	NOUN
ajlm-1255	66	18	+	+	CCONJ
ajlm-1255	66	19	igg	igg	PROPN
ajlm-1255	66	20	serological	serological	ADJ
ajlm-1255	66	21	kits	kit	NOUN
ajlm-1255	66	22	were	be	AUX
ajlm-1255	66	23	validated	validate	VERB
ajlm-1255	66	24	for	for	ADP
ajlm-1255	66	25	sensitivity	sensitivity	NOUN
ajlm-1255	66	26	and	and	CCONJ
ajlm-1255	66	27	specificity	specificity	NOUN
ajlm-1255	66	28	using	use	VERB
ajlm-1255	66	29	rt	rt	PROPN
ajlm-1255	66	30	-	-	PUNCT
ajlm-1255	66	31	pcr	pcr	NOUN
ajlm-1255	66	32	assay	assay	NOUN
ajlm-1255	66	33	as	as	ADP
ajlm-1255	66	34	the	the	DET
ajlm-1255	66	35	reference	reference	NOUN
ajlm-1255	66	36	method	method	NOUN
ajlm-1255	66	37	(	(	PUNCT
ajlm-1255	66	38	table	table	NOUN
ajlm-1255	66	39	1).15	1).15	NOUN
ajlm-1255	66	40	on	on	ADP
ajlm-1255	66	41	the	the	DET
ajlm-1255	66	42	whole	whole	NOUN
ajlm-1255	66	43	,	,	PUNCT
ajlm-1255	66	44	eight	eight	NUM
ajlm-1255	66	45	of	of	ADP
ajlm-1255	66	46	the	the	DET
ajlm-1255	66	47	13	13	NUM
ajlm-1255	66	48	lateral	lateral	ADJ
ajlm-1255	66	49	flow	flow	NOUN
ajlm-1255	66	50	immunoassay	immunoassay	ADJ
ajlm-1255	66	51	membrane	membrane	NOUN
ajlm-1255	66	52	type	type	NOUN
ajlm-1255	66	53	and	and	CCONJ
ajlm-1255	66	54	four	four	NUM
ajlm-1255	66	55	of	of	ADP
ajlm-1255	66	56	the	the	DET
ajlm-1255	66	57	five	five	NUM
ajlm-1255	66	58	lateral	lateral	ADJ
ajlm-1255	66	59	flow	flow	NOUN
ajlm-1255	66	60	immunoassay	immunoassay	ADJ
ajlm-1255	66	61	colloidal	colloidal	NOUN
ajlm-1255	66	62	gold	gold	NOUN
ajlm-1255	66	63	type	type	NOUN
ajlm-1255	66	64	kits	kit	NOUN
ajlm-1255	66	65	were	be	AUX
ajlm-1255	66	66	validated	validate	VERB
ajlm-1255	66	67	.	.	PUNCT
ajlm-1255	67	1	of	of	ADP
ajlm-1255	67	2	the	the	DET
ajlm-1255	67	3	12	12	NUM
ajlm-1255	67	4	serological	serological	ADJ
ajlm-1255	67	5	rdts	rdts	NOUN
ajlm-1255	67	6	validated	validate	VERB
ajlm-1255	67	7	by	by	ADP
ajlm-1255	67	8	rt	rt	PROPN
ajlm-1255	67	9	-	-	PUNCT
ajlm-1255	67	10	pcr	pcr	PROPN
ajlm-1255	67	11	,	,	PUNCT
ajlm-1255	67	12	the	the	DET
ajlm-1255	67	13	igm	igm	PROPN
ajlm-1255	67	14	/	/	SYM
ajlm-1255	67	15	igg	igg	PROPN
ajlm-1255	67	16	duo	duo	PROPN
ajlm-1255	67	17	kit	kit	NOUN
ajlm-1255	67	18	with	with	ADP
ajlm-1255	67	19	non	non	ADJ
ajlm-1255	67	20	-	-	ADJ
ajlm-1255	67	21	colloidal	colloidal	ADJ
ajlm-1255	67	22	gold	gold	NOUN
ajlm-1255	67	23	labelling	labelling	NOUN
ajlm-1255	67	24	system	system	NOUN
ajlm-1255	67	25	was	be	AUX
ajlm-1255	67	26	found	find	VERB
ajlm-1255	67	27	to	to	PART
ajlm-1255	67	28	elicit	elicit	VERB
ajlm-1255	67	29	the	the	DET
ajlm-1255	67	30	highest	high	ADJ
ajlm-1255	67	31	and	and	CCONJ
ajlm-1255	67	32	acceptable	acceptable	ADJ
ajlm-1255	67	33	sensitivity	sensitivity	NOUN
ajlm-1255	67	34	(	(	PUNCT
ajlm-1255	67	35	98	98	NUM
ajlm-1255	67	36	%	%	NOUN
ajlm-1255	67	37	–	–	PUNCT
ajlm-1255	67	38	100	100	NUM
ajlm-1255	67	39	%	%	NOUN
ajlm-1255	67	40	)	)	PUNCT
ajlm-1255	67	41	and	and	CCONJ
ajlm-1255	67	42	specificity	specificity	NOUN
ajlm-1255	67	43	(	(	PUNCT
ajlm-1255	67	44	98	98	NUM
ajlm-1255	67	45	%	%	NOUN
ajlm-1255	67	46	–	–	PUNCT
ajlm-1255	67	47	99	99	NUM
ajlm-1255	67	48	%	%	NOUN
ajlm-1255	67	49	)	)	PUNCT
ajlm-1255	67	50	values	value	NOUN
ajlm-1255	67	51	for	for	ADP
ajlm-1255	67	52	igg	igg	NOUN
ajlm-1255	67	53	and	and	CCONJ
ajlm-1255	67	54	specificity	specificity	NOUN
ajlm-1255	67	55	of	of	ADP
ajlm-1255	67	56	96	96	NUM
ajlm-1255	67	57	%	%	NOUN
ajlm-1255	67	58	–	–	PUNCT
ajlm-1255	67	59	99	99	NUM
ajlm-1255	67	60	%	%	NOUN
ajlm-1255	67	61	for	for	ADP
ajlm-1255	67	62	igm	igm	NOUN
ajlm-1255	67	63	compared	compare	VERB
ajlm-1255	67	64	to	to	ADP
ajlm-1255	67	65	other	other	ADJ
ajlm-1255	67	66	rdt	rdt	ADJ
ajlm-1255	67	67	types	type	NOUN
ajlm-1255	67	68	and	and	CCONJ
ajlm-1255	67	69	the	the	DET
ajlm-1255	67	70	counterpart	counterpart	NOUN
ajlm-1255	67	71	colloidal	colloidal	NOUN
ajlm-1255	67	72	gold	gold	NOUN
ajlm-1255	67	73	system	system	NOUN
ajlm-1255	67	74	-	-	PUNCT
ajlm-1255	67	75	based	base	VERB
ajlm-1255	67	76	igm	igm	PROPN
ajlm-1255	67	77	/	/	SYM
ajlm-1255	67	78	igg	igg	PROPN
ajlm-1255	67	79	duo	duo	PROPN
ajlm-1255	67	80	kit	kit	NOUN
ajlm-1255	67	81	(	(	PUNCT
ajlm-1255	67	82	figure	figure	NOUN
ajlm-1255	67	83	5	5	NUM
ajlm-1255	67	84	)	)	PUNCT
ajlm-1255	67	85	.	.	PUNCT
ajlm-1255	68	1	figure	figure	VERB
ajlm-1255	68	2	5	5	NUM
ajlm-1255	68	3	:	:	PUNCT
ajlm-1255	68	4	performance	performance	NOUN
ajlm-1255	68	5	characteristics	characteristic	NOUN
ajlm-1255	68	6	of	of	ADP
ajlm-1255	68	7	the	the	DET
ajlm-1255	68	8	different	different	ADJ
ajlm-1255	68	9	serological	serological	ADJ
ajlm-1255	68	10	rapid	rapid	ADJ
ajlm-1255	68	11	diagnostic	diagnostic	ADJ
ajlm-1255	68	12	tests	test	NOUN
ajlm-1255	68	13	by	by	ADP
ajlm-1255	68	14	testing	test	VERB
ajlm-1255	68	15	platform	platform	NOUN
ajlm-1255	68	16	;	;	PUNCT
ajlm-1255	68	17	lfia	lfia	NOUN
ajlm-1255	68	18	membrane	membrane	NOUN
ajlm-1255	68	19	(	(	PUNCT
ajlm-1255	68	20	a	a	NOUN
ajlm-1255	68	21	)	)	PUNCT
ajlm-1255	68	22	and	and	CCONJ
ajlm-1255	68	23	colloidal	colloidal	NOUN
ajlm-1255	68	24	gold	gold	NOUN
ajlm-1255	68	25	devices	device	NOUN
ajlm-1255	68	26	(	(	PUNCT
ajlm-1255	68	27	b	b	NOUN
ajlm-1255	68	28	)	)	PUNCT
ajlm-1255	68	29	.	.	PUNCT
ajlm-1255	69	1	implications	implication	NOUN
ajlm-1255	69	2	and	and	CCONJ
ajlm-1255	69	3	recommendations	recommendation	NOUN
ajlm-1255	69	4	the	the	DET
ajlm-1255	69	5	need	need	NOUN
ajlm-1255	69	6	to	to	PART
ajlm-1255	69	7	expand	expand	VERB
ajlm-1255	69	8	diagnostic	diagnostic	ADJ
ajlm-1255	69	9	testing	testing	NOUN
ajlm-1255	69	10	in	in	ADP
ajlm-1255	69	11	order	order	NOUN
ajlm-1255	69	12	to	to	PART
ajlm-1255	69	13	cope	cope	VERB
ajlm-1255	69	14	with	with	ADP
ajlm-1255	69	15	the	the	DET
ajlm-1255	69	16	current	current	ADJ
ajlm-1255	69	17	spread	spread	NOUN
ajlm-1255	69	18	of	of	ADP
ajlm-1255	69	19	covid-19	covid-19	PROPN
ajlm-1255	69	20	infection	infection	NOUN
ajlm-1255	69	21	in	in	ADP
ajlm-1255	69	22	many	many	ADJ
ajlm-1255	69	23	settings	setting	NOUN
ajlm-1255	69	24	in	in	ADP
ajlm-1255	69	25	lmics	lmic	NOUN
ajlm-1255	69	26	where	where	SCONJ
ajlm-1255	69	27	resources	resource	NOUN
ajlm-1255	69	28	for	for	ADP
ajlm-1255	69	29	rt	rt	PROPN
ajlm-1255	69	30	-	-	PUNCT
ajlm-1255	69	31	pcr	pcr	PROPN
ajlm-1255	69	32	are	be	AUX
ajlm-1255	69	33	limited	limited	ADJ
ajlm-1255	69	34	and	and	CCONJ
ajlm-1255	69	35	difficult	difficult	ADJ
ajlm-1255	69	36	to	to	PART
ajlm-1255	69	37	sustain	sustain	VERB
ajlm-1255	69	38	has	have	AUX
ajlm-1255	69	39	made	make	VERB
ajlm-1255	69	40	rdt	rdt	ADJ
ajlm-1255	69	41	kits	kit	NOUN
ajlm-1255	69	42	for	for	ADP
ajlm-1255	69	43	sars	sar	NOUN
ajlm-1255	69	44	-	-	PUNCT
ajlm-1255	69	45	cov-2	cov-2	PART
ajlm-1255	69	46	an	an	DET
ajlm-1255	69	47	important	important	ADJ
ajlm-1255	69	48	tool	tool	NOUN
ajlm-1255	69	49	in	in	ADP
ajlm-1255	69	50	the	the	DET
ajlm-1255	69	51	global	global	ADJ
ajlm-1255	69	52	fight	fight	NOUN
ajlm-1255	69	53	against	against	ADP
ajlm-1255	69	54	the	the	DET
ajlm-1255	69	55	covid-19	covid-19	PROPN
ajlm-1255	69	56	pandemic	pandemic	NOUN
ajlm-1255	69	57	.	.	PUNCT
ajlm-1255	70	1	for	for	ADP
ajlm-1255	70	2	patients	patient	NOUN
ajlm-1255	70	3	with	with	ADP
ajlm-1255	70	4	suspected	suspect	VERB
ajlm-1255	70	5	infection	infection	NOUN
ajlm-1255	70	6	,	,	PUNCT
ajlm-1255	70	7	rt	rt	ADJ
ajlm-1255	70	8	-	-	PUNCT
ajlm-1255	70	9	pcr	pcr	PROPN
ajlm-1255	70	10	is	be	AUX
ajlm-1255	70	11	used	use	VERB
ajlm-1255	70	12	to	to	PART
ajlm-1255	70	13	detect	detect	VERB
ajlm-1255	70	14	sars	sar	NOUN
ajlm-1255	70	15	-	-	PUNCT
ajlm-1255	70	16	cov-2	cov-2	NOUN
ajlm-1255	70	17	in	in	ADP
ajlm-1255	70	18	sputum	sputum	NOUN
ajlm-1255	70	19	,	,	PUNCT
ajlm-1255	70	20	throat	throat	NOUN
ajlm-1255	70	21	and	and	CCONJ
ajlm-1255	70	22	nasopharyngeal	nasopharyngeal	NOUN
ajlm-1255	70	23	swab	swab	NOUN
ajlm-1255	70	24	,	,	PUNCT
ajlm-1255	70	25	and	and	CCONJ
ajlm-1255	70	26	secretions	secretion	NOUN
ajlm-1255	70	27	of	of	ADP
ajlm-1255	70	28	the	the	DET
ajlm-1255	70	29	lower	low	ADJ
ajlm-1255	70	30	respiratory	respiratory	ADJ
ajlm-1255	70	31	tract	tract	NOUN
ajlm-1255	70	32	samples	sample	NOUN
ajlm-1255	70	33	such	such	ADJ
ajlm-1255	70	34	as	as	ADP
ajlm-1255	70	35	bronchoalveolar	bronchoalveolar	ADJ
ajlm-1255	70	36	lavage	lavage	NOUN
ajlm-1255	70	37	and	and	CCONJ
ajlm-1255	70	38	bronchial	bronchial	NOUN
ajlm-1255	70	39	washings.16,17,18	washings.16,17,18	PUNCT
ajlm-1255	70	40	however	however	ADV
ajlm-1255	70	41	,	,	PUNCT
ajlm-1255	70	42	limited	limited	ADJ
ajlm-1255	70	43	facilities	facility	NOUN
ajlm-1255	70	44	and	and	CCONJ
ajlm-1255	70	45	human	human	ADJ
ajlm-1255	70	46	resources	resource	NOUN
ajlm-1255	70	47	for	for	ADP
ajlm-1255	70	48	molecular	molecular	ADJ
ajlm-1255	70	49	testing	testing	NOUN
ajlm-1255	70	50	using	use	VERB
ajlm-1255	70	51	rt	rt	PROPN
ajlm-1255	70	52	-	-	PUNCT
ajlm-1255	70	53	pcr	pcr	NOUN
ajlm-1255	70	54	tends	tend	VERB
ajlm-1255	70	55	to	to	PART
ajlm-1255	70	56	slow	slow	VERB
ajlm-1255	70	57	down	down	ADP
ajlm-1255	70	58	testing	testing	NOUN
ajlm-1255	70	59	for	for	ADP
ajlm-1255	70	60	covid-19	covid-19	PROPN
ajlm-1255	70	61	in	in	ADP
ajlm-1255	70	62	resource	resource	NOUN
ajlm-1255	70	63	-	-	PUNCT
ajlm-1255	70	64	limited	limit	VERB
ajlm-1255	70	65	countries	country	NOUN
ajlm-1255	70	66	.	.	PUNCT
ajlm-1255	71	1	it	it	PRON
ajlm-1255	71	2	has	have	AUX
ajlm-1255	71	3	been	be	AUX
ajlm-1255	71	4	argued	argue	VERB
ajlm-1255	71	5	that	that	SCONJ
ajlm-1255	71	6	rdts	rdts	NOUN
ajlm-1255	71	7	do	do	AUX
ajlm-1255	71	8	not	not	PART
ajlm-1255	71	9	have	have	VERB
ajlm-1255	71	10	sufficient	sufficient	ADJ
ajlm-1255	71	11	evidence	evidence	NOUN
ajlm-1255	71	12	to	to	PART
ajlm-1255	71	13	support	support	VERB
ajlm-1255	71	14	their	their	PRON
ajlm-1255	71	15	use	use	NOUN
ajlm-1255	71	16	in	in	ADP
ajlm-1255	71	17	the	the	DET
ajlm-1255	71	18	covid-19	covid-19	PROPN
ajlm-1255	71	19	pandemic	pandemic	NOUN
ajlm-1255	71	20	and	and	CCONJ
ajlm-1255	71	21	hence	hence	ADV
ajlm-1255	71	22	should	should	AUX
ajlm-1255	71	23	be	be	AUX
ajlm-1255	71	24	used	use	VERB
ajlm-1255	71	25	only	only	ADV
ajlm-1255	71	26	in	in	ADP
ajlm-1255	71	27	a	a	DET
ajlm-1255	71	28	research	research	NOUN
ajlm-1255	71	29	setting.19	setting.19	NOUN
ajlm-1255	71	30	cassaniti	cassaniti	PROPN
ajlm-1255	71	31	et	et	PROPN
ajlm-1255	71	32	al	al	PROPN
ajlm-1255	71	33	.	.	PROPN
ajlm-1255	72	1	have	have	AUX
ajlm-1255	72	2	earlier	early	ADV
ajlm-1255	72	3	reported	report	VERB
ajlm-1255	72	4	low	low	ADJ
ajlm-1255	72	5	sensitivity	sensitivity	NOUN
ajlm-1255	72	6	and	and	CCONJ
ajlm-1255	72	7	specificity	specificity	NOUN
ajlm-1255	72	8	of	of	ADP
ajlm-1255	72	9	serological	serological	ADJ
ajlm-1255	72	10	assay	assay	NOUN
ajlm-1255	72	11	which	which	PRON
ajlm-1255	72	12	led	lead	VERB
ajlm-1255	72	13	to	to	ADP
ajlm-1255	72	14	misdiagnosis	misdiagnosis	NOUN
ajlm-1255	72	15	of	of	ADP
ajlm-1255	72	16	covid-19	covid-19	PROPN
ajlm-1255	72	17	in	in	ADP
ajlm-1255	72	18	the	the	DET
ajlm-1255	72	19	vast	vast	ADJ
ajlm-1255	72	20	majority	majority	NOUN
ajlm-1255	72	21	of	of	ADP
ajlm-1255	72	22	the	the	DET
ajlm-1255	72	23	patients	patient	NOUN
ajlm-1255	72	24	in	in	ADP
ajlm-1255	72	25	their	their	PRON
ajlm-1255	72	26	study	study	NOUN
ajlm-1255	72	27	population.20	population.20	NOUN
ajlm-1255	72	28	the	the	PRON
ajlm-1255	72	29	who	who	PRON
ajlm-1255	72	30	has	have	AUX
ajlm-1255	72	31	emphasised	emphasise	VERB
ajlm-1255	72	32	that	that	SCONJ
ajlm-1255	72	33	tests	test	NOUN
ajlm-1255	72	34	with	with	ADP
ajlm-1255	72	35	inadequate	inadequate	ADJ
ajlm-1255	72	36	quality	quality	NOUN
ajlm-1255	72	37	may	may	AUX
ajlm-1255	72	38	miss	miss	VERB
ajlm-1255	72	39	patients	patient	NOUN
ajlm-1255	72	40	with	with	ADP
ajlm-1255	72	41	active	active	ADJ
ajlm-1255	72	42	infection	infection	NOUN
ajlm-1255	72	43	or	or	CCONJ
ajlm-1255	72	44	falsely	falsely	ADV
ajlm-1255	72	45	categorise	categorise	VERB
ajlm-1255	72	46	patients	patient	NOUN
ajlm-1255	72	47	as	as	ADP
ajlm-1255	72	48	having	have	VERB
ajlm-1255	72	49	the	the	DET
ajlm-1255	72	50	disease	disease	NOUN
ajlm-1255	72	51	,	,	PUNCT
ajlm-1255	72	52	further	far	ADV
ajlm-1255	72	53	hampering	hamper	VERB
ajlm-1255	72	54	disease	disease	NOUN
ajlm-1255	72	55	control	control	NOUN
ajlm-1255	72	56	efforts	effort	NOUN
ajlm-1255	72	57	,	,	PUNCT
ajlm-1255	72	58	hence	hence	ADV
ajlm-1255	72	59	the	the	DET
ajlm-1255	72	60	need	need	NOUN
ajlm-1255	72	61	for	for	ADP
ajlm-1255	72	62	questioning	question	VERB
ajlm-1255	72	63	the	the	DET
ajlm-1255	72	64	performance	performance	NOUN
ajlm-1255	72	65	of	of	ADP
ajlm-1255	72	66	sars	sar	NOUN
ajlm-1255	72	67	-	-	PUNCT
ajlm-1255	72	68	cov-2	cov-2	NOUN
ajlm-1255	72	69	rdt	rdt	PROPN
ajlm-1255	72	70	kits.19,21	kits.19,21	NOUN
ajlm-1255	72	71	most	most	ADJ
ajlm-1255	72	72	manufacturers	manufacturer	NOUN
ajlm-1255	72	73	of	of	ADP
ajlm-1255	72	74	the	the	DET
ajlm-1255	72	75	rdts	rdts	NOUN
ajlm-1255	72	76	have	have	VERB
ajlm-1255	72	77	performance	performance	NOUN
ajlm-1255	72	78	characteristics	characteristic	NOUN
ajlm-1255	72	79	of	of	ADP
ajlm-1255	72	80	the	the	DET
ajlm-1255	72	81	kits	kit	NOUN
ajlm-1255	72	82	validated	validate	VERB
ajlm-1255	72	83	using	use	VERB
ajlm-1255	72	84	the	the	DET
ajlm-1255	72	85	rt	rt	ADJ
ajlm-1255	72	86	-	-	PUNCT
ajlm-1255	72	87	pcr	pcr	NOUN
ajlm-1255	72	88	technique	technique	NOUN
ajlm-1255	72	89	as	as	ADP
ajlm-1255	72	90	the	the	DET
ajlm-1255	72	91	reference	reference	NOUN
ajlm-1255	72	92	method	method	NOUN
ajlm-1255	72	93	.	.	PUNCT
ajlm-1255	73	1	however	however	ADV
ajlm-1255	73	2	,	,	PUNCT
ajlm-1255	73	3	several	several	ADJ
ajlm-1255	73	4	publications	publication	NOUN
ajlm-1255	73	5	have	have	AUX
ajlm-1255	73	6	reported	report	VERB
ajlm-1255	73	7	the	the	DET
ajlm-1255	73	8	possibility	possibility	NOUN
ajlm-1255	73	9	of	of	ADP
ajlm-1255	73	10	false	false	ADJ
ajlm-1255	73	11	-	-	PUNCT
ajlm-1255	73	12	negative	negative	ADJ
ajlm-1255	73	13	results	result	NOUN
ajlm-1255	73	14	using	use	VERB
ajlm-1255	73	15	rt	rt	NOUN
ajlm-1255	73	16	-	-	PUNCT
ajlm-1255	73	17	pcr.22	pcr.22	NOUN
ajlm-1255	73	18	thus	thus	ADV
ajlm-1255	73	19	,	,	PUNCT
ajlm-1255	73	20	the	the	DET
ajlm-1255	73	21	sensitivity	sensitivity	NOUN
ajlm-1255	73	22	and	and	CCONJ
ajlm-1255	73	23	specificity	specificity	NOUN
ajlm-1255	73	24	data	datum	NOUN
ajlm-1255	73	25	of	of	ADP
ajlm-1255	73	26	reviewed	review	VERB
ajlm-1255	73	27	kits	kit	NOUN
ajlm-1255	73	28	should	should	AUX
ajlm-1255	73	29	be	be	AUX
ajlm-1255	73	30	understood	understand	VERB
ajlm-1255	73	31	in	in	ADP
ajlm-1255	73	32	light	light	NOUN
ajlm-1255	73	33	of	of	ADP
ajlm-1255	73	34	this	this	DET
ajlm-1255	73	35	bias	bias	NOUN
ajlm-1255	73	36	.	.	PUNCT
ajlm-1255	74	1	the	the	DET
ajlm-1255	74	2	declaration	declaration	NOUN
ajlm-1255	74	3	of	of	ADP
ajlm-1255	74	4	covid-19	covid-19	PROPN
ajlm-1255	74	5	as	as	ADP
ajlm-1255	74	6	a	a	DET
ajlm-1255	74	7	global	global	ADJ
ajlm-1255	74	8	pandemic	pandemic	NOUN
ajlm-1255	74	9	and	and	CCONJ
ajlm-1255	74	10	the	the	DET
ajlm-1255	74	11	huge	huge	ADJ
ajlm-1255	74	12	concern	concern	NOUN
ajlm-1255	74	13	of	of	ADP
ajlm-1255	74	14	its	its	PRON
ajlm-1255	74	15	transmission	transmission	NOUN
ajlm-1255	74	16	in	in	ADP
ajlm-1255	74	17	lmics	lmic	NOUN
ajlm-1255	74	18	where	where	SCONJ
ajlm-1255	74	19	hiv	hiv	PROPN
ajlm-1255	74	20	,	,	PUNCT
ajlm-1255	74	21	tuberculosis	tuberculosis	NOUN
ajlm-1255	74	22	and	and	CCONJ
ajlm-1255	74	23	malaria	malaria	NOUN
ajlm-1255	74	24	are	be	AUX
ajlm-1255	74	25	currently	currently	ADV
ajlm-1255	74	26	endemic	endemic	ADJ
ajlm-1255	74	27	have	have	AUX
ajlm-1255	74	28	necessitated	necessitate	VERB
ajlm-1255	74	29	the	the	DET
ajlm-1255	74	30	need	need	NOUN
ajlm-1255	74	31	to	to	PART
ajlm-1255	74	32	scale	scale	VERB
ajlm-1255	74	33	up	up	ADP
ajlm-1255	74	34	diagnostic	diagnostic	ADJ
ajlm-1255	74	35	testing	testing	NOUN
ajlm-1255	74	36	to	to	PART
ajlm-1255	74	37	mitigate	mitigate	VERB
ajlm-1255	74	38	further	far	ADV
ajlm-1255	74	39	spread	spread	VERB
ajlm-1255	74	40	and	and	CCONJ
ajlm-1255	74	41	the	the	DET
ajlm-1255	74	42	rising	rise	VERB
ajlm-1255	74	43	number	number	NOUN
ajlm-1255	74	44	of	of	ADP
ajlm-1255	74	45	covid-19	covid-19	PROPN
ajlm-1255	74	46	deaths	death	NOUN
ajlm-1255	74	47	outside	outside	ADP
ajlm-1255	74	48	china.23,24	china.23,24	NOUN
ajlm-1255	74	49	in	in	ADP
ajlm-1255	74	50	many	many	ADJ
ajlm-1255	74	51	settings	setting	NOUN
ajlm-1255	74	52	in	in	ADP
ajlm-1255	74	53	lmics	lmic	NOUN
ajlm-1255	74	54	,	,	PUNCT
ajlm-1255	74	55	such	such	ADJ
ajlm-1255	74	56	as	as	ADP
ajlm-1255	74	57	small	small	ADJ
ajlm-1255	74	58	communities	community	NOUN
ajlm-1255	74	59	,	,	PUNCT
ajlm-1255	74	60	riverine	riverine	NOUN
ajlm-1255	74	61	areas	area	NOUN
ajlm-1255	74	62	,	,	PUNCT
ajlm-1255	74	63	health	health	NOUN
ajlm-1255	74	64	posts	post	NOUN
ajlm-1255	74	65	and	and	CCONJ
ajlm-1255	74	66	primary	primary	ADJ
ajlm-1255	74	67	health	health	NOUN
ajlm-1255	74	68	centres	centre	NOUN
ajlm-1255	74	69	,	,	PUNCT
ajlm-1255	74	70	resources	resource	NOUN
ajlm-1255	74	71	for	for	ADP
ajlm-1255	74	72	rt	rt	NOUN
ajlm-1255	74	73	-	-	PUNCT
ajlm-1255	74	74	pcr	pcr	PROPN
ajlm-1255	74	75	are	be	AUX
ajlm-1255	74	76	absent.23,24	absent.23,24	NOUN
ajlm-1255	74	77	this	this	PRON
ajlm-1255	74	78	has	have	AUX
ajlm-1255	74	79	made	make	VERB
ajlm-1255	74	80	the	the	DET
ajlm-1255	74	81	development	development	NOUN
ajlm-1255	74	82	of	of	ADP
ajlm-1255	74	83	serological	serological	ADJ
ajlm-1255	74	84	rdts	rdts	NOUN
ajlm-1255	74	85	for	for	ADP
ajlm-1255	74	86	the	the	DET
ajlm-1255	74	87	detection	detection	NOUN
ajlm-1255	74	88	of	of	ADP
ajlm-1255	74	89	specific	specific	ADJ
ajlm-1255	74	90	sars	sar	NOUN
ajlm-1255	74	91	-	-	PUNCT
ajlm-1255	74	92	cov-2	cov-2	NOUN
ajlm-1255	74	93	antigens	antigen	NOUN
ajlm-1255	74	94	,	,	PUNCT
ajlm-1255	74	95	anti	anti	ADJ
ajlm-1255	74	96	-	-	ADJ
ajlm-1255	74	97	sars	sar	NOUN
ajlm-1255	74	98	-	-	PUNCT
ajlm-1255	74	99	cov-2	cov-2	NOUN
ajlm-1255	74	100	igm	igm	NOUN
ajlm-1255	74	101	and	and	CCONJ
ajlm-1255	74	102	anti	anti	ADJ
ajlm-1255	74	103	-	-	ADJ
ajlm-1255	74	104	sars	sar	NOUN
ajlm-1255	74	105	-	-	PUNCT
ajlm-1255	74	106	cov-2	cov-2	NOUN
ajlm-1255	74	107	igg	igg	NOUN
ajlm-1255	74	108	an	an	DET
ajlm-1255	74	109	attractive	attractive	ADJ
ajlm-1255	74	110	and	and	CCONJ
ajlm-1255	74	111	very	very	ADV
ajlm-1255	74	112	important	important	ADJ
ajlm-1255	74	113	tool	tool	NOUN
ajlm-1255	74	114	in	in	ADP
ajlm-1255	74	115	the	the	DET
ajlm-1255	74	116	global	global	ADJ
ajlm-1255	74	117	fight	fight	NOUN
ajlm-1255	74	118	against	against	ADP
ajlm-1255	74	119	the	the	DET
ajlm-1255	74	120	covid-19	covid-19	PROPN
ajlm-1255	74	121	pandemic	pandemic	NOUN
ajlm-1255	74	122	in	in	ADP
ajlm-1255	74	123	lmics	lmic	NOUN
ajlm-1255	74	124	.	.	PUNCT
ajlm-1255	75	1	findings	finding	NOUN
ajlm-1255	75	2	from	from	ADP
ajlm-1255	75	3	the	the	DET
ajlm-1255	75	4	18	18	NUM
ajlm-1255	75	5	serological	serological	ADJ
ajlm-1255	75	6	rdt	rdt	PROPN
ajlm-1255	75	7	kits	kit	NOUN
ajlm-1255	75	8	analysed	analyse	VERB
ajlm-1255	75	9	in	in	ADP
ajlm-1255	75	10	this	this	DET
ajlm-1255	75	11	review	review	NOUN
ajlm-1255	75	12	imply	imply	VERB
ajlm-1255	75	13	that	that	SCONJ
ajlm-1255	75	14	three	three	NUM
ajlm-1255	75	15	different	different	ADJ
ajlm-1255	75	16	types	type	NOUN
ajlm-1255	75	17	of	of	ADP
ajlm-1255	75	18	serological	serological	ADJ
ajlm-1255	75	19	rdts	rdts	NOUN
ajlm-1255	75	20	,	,	PUNCT
ajlm-1255	75	21	antigen	antigen	ADV
ajlm-1255	75	22	,	,	PUNCT
ajlm-1255	75	23	total	total	ADJ
ajlm-1255	75	24	immunoglobulin	immunoglobulin	NOUN
ajlm-1255	75	25	,	,	PUNCT
ajlm-1255	75	26	and	and	CCONJ
ajlm-1255	75	27	combined	combine	VERB
ajlm-1255	75	28	igm	igm	PROPN
ajlm-1255	75	29	and	and	CCONJ
ajlm-1255	75	30	igg	igg	PROPN
ajlm-1255	75	31	-	-	PUNCT
ajlm-1255	75	32	based	base	VERB
ajlm-1255	75	33	rdt	rdt	PROPN
ajlm-1255	75	34	with	with	ADP
ajlm-1255	75	35	the	the	DET
ajlm-1255	75	36	ability	ability	NOUN
ajlm-1255	75	37	to	to	PART
ajlm-1255	75	38	provide	provide	VERB
ajlm-1255	75	39	results	result	NOUN
ajlm-1255	75	40	between	between	ADP
ajlm-1255	75	41	2	2	NUM
ajlm-1255	75	42	min	min	NOUN
ajlm-1255	75	43	and	and	CCONJ
ajlm-1255	75	44	30	30	NUM
ajlm-1255	75	45	min	min	NOUN
ajlm-1255	75	46	are	be	AUX
ajlm-1255	75	47	currently	currently	ADV
ajlm-1255	75	48	available	available	ADJ
ajlm-1255	75	49	for	for	ADP
ajlm-1255	75	50	potential	potential	ADJ
ajlm-1255	75	51	large	large	ADJ
ajlm-1255	75	52	-	-	PUNCT
ajlm-1255	75	53	scale	scale	NOUN
ajlm-1255	75	54	testing	testing	NOUN
ajlm-1255	75	55	in	in	ADP
ajlm-1255	75	56	lmics	lmic	NOUN
ajlm-1255	75	57	using	use	VERB
ajlm-1255	75	58	five	five	NUM
ajlm-1255	75	59	types	type	NOUN
ajlm-1255	75	60	of	of	ADP
ajlm-1255	75	61	biological	biological	ADJ
ajlm-1255	75	62	samples	sample	NOUN
ajlm-1255	75	63	(	(	PUNCT
ajlm-1255	75	64	nasopharyngeal	nasopharyngeal	NOUN
ajlm-1255	75	65	swab	swab	NOUN
ajlm-1255	75	66	,	,	PUNCT
ajlm-1255	75	67	throat	throat	NOUN
ajlm-1255	75	68	swab	swab	NOUN
ajlm-1255	75	69	,	,	PUNCT
ajlm-1255	75	70	whole	whole	ADJ
ajlm-1255	75	71	blood	blood	NOUN
ajlm-1255	75	72	,	,	PUNCT
ajlm-1255	75	73	plasma	plasma	NOUN
ajlm-1255	75	74	and	and	CCONJ
ajlm-1255	75	75	serum	serum	NOUN
ajlm-1255	75	76	)	)	PUNCT
ajlm-1255	75	77	.	.	PUNCT
ajlm-1255	76	1	due	due	ADP
ajlm-1255	76	2	to	to	ADP
ajlm-1255	76	3	challenges	challenge	NOUN
ajlm-1255	76	4	associated	associate	VERB
ajlm-1255	76	5	with	with	ADP
ajlm-1255	76	6	more	more	ADV
ajlm-1255	76	7	sensitive	sensitive	ADJ
ajlm-1255	76	8	biological	biological	ADJ
ajlm-1255	76	9	samples	sample	NOUN
ajlm-1255	76	10	such	such	ADJ
ajlm-1255	76	11	as	as	ADP
ajlm-1255	76	12	bronchoalveolar	bronchoalveolar	ADJ
ajlm-1255	76	13	lavage	lavage	NOUN
ajlm-1255	76	14	and	and	CCONJ
ajlm-1255	76	15	sputum	sputum	NOUN
ajlm-1255	76	16	,	,	PUNCT
ajlm-1255	76	17	both	both	CCONJ
ajlm-1255	76	18	nasopharyngeal	nasopharyngeal	ADJ
ajlm-1255	76	19	and	and	CCONJ
ajlm-1255	76	20	throat	throat	NOUN
ajlm-1255	76	21	swabs	swab	NOUN
ajlm-1255	76	22	are	be	AUX
ajlm-1255	76	23	used	use	VERB
ajlm-1255	76	24	for	for	ADP
ajlm-1255	76	25	covid-19	covid-19	PROPN
ajlm-1255	76	26	testing	testing	NOUN
ajlm-1255	76	27	by	by	ADP
ajlm-1255	76	28	rt	rt	NOUN
ajlm-1255	76	29	-	-	PUNCT
ajlm-1255	76	30	pcr	pcr	PROPN
ajlm-1255	76	31	in	in	ADP
ajlm-1255	76	32	many	many	ADJ
ajlm-1255	76	33	settings.7,8,9	settings.7,8,9	PUNCT
ajlm-1255	76	34	also	also	ADV
ajlm-1255	76	35	,	,	PUNCT
ajlm-1255	76	36	whole	whole	ADJ
ajlm-1255	76	37	blood	blood	NOUN
ajlm-1255	76	38	,	,	PUNCT
ajlm-1255	76	39	plasma	plasma	NOUN
ajlm-1255	76	40	or	or	CCONJ
ajlm-1255	76	41	serum	serum	NOUN
ajlm-1255	76	42	is	be	AUX
ajlm-1255	76	43	often	often	ADV
ajlm-1255	76	44	used	use	VERB
ajlm-1255	76	45	as	as	ADP
ajlm-1255	76	46	biological	biological	ADJ
ajlm-1255	76	47	sample	sample	NOUN
ajlm-1255	76	48	for	for	ADP
ajlm-1255	76	49	rt	rt	NOUN
ajlm-1255	76	50	-	-	PUNCT
ajlm-1255	76	51	pcr	pcr	NOUN
ajlm-1255	76	52	for	for	ADP
ajlm-1255	76	53	monitoring	monitor	VERB
ajlm-1255	76	54	viremia	viremia	NOUN
ajlm-1255	76	55	to	to	PART
ajlm-1255	76	56	predict	predict	VERB
ajlm-1255	76	57	covid-19	covid-19	PROPN
ajlm-1255	76	58	severity	severity	NOUN
ajlm-1255	76	59	during	during	ADP
ajlm-1255	76	60	the	the	DET
ajlm-1255	76	61	acute	acute	ADJ
ajlm-1255	76	62	stage	stage	NOUN
ajlm-1255	76	63	of	of	ADP
ajlm-1255	76	64	infection	infection	NOUN
ajlm-1255	76	65	and	and	CCONJ
ajlm-1255	76	66	viral	viral	ADJ
ajlm-1255	76	67	clearance	clearance	NOUN
ajlm-1255	76	68	during	during	ADP
ajlm-1255	76	69	the	the	DET
ajlm-1255	76	70	convalescent	convalescent	NOUN
ajlm-1255	76	71	stage.7,8	stage.7,8	SCONJ
ajlm-1255	76	72	the	the	DET
ajlm-1255	76	73	latter	latter	NOUN
ajlm-1255	76	74	is	be	AUX
ajlm-1255	76	75	currently	currently	ADV
ajlm-1255	76	76	used	use	VERB
ajlm-1255	76	77	to	to	PART
ajlm-1255	76	78	inform	inform	VERB
ajlm-1255	76	79	hospital	hospital	NOUN
ajlm-1255	76	80	discharge	discharge	NOUN
ajlm-1255	76	81	decisions	decision	NOUN
ajlm-1255	76	82	in	in	ADP
ajlm-1255	76	83	many	many	ADJ
ajlm-1255	76	84	countries	country	NOUN
ajlm-1255	76	85	;	;	PUNCT
ajlm-1255	76	86	use	use	NOUN
ajlm-1255	76	87	of	of	ADP
ajlm-1255	76	88	different	different	ADJ
ajlm-1255	76	89	samples	sample	NOUN
ajlm-1255	76	90	for	for	ADP
ajlm-1255	76	91	diagnosis	diagnosis	NOUN
ajlm-1255	76	92	and	and	CCONJ
ajlm-1255	76	93	viral	viral	ADJ
ajlm-1255	76	94	clearance	clearance	NOUN
ajlm-1255	76	95	determination	determination	NOUN
ajlm-1255	76	96	can	can	AUX
ajlm-1255	76	97	negatively	negatively	ADV
ajlm-1255	76	98	impact	impact	VERB
ajlm-1255	76	99	on	on	ADP
ajlm-1255	76	100	discharge	discharge	NOUN
ajlm-1255	76	101	decision	decision	NOUN
ajlm-1255	76	102	-	-	PUNCT
ajlm-1255	76	103	making.8,9,10,12	making.8,9,10,12	NOUN
ajlm-1255	76	104	a	a	DET
ajlm-1255	76	105	potential	potential	ADJ
ajlm-1255	76	106	way	way	NOUN
ajlm-1255	76	107	of	of	ADP
ajlm-1255	76	108	circumventing	circumvent	VERB
ajlm-1255	76	109	discharge	discharge	NOUN
ajlm-1255	76	110	decision	decision	NOUN
ajlm-1255	76	111	errors	error	NOUN
ajlm-1255	76	112	is	be	AUX
ajlm-1255	76	113	to	to	PART
ajlm-1255	76	114	employ	employ	VERB
ajlm-1255	76	115	a	a	DET
ajlm-1255	76	116	diagnostic	diagnostic	ADJ
ajlm-1255	76	117	tool	tool	NOUN
ajlm-1255	76	118	that	that	PRON
ajlm-1255	76	119	uses	use	VERB
ajlm-1255	76	120	the	the	DET
ajlm-1255	76	121	same	same	ADJ
ajlm-1255	76	122	type	type	NOUN
ajlm-1255	76	123	of	of	ADP
ajlm-1255	76	124	sample	sample	NOUN
ajlm-1255	76	125	for	for	ADP
ajlm-1255	76	126	both	both	DET
ajlm-1255	76	127	diagnosis	diagnosis	NOUN
ajlm-1255	76	128	and	and	CCONJ
ajlm-1255	76	129	viraemia	viraemia	NOUN
ajlm-1255	76	130	monitoring	monitoring	NOUN
ajlm-1255	76	131	such	such	ADJ
ajlm-1255	76	132	as	as	ADP
ajlm-1255	76	133	the	the	DET
ajlm-1255	76	134	sars	sar	NOUN
ajlm-1255	76	135	-	-	PUNCT
ajlm-1255	76	136	cov-2	cov-2	NOUN
ajlm-1255	76	137	antigen	antigen	NOUN
ajlm-1255	76	138	and	and	CCONJ
ajlm-1255	76	139	specific	specific	ADJ
ajlm-1255	76	140	anti	anti	ADJ
ajlm-1255	76	141	-	-	ADJ
ajlm-1255	76	142	sars	sar	NOUN
ajlm-1255	76	143	-	-	PUNCT
ajlm-1255	76	144	cov-2	cov-2	NOUN
ajlm-1255	76	145	igm	igm	PROPN
ajlm-1255	76	146	/	/	SYM
ajlm-1255	76	147	igg	igg	PROPN
ajlm-1255	76	148	duo	duo	PROPN
ajlm-1255	76	149	detection	detection	NOUN
ajlm-1255	76	150	kit	kit	NOUN
ajlm-1255	76	151	identified	identify	VERB
ajlm-1255	76	152	in	in	ADP
ajlm-1255	76	153	this	this	DET
ajlm-1255	76	154	review	review	NOUN
ajlm-1255	76	155	.	.	PUNCT
ajlm-1255	77	1	this	this	PRON
ajlm-1255	77	2	can	can	AUX
ajlm-1255	77	3	be	be	AUX
ajlm-1255	77	4	integrated	integrate	VERB
ajlm-1255	77	5	into	into	ADP
ajlm-1255	77	6	the	the	DET
ajlm-1255	77	7	local	local	ADJ
ajlm-1255	77	8	covid-19	covid-19	PROPN
ajlm-1255	77	9	management	management	NOUN
ajlm-1255	77	10	guidelines	guideline	NOUN
ajlm-1255	77	11	in	in	ADP
ajlm-1255	77	12	lmics	lmic	NOUN
ajlm-1255	77	13	.	.	PUNCT
ajlm-1255	78	1	this	this	DET
ajlm-1255	78	2	guideline	guideline	NOUN
ajlm-1255	78	3	is	be	AUX
ajlm-1255	78	4	currently	currently	ADV
ajlm-1255	78	5	being	be	AUX
ajlm-1255	78	6	used	use	VERB
ajlm-1255	78	7	in	in	ADP
ajlm-1255	78	8	malaysia	malaysia	PROPN
ajlm-1255	78	9	and	and	CCONJ
ajlm-1255	78	10	europe.25,26	europe.25,26	VERB
ajlm-1255	78	11	the	the	DET
ajlm-1255	78	12	primary	primary	ADJ
ajlm-1255	78	13	weakness	weakness	NOUN
ajlm-1255	78	14	of	of	ADP
ajlm-1255	78	15	rt	rt	NOUN
ajlm-1255	78	16	-	-	PUNCT
ajlm-1255	78	17	pcr	pcr	PROPN
ajlm-1255	78	18	for	for	ADP
ajlm-1255	78	19	covid-19	covid-19	PROPN
ajlm-1255	78	20	diagnosis	diagnosis	NOUN
ajlm-1255	78	21	lies	lie	VERB
ajlm-1255	78	22	in	in	ADP
ajlm-1255	78	23	its	its	PRON
ajlm-1255	78	24	inability	inability	NOUN
ajlm-1255	78	25	to	to	PART
ajlm-1255	78	26	detect	detect	VERB
ajlm-1255	78	27	infection	infection	NOUN
ajlm-1255	78	28	using	use	VERB
ajlm-1255	78	29	nasopharyngeal	nasopharyngeal	ADJ
ajlm-1255	78	30	samples	sample	NOUN
ajlm-1255	78	31	collected	collect	VERB
ajlm-1255	78	32	outside	outside	ADP
ajlm-1255	78	33	the	the	DET
ajlm-1255	78	34	viral	viral	ADJ
ajlm-1255	78	35	rna	rna	NOUN
ajlm-1255	78	36	shedding	shedding	NOUN
ajlm-1255	78	37	period	period	NOUN
ajlm-1255	78	38	.	.	PUNCT
ajlm-1255	79	1	the	the	DET
ajlm-1255	79	2	shedding	shed	VERB
ajlm-1255	79	3	period	period	NOUN
ajlm-1255	79	4	is	be	AUX
ajlm-1255	79	5	characterised	characterise	VERB
ajlm-1255	79	6	by	by	ADP
ajlm-1255	79	7	presence	presence	NOUN
ajlm-1255	79	8	of	of	ADP
ajlm-1255	79	9	low	low	ADJ
ajlm-1255	79	10	viral	viral	ADJ
ajlm-1255	79	11	rna	rna	NOUN
ajlm-1255	79	12	,	,	PUNCT
ajlm-1255	79	13	such	such	ADJ
ajlm-1255	79	14	as	as	ADP
ajlm-1255	79	15	seen	see	VERB
ajlm-1255	79	16	in	in	ADP
ajlm-1255	79	17	asymptomatic	asymptomatic	ADJ
ajlm-1255	79	18	,	,	PUNCT
ajlm-1255	79	19	pre	pre	ADJ
ajlm-1255	79	20	-	-	ADJ
ajlm-1255	79	21	symptom	symptom	ADJ
ajlm-1255	79	22	days	day	NOUN
ajlm-1255	79	23	(	(	PUNCT
ajlm-1255	79	24	~2	~2	NOUN
ajlm-1255	79	25	days	day	NOUN
ajlm-1255	79	26	prior	prior	ADV
ajlm-1255	79	27	to	to	ADP
ajlm-1255	79	28	symptom	symptom	NOUN
ajlm-1255	79	29	onset	onset	NOUN
ajlm-1255	79	30	)	)	PUNCT
ajlm-1255	79	31	and	and	CCONJ
ajlm-1255	79	32	post	post	ADJ
ajlm-1255	79	33	-	-	ADJ
ajlm-1255	79	34	infection	infection	ADJ
ajlm-1255	79	35	days	day	NOUN
ajlm-1255	79	36	(	(	PUNCT
ajlm-1255	79	37	~14	~14	X
ajlm-1255	79	38	post	post	NOUN
ajlm-1255	79	39	infection	infection	NOUN
ajlm-1255	79	40	onset).26,27	onset).26,27	PROPN
ajlm-1255	79	41	also	also	ADV
ajlm-1255	79	42	,	,	PUNCT
ajlm-1255	79	43	the	the	DET
ajlm-1255	79	44	rt	rt	NOUN
ajlm-1255	79	45	-	-	PUNCT
ajlm-1255	79	46	pcr	pcr	NOUN
ajlm-1255	79	47	,	,	PUNCT
ajlm-1255	79	48	may	may	AUX
ajlm-1255	79	49	also	also	ADV
ajlm-1255	79	50	miss	miss	VERB
ajlm-1255	79	51	infections	infection	NOUN
ajlm-1255	79	52	due	due	ADJ
ajlm-1255	79	53	to	to	ADP
ajlm-1255	79	54	poor	poor	ADJ
ajlm-1255	79	55	sample	sample	NOUN
ajlm-1255	79	56	collection	collection	NOUN
ajlm-1255	79	57	and	and	CCONJ
ajlm-1255	79	58	preparation	preparation	NOUN
ajlm-1255	79	59	as	as	ADV
ajlm-1255	79	60	well	well	ADV
ajlm-1255	79	61	as	as	ADP
ajlm-1255	79	62	poor	poor	ADJ
ajlm-1255	79	63	storage	storage	NOUN
ajlm-1255	79	64	of	of	ADP
ajlm-1255	79	65	isolated	isolated	ADJ
ajlm-1255	79	66	rna	rna	NOUN
ajlm-1255	79	67	.	.	PUNCT
ajlm-1255	80	1	these	these	DET
ajlm-1255	80	2	weaknesses	weakness	NOUN
ajlm-1255	80	3	can	can	AUX
ajlm-1255	80	4	be	be	AUX
ajlm-1255	80	5	addressed	address	VERB
ajlm-1255	80	6	by	by	ADP
ajlm-1255	80	7	serological	serological	ADJ
ajlm-1255	80	8	rdts	rdts	NOUN
ajlm-1255	80	9	,	,	PUNCT
ajlm-1255	80	10	which	which	PRON
ajlm-1255	80	11	detect	detect	VERB
ajlm-1255	80	12	the	the	DET
ajlm-1255	80	13	more	more	ADV
ajlm-1255	80	14	stable	stable	ADJ
ajlm-1255	80	15	viral	viral	ADJ
ajlm-1255	80	16	immunogenic	immunogenic	ADJ
ajlm-1255	80	17	proteins	protein	NOUN
ajlm-1255	80	18	such	such	ADJ
ajlm-1255	80	19	as	as	ADP
ajlm-1255	80	20	the	the	DET
ajlm-1255	80	21	s	s	X
ajlm-1255	80	22	and	and	CCONJ
ajlm-1255	80	23	n	n	PRON
ajlm-1255	80	24	proteins	protein	NOUN
ajlm-1255	80	25	,	,	PUNCT
ajlm-1255	80	26	which	which	PRON
ajlm-1255	80	27	persist	persist	VERB
ajlm-1255	80	28	more	more	ADV
ajlm-1255	80	29	than	than	ADP
ajlm-1255	80	30	rna	rna	NOUN
ajlm-1255	80	31	or	or	CCONJ
ajlm-1255	80	32	anti	anti	ADJ
ajlm-1255	80	33	-	-	ADJ
ajlm-1255	80	34	sars	sar	NOUN
ajlm-1255	80	35	-	-	PUNCT
ajlm-1255	80	36	cov-2	cov-2	NOUN
ajlm-1255	80	37	igm	igm	NOUN
ajlm-1255	80	38	and	and	CCONJ
ajlm-1255	80	39	igg	igg	PROPN
ajlm-1255	80	40	which	which	PRON
ajlm-1255	80	41	have	have	AUX
ajlm-1255	80	42	been	be	AUX
ajlm-1255	80	43	reported	report	VERB
ajlm-1255	80	44	to	to	PART
ajlm-1255	80	45	peak	peak	VERB
ajlm-1255	80	46	between	between	ADP
ajlm-1255	80	47	2	2	NUM
ajlm-1255	80	48	and	and	CCONJ
ajlm-1255	80	49	3	3	NUM
ajlm-1255	80	50	weeks	week	NOUN
ajlm-1255	80	51	and	and	CCONJ
ajlm-1255	80	52	17	17	NUM
ajlm-1255	80	53	days	day	NOUN
ajlm-1255	80	54	post	post	NOUN
ajlm-1255	80	55	infection	infection	NOUN
ajlm-1255	80	56	onset.26,27	onset.26,27	NOUN
ajlm-1255	80	57	guo	guo	PROPN
ajlm-1255	80	58	et	et	PROPN
ajlm-1255	80	59	al.28	al.28	PROPN
ajlm-1255	80	60	reported	report	VERB
ajlm-1255	80	61	an	an	DET
ajlm-1255	80	62	improvement	improvement	NOUN
ajlm-1255	80	63	of	of	ADP
ajlm-1255	80	64	covid-19	covid-19	PROPN
ajlm-1255	80	65	identification	identification	NOUN
ajlm-1255	80	66	by	by	ADP
ajlm-1255	80	67	rt	rt	NOUN
ajlm-1255	80	68	-	-	PUNCT
ajlm-1255	80	69	pcr	pcr	PROPN
ajlm-1255	80	70	from	from	ADP
ajlm-1255	80	71	51.9	51.9	NUM
ajlm-1255	80	72	%	%	NOUN
ajlm-1255	80	73	to	to	ADP
ajlm-1255	80	74	98.6	98.6	NUM
ajlm-1255	80	75	%	%	NOUN
ajlm-1255	80	76	with	with	ADP
ajlm-1255	80	77	the	the	DET
ajlm-1255	80	78	integration	integration	NOUN
ajlm-1255	80	79	of	of	ADP
ajlm-1255	80	80	an	an	DET
ajlm-1255	80	81	igm	igm	PROPN
ajlm-1255	80	82	-	-	PUNCT
ajlm-1255	80	83	based	base	VERB
ajlm-1255	80	84	immunoassay	immunoassay	PROPN
ajlm-1255	80	85	.	.	PUNCT
ajlm-1255	81	1	however	however	ADV
ajlm-1255	81	2	,	,	PUNCT
ajlm-1255	81	3	the	the	DET
ajlm-1255	81	4	results	result	NOUN
ajlm-1255	81	5	of	of	ADP
ajlm-1255	81	6	sensitivity	sensitivity	NOUN
ajlm-1255	81	7	(	(	PUNCT
ajlm-1255	81	8	18.4	18.4	NUM
ajlm-1255	81	9	%	%	NOUN
ajlm-1255	81	10	–	–	PUNCT
ajlm-1255	81	11	100	100	NUM
ajlm-1255	81	12	%	%	NOUN
ajlm-1255	81	13	)	)	PUNCT
ajlm-1255	81	14	and	and	CCONJ
ajlm-1255	81	15	specificity	specificity	NOUN
ajlm-1255	81	16	(	(	PUNCT
ajlm-1255	81	17	90.6	90.6	NUM
ajlm-1255	81	18	%	%	NOUN
ajlm-1255	81	19	–	–	PUNCT
ajlm-1255	81	20	100.0	100.0	NUM
ajlm-1255	81	21	%	%	NOUN
ajlm-1255	81	22	)	)	PUNCT
ajlm-1255	81	23	reported	report	VERB
ajlm-1255	81	24	for	for	ADP
ajlm-1255	81	25	12	12	NUM
ajlm-1255	81	26	of	of	ADP
ajlm-1255	81	27	the	the	DET
ajlm-1255	81	28	18	18	NUM
ajlm-1255	81	29	reviewed	review	VERB
ajlm-1255	81	30	serological	serological	ADJ
ajlm-1255	81	31	rdt	rdt	PROPN
ajlm-1255	81	32	kits	kit	NOUN
ajlm-1255	81	33	by	by	ADP
ajlm-1255	81	34	their	their	PRON
ajlm-1255	81	35	manufacturers	manufacturer	NOUN
ajlm-1255	81	36	imply	imply	VERB
ajlm-1255	81	37	that	that	SCONJ
ajlm-1255	81	38	the	the	DET
ajlm-1255	81	39	currently	currently	ADV
ajlm-1255	81	40	available	available	ADJ
ajlm-1255	81	41	covid-19	covid-19	PROPN
ajlm-1255	81	42	rdts	rdts	NOUN
ajlm-1255	81	43	are	be	AUX
ajlm-1255	81	44	not	not	PART
ajlm-1255	81	45	equally	equally	ADV
ajlm-1255	81	46	accurate	accurate	ADJ
ajlm-1255	81	47	and	and	CCONJ
ajlm-1255	81	48	only	only	ADV
ajlm-1255	81	49	a	a	DET
ajlm-1255	81	50	few	few	ADJ
ajlm-1255	81	51	of	of	ADP
ajlm-1255	81	52	them	they	PRON
ajlm-1255	81	53	pass	pass	VERB
ajlm-1255	81	54	the	the	DET
ajlm-1255	81	55	sensitivity	sensitivity	NOUN
ajlm-1255	81	56	and	and	CCONJ
ajlm-1255	81	57	specificity	specificity	NOUN
ajlm-1255	81	58	benchmark	benchmark	NOUN
ajlm-1255	81	59	of	of	ADP
ajlm-1255	81	60	95	95	NUM
ajlm-1255	81	61	%	%	NOUN
ajlm-1255	81	62	.	.	PUNCT
ajlm-1255	82	1	zainol	zainol	NOUN
ajlm-1255	82	2	et	et	PROPN
ajlm-1255	82	3	al.29	al.29	PROPN
ajlm-1255	82	4	recently	recently	ADV
ajlm-1255	82	5	reported	report	VERB
ajlm-1255	82	6	a	a	DET
ajlm-1255	82	7	sensitivity	sensitivity	NOUN
ajlm-1255	82	8	range	range	NOUN
ajlm-1255	82	9	of	of	ADP
ajlm-1255	82	10	72.7	72.7	NUM
ajlm-1255	82	11	%	%	NOUN
ajlm-1255	82	12	–	–	PUNCT
ajlm-1255	82	13	100.0	100.0	NUM
ajlm-1255	82	14	%	%	NOUN
ajlm-1255	82	15	and	and	CCONJ
ajlm-1255	82	16	specificity	specificity	NOUN
ajlm-1255	82	17	range	range	NOUN
ajlm-1255	82	18	of	of	ADP
ajlm-1255	82	19	98.7	98.7	NUM
ajlm-1255	82	20	%	%	NOUN
ajlm-1255	82	21	–	–	PUNCT
ajlm-1255	82	22	100.0	100.0	NUM
ajlm-1255	82	23	%	%	NOUN
ajlm-1255	82	24	for	for	ADP
ajlm-1255	82	25	igm	igm	PROPN
ajlm-1255	82	26	/	/	SYM
ajlm-1255	82	27	igg	igg	PROPN
ajlm-1255	82	28	duo	duo	NOUN
ajlm-1255	82	29	-	-	PUNCT
ajlm-1255	82	30	based	base	VERB
ajlm-1255	82	31	serological	serological	ADJ
ajlm-1255	82	32	rdt	rdt	PROPN
ajlm-1255	82	33	kits	kit	NOUN
ajlm-1255	82	34	for	for	ADP
ajlm-1255	82	35	covid-19	covid-19	PROPN
ajlm-1255	82	36	in	in	ADP
ajlm-1255	82	37	their	their	PRON
ajlm-1255	82	38	review	review	NOUN
ajlm-1255	82	39	in	in	ADP
ajlm-1255	82	40	which	which	PRON
ajlm-1255	82	41	nine	nine	NUM
ajlm-1255	82	42	serological	serological	ADJ
ajlm-1255	82	43	kits	kit	NOUN
ajlm-1255	82	44	were	be	AUX
ajlm-1255	82	45	analysed	analyse	VERB
ajlm-1255	82	46	.	.	PUNCT
ajlm-1255	83	1	the	the	DET
ajlm-1255	83	2	authors	author	NOUN
ajlm-1255	83	3	also	also	ADV
ajlm-1255	83	4	reported	report	VERB
ajlm-1255	83	5	a	a	DET
ajlm-1255	83	6	sensitivity	sensitivity	NOUN
ajlm-1255	83	7	range	range	NOUN
ajlm-1255	83	8	of	of	ADP
ajlm-1255	83	9	86.4	86.4	NUM
ajlm-1255	83	10	%	%	NOUN
ajlm-1255	83	11	–	–	PUNCT
ajlm-1255	83	12	90.6	90.6	NUM
ajlm-1255	83	13	%	%	NOUN
ajlm-1255	83	14	and	and	CCONJ
ajlm-1255	83	15	a	a	DET
ajlm-1255	83	16	specificity	specificity	NOUN
ajlm-1255	83	17	of	of	ADP
ajlm-1255	83	18	99	99	NUM
ajlm-1255	83	19	%	%	NOUN
ajlm-1255	83	20	for	for	ADP
ajlm-1255	83	21	total	total	ADJ
ajlm-1255	83	22	immunoglobulin	immunoglobulin	NOUN
ajlm-1255	83	23	-	-	PUNCT
ajlm-1255	83	24	based	base	VERB
ajlm-1255	83	25	rdts	rdts	NOUN
ajlm-1255	83	26	.	.	PUNCT
ajlm-1255	84	1	in	in	ADP
ajlm-1255	84	2	brazil	brazil	PROPN
ajlm-1255	84	3	,	,	PUNCT
ajlm-1255	84	4	castro	castro	PROPN
ajlm-1255	84	5	et	et	PROPN
ajlm-1255	84	6	al.30	al.30	PROPN
ajlm-1255	84	7	reported	report	VERB
ajlm-1255	84	8	a	a	DET
ajlm-1255	84	9	mean	mean	ADJ
ajlm-1255	84	10	(	(	PUNCT
ajlm-1255	84	11	range	range	NOUN
ajlm-1255	84	12	)	)	PUNCT
ajlm-1255	84	13	anti	anti	ADJ
ajlm-1255	84	14	-	-	ADJ
ajlm-1255	84	15	sars	sar	NOUN
ajlm-1255	84	16	-	-	PUNCT
ajlm-1255	84	17	cov-2	cov-2	NOUN
ajlm-1255	84	18	igm	igm	NOUN
ajlm-1255	84	19	sensitivity	sensitivity	NOUN
ajlm-1255	84	20	of	of	ADP
ajlm-1255	84	21	82	82	NUM
ajlm-1255	84	22	%	%	NOUN
ajlm-1255	84	23	(	(	PUNCT
ajlm-1255	84	24	76	76	NUM
ajlm-1255	84	25	%	%	NOUN
ajlm-1255	84	26	–	–	PUNCT
ajlm-1255	84	27	87	87	NUM
ajlm-1255	84	28	%	%	NOUN
ajlm-1255	84	29	)	)	PUNCT
ajlm-1255	84	30	and	and	CCONJ
ajlm-1255	84	31	specificity	specificity	NOUN
ajlm-1255	84	32	of	of	ADP
ajlm-1255	84	33	97	97	NUM
ajlm-1255	84	34	%	%	NOUN
ajlm-1255	84	35	(	(	PUNCT
ajlm-1255	84	36	96	96	NUM
ajlm-1255	84	37	%	%	NOUN
ajlm-1255	84	38	–	–	PUNCT
ajlm-1255	84	39	98	98	NUM
ajlm-1255	84	40	%	%	NOUN
ajlm-1255	84	41	)	)	PUNCT
ajlm-1255	84	42	and	and	CCONJ
ajlm-1255	84	43	anti	anti	ADJ
ajlm-1255	84	44	-	-	ADJ
ajlm-1255	84	45	sars	sar	NOUN
ajlm-1255	84	46	-	-	PUNCT
ajlm-1255	84	47	cov-2	cov-2	NOUN
ajlm-1255	84	48	igg	igg	NOUN
ajlm-1255	84	49	sensitivity	sensitivity	NOUN
ajlm-1255	84	50	of	of	ADP
ajlm-1255	84	51	97	97	NUM
ajlm-1255	84	52	%	%	NOUN
ajlm-1255	84	53	(	(	PUNCT
ajlm-1255	84	54	90	90	NUM
ajlm-1255	84	55	%	%	NOUN
ajlm-1255	84	56	–	–	PUNCT
ajlm-1255	84	57	99	99	NUM
ajlm-1255	84	58	%	%	NOUN
ajlm-1255	84	59	)	)	PUNCT
ajlm-1255	84	60	and	and	CCONJ
ajlm-1255	84	61	specificity	specificity	NOUN
ajlm-1255	84	62	of	of	ADP
ajlm-1255	84	63	98	98	NUM
ajlm-1255	84	64	%	%	NOUN
ajlm-1255	84	65	(	(	PUNCT
ajlm-1255	84	66	97	97	NUM
ajlm-1255	84	67	%	%	NOUN
ajlm-1255	84	68	–	–	PUNCT
ajlm-1255	84	69	99	99	NUM
ajlm-1255	84	70	%	%	NOUN
ajlm-1255	84	71	)	)	PUNCT
ajlm-1255	84	72	.	.	PUNCT
ajlm-1255	85	1	although	although	SCONJ
ajlm-1255	85	2	in	in	ADP
ajlm-1255	85	3	this	this	DET
ajlm-1255	85	4	review	review	NOUN
ajlm-1255	85	5	,	,	PUNCT
ajlm-1255	85	6	only	only	ADV
ajlm-1255	85	7	5	5	NUM
ajlm-1255	85	8	of	of	ADP
ajlm-1255	85	9	the	the	DET
ajlm-1255	85	10	18	18	NUM
ajlm-1255	85	11	serological	serological	ADJ
ajlm-1255	85	12	rdt	rdt	PROPN
ajlm-1255	85	13	kits	kit	NOUN
ajlm-1255	85	14	offered	offer	VERB
ajlm-1255	85	15	combined	combine	VERB
ajlm-1255	85	16	igm	igm	PROPN
ajlm-1255	85	17	and	and	CCONJ
ajlm-1255	85	18	igg	igg	PROPN
ajlm-1255	85	19	detection	detection	PROPN
ajlm-1255	85	20	,	,	PUNCT
ajlm-1255	85	21	we	we	PRON
ajlm-1255	85	22	also	also	ADV
ajlm-1255	85	23	found	find	VERB
ajlm-1255	85	24	a	a	DET
ajlm-1255	85	25	better	well	ADJ
ajlm-1255	85	26	performance	performance	NOUN
ajlm-1255	85	27	characteristic	characteristic	ADJ
ajlm-1255	85	28	for	for	ADP
ajlm-1255	85	29	this	this	DET
ajlm-1255	85	30	type	type	NOUN
ajlm-1255	85	31	of	of	ADP
ajlm-1255	85	32	rdt	rdt	PROPN
ajlm-1255	85	33	kit	kit	NOUN
ajlm-1255	85	34	compared	compare	VERB
ajlm-1255	85	35	to	to	ADP
ajlm-1255	85	36	the	the	DET
ajlm-1255	85	37	antigen	antigen	NOUN
ajlm-1255	85	38	and	and	CCONJ
ajlm-1255	85	39	total	total	ADJ
ajlm-1255	85	40	immunoglobulin	immunoglobulin	NOUN
ajlm-1255	85	41	kits	kit	NOUN
ajlm-1255	85	42	using	use	VERB
ajlm-1255	85	43	non	non	ADJ
ajlm-1255	85	44	-	-	ADJ
ajlm-1255	85	45	colloidal	colloidal	ADJ
ajlm-1255	85	46	gold	gold	NOUN
ajlm-1255	85	47	labelling	labelling	NOUN
ajlm-1255	85	48	system	system	NOUN
ajlm-1255	85	49	with	with	ADP
ajlm-1255	85	50	acceptable	acceptable	ADJ
ajlm-1255	85	51	sensitivity	sensitivity	NOUN
ajlm-1255	85	52	(	(	PUNCT
ajlm-1255	85	53	98	98	NUM
ajlm-1255	85	54	%	%	NOUN
ajlm-1255	85	55	–	–	PUNCT
ajlm-1255	85	56	100	100	NUM
ajlm-1255	85	57	%	%	NOUN
ajlm-1255	85	58	)	)	PUNCT
ajlm-1255	85	59	and	and	CCONJ
ajlm-1255	85	60	a	a	DET
ajlm-1255	85	61	specificity	specificity	NOUN
ajlm-1255	85	62	(	(	PUNCT
ajlm-1255	85	63	98	98	NUM
ajlm-1255	85	64	%	%	NOUN
ajlm-1255	85	65	–	–	PUNCT
ajlm-1255	85	66	99	99	NUM
ajlm-1255	85	67	%	%	NOUN
ajlm-1255	85	68	)	)	PUNCT
ajlm-1255	85	69	values	value	NOUN
ajlm-1255	85	70	for	for	ADP
ajlm-1255	85	71	igg	igg	NOUN
ajlm-1255	85	72	and	and	CCONJ
ajlm-1255	85	73	specificity	specificity	NOUN
ajlm-1255	85	74	of	of	ADP
ajlm-1255	85	75	96	96	NUM
ajlm-1255	85	76	%	%	NOUN
ajlm-1255	85	77	–	–	PUNCT
ajlm-1255	85	78	99	99	NUM
ajlm-1255	85	79	%	%	NOUN
ajlm-1255	85	80	for	for	ADP
ajlm-1255	85	81	igm	igm	PROPN
ajlm-1255	85	82	,	,	PUNCT
ajlm-1255	85	83	suggesting	suggest	VERB
ajlm-1255	85	84	the	the	DET
ajlm-1255	85	85	ability	ability	NOUN
ajlm-1255	85	86	of	of	ADP
ajlm-1255	85	87	these	these	DET
ajlm-1255	85	88	kits	kit	NOUN
ajlm-1255	85	89	to	to	PART
ajlm-1255	85	90	detect	detect	VERB
ajlm-1255	85	91	past	past	ADJ
ajlm-1255	85	92	infections	infection	NOUN
ajlm-1255	85	93	,	,	PUNCT
ajlm-1255	85	94	confirm	confirm	VERB
ajlm-1255	85	95	true	true	ADJ
ajlm-1255	85	96	negative	negative	ADJ
ajlm-1255	85	97	results	result	NOUN
ajlm-1255	85	98	and	and	CCONJ
ajlm-1255	85	99	rule	rule	VERB
ajlm-1255	85	100	out	out	ADP
ajlm-1255	85	101	false	false	ADJ
ajlm-1255	85	102	positive	positive	ADJ
ajlm-1255	85	103	covid-19	covid-19	PROPN
ajlm-1255	85	104	testing	testing	NOUN
ajlm-1255	85	105	results	result	NOUN
ajlm-1255	85	106	by	by	ADP
ajlm-1255	85	107	rt	rt	NOUN
ajlm-1255	85	108	-	-	PUNCT
ajlm-1255	85	109	pcr	pcr	NOUN
ajlm-1255	85	110	.	.	PUNCT
ajlm-1255	86	1	however	however	ADV
ajlm-1255	86	2	,	,	PUNCT
ajlm-1255	86	3	the	the	DET
ajlm-1255	86	4	performance	performance	NOUN
ajlm-1255	86	5	of	of	ADP
ajlm-1255	86	6	these	these	DET
ajlm-1255	86	7	kits	kit	NOUN
ajlm-1255	86	8	to	to	PART
ajlm-1255	86	9	confirm	confirm	VERB
ajlm-1255	86	10	recent	recent	ADJ
ajlm-1255	86	11	infections	infection	NOUN
ajlm-1255	86	12	seems	seem	VERB
ajlm-1255	86	13	to	to	PART
ajlm-1255	86	14	be	be	AUX
ajlm-1255	86	15	below	below	ADP
ajlm-1255	86	16	the	the	DET
ajlm-1255	86	17	benchmark	benchmark	NOUN
ajlm-1255	86	18	of	of	ADP
ajlm-1255	86	19	95	95	NUM
ajlm-1255	86	20	%	%	NOUN
ajlm-1255	86	21	,	,	PUNCT
ajlm-1255	86	22	since	since	SCONJ
ajlm-1255	86	23	they	they	PRON
ajlm-1255	86	24	had	have	VERB
ajlm-1255	86	25	a	a	DET
ajlm-1255	86	26	sensitivity	sensitivity	NOUN
ajlm-1255	86	27	range	range	NOUN
ajlm-1255	86	28	of	of	ADP
ajlm-1255	86	29	85	85	NUM
ajlm-1255	86	30	%	%	NOUN
ajlm-1255	86	31	–	–	PUNCT
ajlm-1255	86	32	94	94	NUM
ajlm-1255	86	33	%	%	NOUN
ajlm-1255	86	34	,	,	PUNCT
ajlm-1255	86	35	which	which	PRON
ajlm-1255	86	36	was	be	AUX
ajlm-1255	86	37	even	even	ADV
ajlm-1255	86	38	lower	low	ADJ
ajlm-1255	86	39	for	for	ADP
ajlm-1255	86	40	colloidal	colloidal	NOUN
ajlm-1255	86	41	gold	gold	NOUN
ajlm-1255	86	42	labelling	labelling	NOUN
ajlm-1255	86	43	systems	system	NOUN
ajlm-1255	86	44	at	at	ADP
ajlm-1255	86	45	57.1	57.1	NUM
ajlm-1255	86	46	%	%	NOUN
ajlm-1255	86	47	.	.	PUNCT
ajlm-1255	87	1	meanwhile	meanwhile	ADV
ajlm-1255	87	2	,	,	PUNCT
ajlm-1255	87	3	the	the	DET
ajlm-1255	87	4	improvement	improvement	NOUN
ajlm-1255	87	5	offered	offer	VERB
ajlm-1255	87	6	by	by	ADP
ajlm-1255	87	7	the	the	DET
ajlm-1255	87	8	antigen	antigen	NOUN
ajlm-1255	87	9	-	-	PUNCT
ajlm-1255	87	10	based	base	VERB
ajlm-1255	87	11	rdt	rdt	PROPN
ajlm-1255	87	12	kits	kit	NOUN
ajlm-1255	87	13	in	in	ADP
ajlm-1255	87	14	this	this	DET
ajlm-1255	87	15	review	review	NOUN
ajlm-1255	87	16	can	can	AUX
ajlm-1255	87	17	be	be	AUX
ajlm-1255	87	18	said	say	VERB
ajlm-1255	87	19	to	to	PART
ajlm-1255	87	20	be	be	AUX
ajlm-1255	87	21	none	none	NOUN
ajlm-1255	87	22	or	or	CCONJ
ajlm-1255	87	23	marginal	marginal	ADJ
ajlm-1255	87	24	at	at	ADP
ajlm-1255	87	25	84.4	84.4	NUM
ajlm-1255	87	26	%	%	NOUN
ajlm-1255	87	27	–	–	PUNCT
ajlm-1255	87	28	96	96	NUM
ajlm-1255	87	29	%	%	NOUN
ajlm-1255	87	30	.	.	PUNCT
ajlm-1255	88	1	another	another	DET
ajlm-1255	88	2	implication	implication	NOUN
ajlm-1255	88	3	of	of	ADP
ajlm-1255	88	4	these	these	DET
ajlm-1255	88	5	findings	finding	NOUN
ajlm-1255	88	6	is	be	AUX
ajlm-1255	88	7	that	that	SCONJ
ajlm-1255	88	8	more	more	ADJ
ajlm-1255	88	9	than	than	ADP
ajlm-1255	88	10	one	one	NUM
ajlm-1255	88	11	serological	serological	ADJ
ajlm-1255	88	12	rdt	rdt	ADJ
ajlm-1255	88	13	kit	kit	NOUN
ajlm-1255	88	14	may	may	AUX
ajlm-1255	88	15	be	be	AUX
ajlm-1255	88	16	needed	need	VERB
ajlm-1255	88	17	for	for	ADP
ajlm-1255	88	18	a	a	DET
ajlm-1255	88	19	sars	sar	NOUN
ajlm-1255	88	20	-	-	PUNCT
ajlm-1255	88	21	cov-2	cov-2	NOUN
ajlm-1255	88	22	detection	detection	NOUN
ajlm-1255	88	23	algorithm	algorithm	NOUN
ajlm-1255	88	24	to	to	PART
ajlm-1255	88	25	improve	improve	VERB
ajlm-1255	88	26	confirmation	confirmation	NOUN
ajlm-1255	88	27	and	and	CCONJ
ajlm-1255	88	28	diagnosis	diagnosis	NOUN
ajlm-1255	88	29	of	of	ADP
ajlm-1255	88	30	covid-19	covid-19	PROPN
ajlm-1255	88	31	by	by	ADP
ajlm-1255	88	32	rt	rt	PROPN
ajlm-1255	88	33	-	-	PUNCT
ajlm-1255	88	34	pcr	pcr	NOUN
ajlm-1255	88	35	,	,	PUNCT
ajlm-1255	88	36	if	if	SCONJ
ajlm-1255	88	37	deployed	deploy	VERB
ajlm-1255	88	38	in	in	ADP
ajlm-1255	88	39	lmics	lmic	NOUN
ajlm-1255	88	40	.	.	PUNCT
ajlm-1255	89	1	it	it	PRON
ajlm-1255	89	2	is	be	AUX
ajlm-1255	89	3	also	also	ADV
ajlm-1255	89	4	important	important	ADJ
ajlm-1255	89	5	to	to	PART
ajlm-1255	89	6	note	note	VERB
ajlm-1255	89	7	that	that	SCONJ
ajlm-1255	89	8	6	6	NUM
ajlm-1255	89	9	of	of	ADP
ajlm-1255	89	10	the	the	DET
ajlm-1255	89	11	18	18	NUM
ajlm-1255	89	12	reviewed	review	VERB
ajlm-1255	89	13	serological	serological	ADJ
ajlm-1255	89	14	rdt	rdt	PROPN
ajlm-1255	89	15	kits	kit	NOUN
ajlm-1255	89	16	lacked	lack	VERB
ajlm-1255	89	17	reports	report	NOUN
ajlm-1255	89	18	on	on	ADP
ajlm-1255	89	19	sensitivity	sensitivity	NOUN
ajlm-1255	89	20	and	and	CCONJ
ajlm-1255	89	21	specificity	specificity	NOUN
ajlm-1255	89	22	,	,	PUNCT
ajlm-1255	89	23	thus	thus	ADV
ajlm-1255	89	24	the	the	DET
ajlm-1255	89	25	accuracy	accuracy	NOUN
ajlm-1255	89	26	in	in	ADP
ajlm-1255	89	27	diagnosising	diagnosise	VERB
ajlm-1255	89	28	covid-19	covid-19	PROPN
ajlm-1255	89	29	is	be	AUX
ajlm-1255	89	30	unknown	unknown	ADJ
ajlm-1255	89	31	as	as	ADP
ajlm-1255	89	32	at	at	ADP
ajlm-1255	89	33	the	the	DET
ajlm-1255	89	34	time	time	NOUN
ajlm-1255	89	35	of	of	ADP
ajlm-1255	89	36	this	this	DET
ajlm-1255	89	37	review	review	NOUN
ajlm-1255	89	38	.	.	PUNCT
ajlm-1255	90	1	this	this	DET
ajlm-1255	90	2	finding	finding	NOUN
ajlm-1255	90	3	further	far	ADV
ajlm-1255	90	4	reiterates	reiterate	VERB
ajlm-1255	90	5	the	the	DET
ajlm-1255	90	6	difficulty	difficulty	NOUN
ajlm-1255	90	7	associated	associate	VERB
ajlm-1255	90	8	with	with	ADP
ajlm-1255	90	9	sars	sar	NOUN
ajlm-1255	90	10	-	-	PUNCT
ajlm-1255	90	11	cov-2	cov-2	NOUN
ajlm-1255	90	12	serological	serological	ADJ
ajlm-1255	90	13	rdt	rdt	PROPN
ajlm-1255	90	14	kit	kit	NOUN
ajlm-1255	90	15	validation	validation	NOUN
ajlm-1255	90	16	by	by	ADP
ajlm-1255	90	17	manufacturers	manufacturer	NOUN
ajlm-1255	90	18	,	,	PUNCT
ajlm-1255	90	19	since	since	SCONJ
ajlm-1255	90	20	rt	rt	PROPN
ajlm-1255	90	21	-	-	PUNCT
ajlm-1255	90	22	pcr	pcr	NOUN
ajlm-1255	90	23	the	the	DET
ajlm-1255	90	24	reference	reference	NOUN
ajlm-1255	90	25	method	method	NOUN
ajlm-1255	90	26	targets	target	VERB
ajlm-1255	90	27	viral	viral	ADJ
ajlm-1255	90	28	rna	rna	NOUN
ajlm-1255	90	29	instead	instead	ADV
ajlm-1255	90	30	of	of	ADP
ajlm-1255	90	31	specific	specific	ADJ
ajlm-1255	90	32	sars	sar	NOUN
ajlm-1255	90	33	-	-	PUNCT
ajlm-1255	90	34	cov-2	cov-2	NOUN
ajlm-1255	90	35	antibodies	antibody	NOUN
ajlm-1255	90	36	or	or	CCONJ
ajlm-1255	90	37	antigens	antigen	NOUN
ajlm-1255	90	38	.	.	PUNCT
ajlm-1255	91	1	a	a	DET
ajlm-1255	91	2	similar	similar	ADJ
ajlm-1255	91	3	opinion	opinion	NOUN
ajlm-1255	91	4	has	have	AUX
ajlm-1255	91	5	been	be	AUX
ajlm-1255	91	6	shared	share	VERB
ajlm-1255	91	7	by	by	ADP
ajlm-1255	91	8	castrol	castrol	NOUN
ajlm-1255	91	9	et	et	PROPN
ajlm-1255	91	10	al	al	PROPN
ajlm-1255	91	11	.	.	PROPN
ajlm-1255	91	12	,30	,30	PUNCT
ajlm-1255	91	13	given	give	VERB
ajlm-1255	91	14	the	the	DET
ajlm-1255	91	15	well	well	ADV
ajlm-1255	91	16	-	-	PUNCT
ajlm-1255	91	17	documented	document	VERB
ajlm-1255	91	18	differences	difference	NOUN
ajlm-1255	91	19	in	in	ADP
ajlm-1255	91	20	the	the	DET
ajlm-1255	91	21	kinetics	kinetic	NOUN
ajlm-1255	91	22	of	of	ADP
ajlm-1255	91	23	the	the	DET
ajlm-1255	91	24	viral	viral	ADJ
ajlm-1255	91	25	rna	rna	NOUN
ajlm-1255	91	26	(	(	PUNCT
ajlm-1255	91	27	even	even	ADV
ajlm-1255	91	28	between	between	ADP
ajlm-1255	91	29	samples	sample	NOUN
ajlm-1255	91	30	)	)	PUNCT
ajlm-1255	91	31	and	and	CCONJ
ajlm-1255	91	32	anti	anti	ADJ
ajlm-1255	91	33	-	-	ADJ
ajlm-1255	91	34	sars	sar	NOUN
ajlm-1255	91	35	-	-	PUNCT
ajlm-1255	91	36	cov-2	cov-2	NOUN
ajlm-1255	91	37	antibodies	antibody	NOUN
ajlm-1255	91	38	in	in	ADP
ajlm-1255	91	39	infected	infected	ADJ
ajlm-1255	91	40	individuals	individual	NOUN
ajlm-1255	91	41	.	.	PUNCT
ajlm-1255	92	1	as	as	ADP
ajlm-1255	92	2	of	of	ADP
ajlm-1255	92	3	01	01	NUM
ajlm-1255	92	4	april	april	PROPN
ajlm-1255	92	5	2020	2020	NUM
ajlm-1255	92	6	,	,	PUNCT
ajlm-1255	92	7	the	the	DET
ajlm-1255	92	8	death	death	NOUN
ajlm-1255	92	9	toll	toll	NOUN
ajlm-1255	92	10	for	for	ADP
ajlm-1255	92	11	covid-19	covid-19	PROPN
ajlm-1255	92	12	was	be	AUX
ajlm-1255	92	13	over	over	ADP
ajlm-1255	92	14	a	a	DET
ajlm-1255	92	15	million	million	NUM
ajlm-1255	92	16	globally	globally	ADV
ajlm-1255	92	17	and	and	CCONJ
ajlm-1255	92	18	the	the	DET
ajlm-1255	92	19	need	need	NOUN
ajlm-1255	92	20	for	for	ADP
ajlm-1255	92	21	accurate	accurate	ADJ
ajlm-1255	92	22	intervention	intervention	NOUN
ajlm-1255	92	23	to	to	PART
ajlm-1255	92	24	stop	stop	VERB
ajlm-1255	92	25	transmission	transmission	NOUN
ajlm-1255	92	26	and	and	CCONJ
ajlm-1255	92	27	re	re	NOUN
ajlm-1255	92	28	-	-	NOUN
ajlm-1255	92	29	infection	infection	NOUN
ajlm-1255	92	30	of	of	ADP
ajlm-1255	92	31	covid-19	covid-19	PROPN
ajlm-1255	92	32	is	be	AUX
ajlm-1255	92	33	now	now	ADV
ajlm-1255	92	34	extremely	extremely	ADV
ajlm-1255	92	35	necessary	necessary	ADJ
ajlm-1255	92	36	.	.	PUNCT
ajlm-1255	93	1	the	the	PRON
ajlm-1255	93	2	who	who	PRON
ajlm-1255	93	3	advises	advise	VERB
ajlm-1255	93	4	countries	country	NOUN
ajlm-1255	93	5	to	to	PART
ajlm-1255	93	6	improve	improve	VERB
ajlm-1255	93	7	the	the	DET
ajlm-1255	93	8	rate	rate	NOUN
ajlm-1255	93	9	of	of	ADP
ajlm-1255	93	10	testing	testing	NOUN
ajlm-1255	93	11	to	to	PART
ajlm-1255	93	12	identify	identify	VERB
ajlm-1255	93	13	an	an	DET
ajlm-1255	93	14	infected	infected	ADJ
ajlm-1255	93	15	individual	individual	NOUN
ajlm-1255	93	16	for	for	ADP
ajlm-1255	93	17	appropriate	appropriate	ADJ
ajlm-1255	93	18	isolation	isolation	NOUN
ajlm-1255	93	19	and	and	CCONJ
ajlm-1255	93	20	treatment	treatment	NOUN
ajlm-1255	93	21	.	.	PUNCT
ajlm-1255	94	1	the	the	DET
ajlm-1255	94	2	availability	availability	NOUN
ajlm-1255	94	3	of	of	ADP
ajlm-1255	94	4	efficient	efficient	ADJ
ajlm-1255	94	5	and	and	CCONJ
ajlm-1255	94	6	rapid	rapid	ADJ
ajlm-1255	94	7	diagnostics	diagnostic	NOUN
ajlm-1255	94	8	for	for	ADP
ajlm-1255	94	9	covid-19	covid-19	PROPN
ajlm-1255	94	10	has	have	AUX
ajlm-1255	94	11	been	be	AUX
ajlm-1255	94	12	indicated	indicate	VERB
ajlm-1255	94	13	as	as	ADP
ajlm-1255	94	14	one	one	NUM
ajlm-1255	94	15	of	of	ADP
ajlm-1255	94	16	the	the	DET
ajlm-1255	94	17	mitigation	mitigation	NOUN
ajlm-1255	94	18	strategies	strategy	NOUN
ajlm-1255	94	19	to	to	PART
ajlm-1255	94	20	control	control	VERB
ajlm-1255	94	21	the	the	DET
ajlm-1255	94	22	pandemic	pandemic	ADJ
ajlm-1255	94	23	.	.	PUNCT
ajlm-1255	95	1	rapid	rapid	ADJ
ajlm-1255	95	2	diagnostic	diagnostic	ADJ
ajlm-1255	95	3	tests	test	NOUN
ajlm-1255	95	4	are	be	AUX
ajlm-1255	95	5	cheaper	cheap	ADJ
ajlm-1255	95	6	and	and	CCONJ
ajlm-1255	95	7	more	more	ADV
ajlm-1255	95	8	readily	readily	ADV
ajlm-1255	95	9	available	available	ADJ
ajlm-1255	95	10	;	;	PUNCT
ajlm-1255	95	11	thus	thus	ADV
ajlm-1255	95	12	,	,	PUNCT
ajlm-1255	95	13	they	they	PRON
ajlm-1255	95	14	might	might	AUX
ajlm-1255	95	15	be	be	AUX
ajlm-1255	95	16	more	more	ADV
ajlm-1255	95	17	useful	useful	ADJ
ajlm-1255	95	18	stopping	stopping	NOUN
ajlm-1255	95	19	transmission	transmission	NOUN
ajlm-1255	95	20	by	by	ADP
ajlm-1255	95	21	rapidly	rapidly	ADV
ajlm-1255	95	22	identifying	identify	VERB
ajlm-1255	95	23	positive	positive	ADJ
ajlm-1255	95	24	and	and	CCONJ
ajlm-1255	95	25	previous	previous	ADJ
ajlm-1255	95	26	cases	case	NOUN
ajlm-1255	95	27	particularly	particularly	ADV
ajlm-1255	95	28	in	in	ADP
ajlm-1255	95	29	lmics	lmic	NOUN
ajlm-1255	95	30	.	.	PUNCT
ajlm-1255	96	1	these	these	DET
ajlm-1255	96	2	data	datum	NOUN
ajlm-1255	96	3	will	will	AUX
ajlm-1255	96	4	in	in	ADP
ajlm-1255	96	5	turn	turn	NOUN
ajlm-1255	96	6	be	be	AUX
ajlm-1255	96	7	useful	useful	ADJ
ajlm-1255	96	8	for	for	ADP
ajlm-1255	96	9	both	both	DET
ajlm-1255	96	10	disease	disease	NOUN
ajlm-1255	96	11	diagnosis	diagnosis	NOUN
ajlm-1255	96	12	and	and	CCONJ
ajlm-1255	96	13	surveillance	surveillance	NOUN
ajlm-1255	96	14	.	.	PUNCT
ajlm-1255	97	1	the	the	DET
ajlm-1255	97	2	rdt	rdt	PROPN
ajlm-1255	97	3	will	will	AUX
ajlm-1255	97	4	either	either	CCONJ
ajlm-1255	97	5	detect	detect	VERB
ajlm-1255	97	6	the	the	DET
ajlm-1255	97	7	presence	presence	NOUN
ajlm-1255	97	8	of	of	ADP
ajlm-1255	97	9	viral	viral	ADJ
ajlm-1255	97	10	proteins	protein	NOUN
ajlm-1255	97	11	(	(	PUNCT
ajlm-1255	97	12	antigens	antigen	NOUN
ajlm-1255	97	13	)	)	PUNCT
ajlm-1255	97	14	expressed	express	VERB
ajlm-1255	97	15	by	by	ADP
ajlm-1255	97	16	the	the	DET
ajlm-1255	97	17	covid-19	covid-19	PROPN
ajlm-1255	97	18	virus	virus	NOUN
ajlm-1255	97	19	or	or	CCONJ
ajlm-1255	97	20	the	the	DET
ajlm-1255	97	21	presence	presence	NOUN
ajlm-1255	97	22	of	of	ADP
ajlm-1255	97	23	antibodies	antibody	NOUN
ajlm-1255	97	24	in	in	ADP
ajlm-1255	97	25	the	the	DET
ajlm-1255	97	26	blood	blood	NOUN
ajlm-1255	97	27	of	of	ADP
ajlm-1255	97	28	covid-19	covid-19	PROPN
ajlm-1255	97	29	-	-	PUNCT
ajlm-1255	97	30	infected	infect	VERB
ajlm-1255	97	31	people.31,32	people.31,32	VERB
ajlm-1255	97	32	the	the	DET
ajlm-1255	97	33	performance	performance	NOUN
ajlm-1255	97	34	of	of	ADP
ajlm-1255	97	35	the	the	DET
ajlm-1255	97	36	kits	kit	NOUN
ajlm-1255	97	37	has	have	AUX
ajlm-1255	97	38	been	be	AUX
ajlm-1255	97	39	shown	show	VERB
ajlm-1255	97	40	to	to	PART
ajlm-1255	97	41	depend	depend	VERB
ajlm-1255	97	42	on	on	ADP
ajlm-1255	97	43	several	several	ADJ
ajlm-1255	97	44	factors	factor	NOUN
ajlm-1255	97	45	such	such	ADJ
ajlm-1255	97	46	as	as	ADP
ajlm-1255	97	47	the	the	DET
ajlm-1255	97	48	onset	onset	NOUN
ajlm-1255	97	49	of	of	ADP
ajlm-1255	97	50	illness	illness	NOUN
ajlm-1255	97	51	,	,	PUNCT
ajlm-1255	97	52	the	the	DET
ajlm-1255	97	53	viral	viral	ADJ
ajlm-1255	97	54	load	load	NOUN
ajlm-1255	97	55	in	in	ADP
ajlm-1255	97	56	the	the	DET
ajlm-1255	97	57	specimen	speciman	NOUN
ajlm-1255	97	58	,	,	PUNCT
ajlm-1255	97	59	the	the	DET
ajlm-1255	97	60	integrity	integrity	NOUN
ajlm-1255	97	61	of	of	ADP
ajlm-1255	97	62	the	the	DET
ajlm-1255	97	63	specimen	speciman	NOUN
ajlm-1255	97	64	collected	collect	VERB
ajlm-1255	97	65	from	from	ADP
ajlm-1255	97	66	suspected	suspect	VERB
ajlm-1255	97	67	cases	case	NOUN
ajlm-1255	97	68	,	,	PUNCT
ajlm-1255	97	69	processing	processing	NOUN
ajlm-1255	97	70	,	,	PUNCT
ajlm-1255	97	71	age	age	NOUN
ajlm-1255	97	72	,	,	PUNCT
ajlm-1255	97	73	nutritional	nutritional	ADJ
ajlm-1255	97	74	status	status	NOUN
ajlm-1255	97	75	,	,	PUNCT
ajlm-1255	97	76	the	the	DET
ajlm-1255	97	77	severity	severity	NOUN
ajlm-1255	97	78	of	of	ADP
ajlm-1255	97	79	the	the	DET
ajlm-1255	97	80	disease	disease	NOUN
ajlm-1255	97	81	,	,	PUNCT
ajlm-1255	97	82	and	and	CCONJ
ajlm-1255	97	83	certain	certain	ADJ
ajlm-1255	97	84	medications	medication	NOUN
ajlm-1255	97	85	or	or	CCONJ
ajlm-1255	97	86	underlying	underlie	VERB
ajlm-1255	97	87	disease	disease	NOUN
ajlm-1255	97	88	condition	condition	NOUN
ajlm-1255	97	89	,	,	PUNCT
ajlm-1255	97	90	especially	especially	ADV
ajlm-1255	97	91	immune	immune	ADJ
ajlm-1255	97	92	suppression	suppression	NOUN
ajlm-1255	97	93	diseases	disease	NOUN
ajlm-1255	97	94	and	and	CCONJ
ajlm-1255	97	95	the	the	DET
ajlm-1255	97	96	precise	precise	ADJ
ajlm-1255	97	97	formulation	formulation	NOUN
ajlm-1255	97	98	of	of	ADP
ajlm-1255	97	99	the	the	DET
ajlm-1255	97	100	reagents	reagent	NOUN
ajlm-1255	97	101	in	in	ADP
ajlm-1255	97	102	the	the	DET
ajlm-1255	97	103	test	test	NOUN
ajlm-1255	97	104	kits.19	kits.19	VERB
ajlm-1255	97	105	the	the	DET
ajlm-1255	97	106	lmics	lmic	NOUN
ajlm-1255	97	107	reported	report	VERB
ajlm-1255	97	108	the	the	DET
ajlm-1255	97	109	lowest	low	ADJ
ajlm-1255	97	110	rate	rate	NOUN
ajlm-1255	97	111	of	of	ADP
ajlm-1255	97	112	testing	testing	NOUN
ajlm-1255	97	113	per	per	ADP
ajlm-1255	97	114	population	population	NOUN
ajlm-1255	97	115	with	with	ADP
ajlm-1255	97	116	corresponding	correspond	VERB
ajlm-1255	97	117	lower	low	ADJ
ajlm-1255	97	118	numbers	number	NOUN
ajlm-1255	97	119	of	of	ADP
ajlm-1255	97	120	cases	case	NOUN
ajlm-1255	97	121	compared	compare	VERB
ajlm-1255	97	122	with	with	ADP
ajlm-1255	97	123	developed	develop	VERB
ajlm-1255	97	124	countries	country	NOUN
ajlm-1255	97	125	.	.	PUNCT
ajlm-1255	98	1	this	this	PRON
ajlm-1255	98	2	may	may	AUX
ajlm-1255	98	3	be	be	AUX
ajlm-1255	98	4	an	an	DET
ajlm-1255	98	5	indication	indication	NOUN
ajlm-1255	98	6	of	of	ADP
ajlm-1255	98	7	limited	limited	ADJ
ajlm-1255	98	8	testing	testing	NOUN
ajlm-1255	98	9	resources	resource	NOUN
ajlm-1255	98	10	and	and	CCONJ
ajlm-1255	98	11	facilities	facility	NOUN
ajlm-1255	98	12	due	due	ADP
ajlm-1255	98	13	to	to	ADP
ajlm-1255	98	14	the	the	DET
ajlm-1255	98	15	challenges	challenge	NOUN
ajlm-1255	98	16	associated	associate	VERB
ajlm-1255	98	17	with	with	ADP
ajlm-1255	98	18	rt	rt	PROPN
ajlm-1255	98	19	-	-	PUNCT
ajlm-1255	98	20	pcr	pcr	NOUN
ajlm-1255	98	21	.	.	PUNCT
ajlm-1255	99	1	therefore	therefore	ADV
ajlm-1255	99	2	,	,	PUNCT
ajlm-1255	99	3	there	there	PRON
ajlm-1255	99	4	may	may	AUX
ajlm-1255	99	5	be	be	AUX
ajlm-1255	99	6	several	several	ADJ
ajlm-1255	99	7	cases	case	NOUN
ajlm-1255	99	8	in	in	ADP
ajlm-1255	99	9	this	this	DET
ajlm-1255	99	10	population	population	NOUN
ajlm-1255	99	11	that	that	PRON
ajlm-1255	99	12	are	be	AUX
ajlm-1255	99	13	not	not	PART
ajlm-1255	99	14	detected	detect	VERB
ajlm-1255	99	15	with	with	ADP
ajlm-1255	99	16	antecedent	antecedent	NOUN
ajlm-1255	99	17	clinical	clinical	ADJ
ajlm-1255	99	18	implications	implication	NOUN
ajlm-1255	99	19	.	.	PUNCT
ajlm-1255	100	1	the	the	DET
ajlm-1255	100	2	use	use	NOUN
ajlm-1255	100	3	of	of	ADP
ajlm-1255	100	4	rdts	rdts	ADJ
ajlm-1255	100	5	will	will	AUX
ajlm-1255	100	6	not	not	PART
ajlm-1255	100	7	only	only	ADV
ajlm-1255	100	8	help	help	VERB
ajlm-1255	100	9	to	to	PART
ajlm-1255	100	10	detect	detect	VERB
ajlm-1255	100	11	currently	currently	ADV
ajlm-1255	100	12	infected	infect	VERB
ajlm-1255	100	13	or	or	CCONJ
ajlm-1255	100	14	previously	previously	ADV
ajlm-1255	100	15	exposed	expose	VERB
ajlm-1255	100	16	individuals	individual	NOUN
ajlm-1255	100	17	who	who	PRON
ajlm-1255	100	18	have	have	AUX
ajlm-1255	100	19	developed	develop	VERB
ajlm-1255	100	20	immunity	immunity	NOUN
ajlm-1255	100	21	as	as	ADV
ajlm-1255	100	22	well	well	ADV
ajlm-1255	100	23	as	as	ADP
ajlm-1255	100	24	identify	identify	VERB
ajlm-1255	100	25	asymptomatic	asymptomatic	ADJ
ajlm-1255	100	26	carriers	carrier	NOUN
ajlm-1255	100	27	.	.	PUNCT
ajlm-1255	101	1	these	these	PRON
ajlm-1255	101	2	will	will	AUX
ajlm-1255	101	3	inform	inform	VERB
ajlm-1255	101	4	decisions	decision	NOUN
ajlm-1255	101	5	for	for	ADP
ajlm-1255	101	6	public	public	ADJ
ajlm-1255	101	7	health	health	NOUN
ajlm-1255	101	8	measures	measure	NOUN
ajlm-1255	101	9	,	,	PUNCT
ajlm-1255	101	10	for	for	ADP
ajlm-1255	101	11	example	example	NOUN
ajlm-1255	101	12	,	,	PUNCT
ajlm-1255	101	13	cases	case	NOUN
ajlm-1255	101	14	among	among	ADP
ajlm-1255	101	15	a	a	DET
ajlm-1255	101	16	more	more	ADV
ajlm-1255	101	17	igm	igm	ADJ
ajlm-1255	101	18	-	-	PUNCT
ajlm-1255	101	19	positive	positive	ADJ
ajlm-1255	101	20	population	population	NOUN
ajlm-1255	101	21	may	may	AUX
ajlm-1255	101	22	be	be	AUX
ajlm-1255	101	23	an	an	DET
ajlm-1255	101	24	indication	indication	NOUN
ajlm-1255	101	25	of	of	ADP
ajlm-1255	101	26	a	a	DET
ajlm-1255	101	27	subclinical	subclinical	ADJ
ajlm-1255	101	28	outbreak	outbreak	NOUN
ajlm-1255	101	29	.	.	PUNCT
ajlm-1255	102	1	the	the	DET
ajlm-1255	102	2	economic	economic	ADJ
ajlm-1255	102	3	impact	impact	NOUN
ajlm-1255	102	4	of	of	ADP
ajlm-1255	102	5	movement	movement	NOUN
ajlm-1255	102	6	restrictions	restriction	NOUN
ajlm-1255	102	7	and	and	CCONJ
ajlm-1255	102	8	lockdowns	lockdown	NOUN
ajlm-1255	102	9	in	in	ADP
ajlm-1255	102	10	many	many	ADJ
ajlm-1255	102	11	of	of	ADP
ajlm-1255	102	12	these	these	DET
ajlm-1255	102	13	countries	country	NOUN
ajlm-1255	102	14	is	be	AUX
ajlm-1255	102	15	not	not	PART
ajlm-1255	102	16	well	well	ADV
ajlm-1255	102	17	managed	manage	VERB
ajlm-1255	102	18	,	,	PUNCT
ajlm-1255	102	19	adding	add	VERB
ajlm-1255	102	20	unimaginable	unimaginable	ADJ
ajlm-1255	102	21	suffering	suffering	NOUN
ajlm-1255	102	22	in	in	ADP
ajlm-1255	102	23	an	an	DET
ajlm-1255	102	24	already	already	ADV
ajlm-1255	102	25	impoverished	impoverished	ADJ
ajlm-1255	102	26	population	population	NOUN
ajlm-1255	102	27	.	.	PUNCT
ajlm-1255	103	1	the	the	DET
ajlm-1255	103	2	use	use	NOUN
ajlm-1255	103	3	of	of	ADP
ajlm-1255	103	4	rdts	rdts	NOUN
ajlm-1255	103	5	for	for	ADP
ajlm-1255	103	6	the	the	DET
ajlm-1255	103	7	screening	screening	NOUN
ajlm-1255	103	8	of	of	ADP
ajlm-1255	103	9	covid-19	covid-19	PROPN
ajlm-1255	103	10	may	may	AUX
ajlm-1255	103	11	help	help	VERB
ajlm-1255	103	12	to	to	PART
ajlm-1255	103	13	determine	determine	VERB
ajlm-1255	103	14	individuals	individual	NOUN
ajlm-1255	103	15	who	who	PRON
ajlm-1255	103	16	are	be	AUX
ajlm-1255	103	17	at	at	ADP
ajlm-1255	103	18	lower	low	ADJ
ajlm-1255	103	19	risk	risk	NOUN
ajlm-1255	103	20	and	and	CCONJ
ajlm-1255	103	21	may	may	AUX
ajlm-1255	103	22	be	be	AUX
ajlm-1255	103	23	permitted	permit	VERB
ajlm-1255	103	24	to	to	PART
ajlm-1255	103	25	go	go	VERB
ajlm-1255	103	26	back	back	ADV
ajlm-1255	103	27	to	to	ADP
ajlm-1255	103	28	work	work	NOUN
ajlm-1255	103	29	.	.	PUNCT
ajlm-1255	104	1	when	when	SCONJ
ajlm-1255	104	2	coupled	couple	VERB
ajlm-1255	104	3	with	with	ADP
ajlm-1255	104	4	clinical	clinical	ADJ
ajlm-1255	104	5	symptoms	symptom	NOUN
ajlm-1255	104	6	and	and	CCONJ
ajlm-1255	104	7	molecular	molecular	ADJ
ajlm-1255	104	8	testing	testing	NOUN
ajlm-1255	104	9	,	,	PUNCT
ajlm-1255	104	10	rdts	rdts	PROPN
ajlm-1255	104	11	may	may	AUX
ajlm-1255	104	12	serve	serve	VERB
ajlm-1255	104	13	as	as	ADP
ajlm-1255	104	14	a	a	DET
ajlm-1255	104	15	first	first	ADJ
ajlm-1255	104	16	-	-	PUNCT
ajlm-1255	104	17	line	line	NOUN
ajlm-1255	104	18	tool	tool	NOUN
ajlm-1255	104	19	for	for	ADP
ajlm-1255	104	20	diagnosis	diagnosis	NOUN
ajlm-1255	104	21	and	and	CCONJ
ajlm-1255	104	22	help	help	VERB
ajlm-1255	104	23	to	to	PART
ajlm-1255	104	24	better	well	ADV
ajlm-1255	104	25	understand	understand	VERB
ajlm-1255	104	26	the	the	DET
ajlm-1255	104	27	spread	spread	NOUN
ajlm-1255	104	28	of	of	ADP
ajlm-1255	104	29	diseases	disease	NOUN
ajlm-1255	104	30	.	.	PUNCT
ajlm-1255	105	1	although	although	SCONJ
ajlm-1255	105	2	the	the	DET
ajlm-1255	105	3	covid-19	covid-19	PROPN
ajlm-1255	105	4	test	test	NOUN
ajlm-1255	105	5	kit	kit	NOUN
ajlm-1255	105	6	market	market	NOUN
ajlm-1255	105	7	is	be	AUX
ajlm-1255	105	8	in	in	ADP
ajlm-1255	105	9	its	its	PRON
ajlm-1255	105	10	infancy	infancy	NOUN
ajlm-1255	105	11	,	,	PUNCT
ajlm-1255	105	12	the	the	DET
ajlm-1255	105	13	global	global	ADJ
ajlm-1255	105	14	covid-19	covid-19	PROPN
ajlm-1255	105	15	outbreak	outbreak	NOUN
ajlm-1255	105	16	and	and	CCONJ
ajlm-1255	105	17	up	up	ADV
ajlm-1255	105	18	-	-	PUNCT
ajlm-1255	105	19	surging	surge	VERB
ajlm-1255	105	20	cases	case	NOUN
ajlm-1255	105	21	are	be	AUX
ajlm-1255	105	22	driving	drive	VERB
ajlm-1255	105	23	the	the	DET
ajlm-1255	105	24	demand	demand	NOUN
ajlm-1255	105	25	for	for	ADP
ajlm-1255	105	26	rdts	rdts	ADJ
ajlm-1255	105	27	,	,	PUNCT
ajlm-1255	105	28	hence	hence	ADV
ajlm-1255	105	29	researchers	researcher	NOUN
ajlm-1255	105	30	throughout	throughout	ADP
ajlm-1255	105	31	the	the	DET
ajlm-1255	105	32	world	world	NOUN
ajlm-1255	105	33	are	be	AUX
ajlm-1255	105	34	striving	strive	VERB
ajlm-1255	105	35	to	to	PART
ajlm-1255	105	36	develop	develop	VERB
ajlm-1255	105	37	rdts	rdts	ADJ
ajlm-1255	105	38	to	to	PART
ajlm-1255	105	39	track	track	VERB
ajlm-1255	105	40	infected	infected	ADJ
ajlm-1255	105	41	people	people	NOUN
ajlm-1255	105	42	.	.	PUNCT
ajlm-1255	106	1	to	to	ADP
ajlm-1255	106	2	date	date	NOUN
ajlm-1255	106	3	,	,	PUNCT
ajlm-1255	106	4	very	very	ADV
ajlm-1255	106	5	few	few	ADJ
ajlm-1255	106	6	countries	country	NOUN
ajlm-1255	106	7	have	have	AUX
ajlm-1255	106	8	succeeded	succeed	VERB
ajlm-1255	106	9	in	in	ADP
ajlm-1255	106	10	developing	develop	VERB
ajlm-1255	106	11	sars	sar	NOUN
ajlm-1255	106	12	-	-	PUNCT
ajlm-1255	106	13	cov-2	cov-2	NOUN
ajlm-1255	106	14	testing	testing	NOUN
ajlm-1255	106	15	kits	kit	NOUN
ajlm-1255	106	16	,	,	PUNCT
ajlm-1255	106	17	while	while	SCONJ
ajlm-1255	106	18	some	some	PRON
ajlm-1255	106	19	are	be	AUX
ajlm-1255	106	20	still	still	ADV
ajlm-1255	106	21	working	work	VERB
ajlm-1255	106	22	on	on	ADP
ajlm-1255	106	23	improving	improve	VERB
ajlm-1255	106	24	the	the	DET
ajlm-1255	106	25	performance	performance	NOUN
ajlm-1255	106	26	of	of	ADP
ajlm-1255	106	27	their	their	PRON
ajlm-1255	106	28	products	product	NOUN
ajlm-1255	106	29	.	.	PUNCT
ajlm-1255	107	1	with	with	ADP
ajlm-1255	107	2	the	the	DET
ajlm-1255	107	3	dedicated	dedicated	ADJ
ajlm-1255	107	4	global	global	ADJ
ajlm-1255	107	5	efforts	effort	NOUN
ajlm-1255	107	6	on	on	ADP
ajlm-1255	107	7	preventing	prevent	VERB
ajlm-1255	107	8	the	the	DET
ajlm-1255	107	9	spread	spread	NOUN
ajlm-1255	107	10	of	of	ADP
ajlm-1255	107	11	covid-19	covid-19	PROPN
ajlm-1255	107	12	and	and	CCONJ
ajlm-1255	107	13	flattening	flatten	VERB
ajlm-1255	107	14	the	the	DET
ajlm-1255	107	15	curve	curve	NOUN
ajlm-1255	107	16	,	,	PUNCT
ajlm-1255	107	17	significant	significant	ADJ
ajlm-1255	107	18	improvement	improvement	NOUN
ajlm-1255	107	19	must	must	AUX
ajlm-1255	107	20	have	have	AUX
ajlm-1255	107	21	occurred	occur	VERB
ajlm-1255	107	22	in	in	ADP
ajlm-1255	107	23	improving	improve	VERB
ajlm-1255	107	24	the	the	DET
ajlm-1255	107	25	performance	performance	NOUN
ajlm-1255	107	26	of	of	ADP
ajlm-1255	107	27	covid-19	covid-19	PROPN
ajlm-1255	107	28	test	test	NOUN
ajlm-1255	107	29	kits	kit	NOUN
ajlm-1255	107	30	.	.	PUNCT
ajlm-1255	108	1	increasing	increase	VERB
ajlm-1255	108	2	accessibility	accessibility	NOUN
ajlm-1255	108	3	to	to	ADP
ajlm-1255	108	4	testing	test	VERB
ajlm-1255	108	5	among	among	ADP
ajlm-1255	108	6	other	other	ADJ
ajlm-1255	108	7	interventions	intervention	NOUN
ajlm-1255	108	8	has	have	AUX
ajlm-1255	108	9	improved	improve	VERB
ajlm-1255	108	10	the	the	DET
ajlm-1255	108	11	containment	containment	NOUN
ajlm-1255	108	12	and	and	CCONJ
ajlm-1255	108	13	transmission	transmission	NOUN
ajlm-1255	108	14	of	of	ADP
ajlm-1255	108	15	the	the	DET
ajlm-1255	108	16	infection	infection	NOUN
ajlm-1255	108	17	.	.	PUNCT
ajlm-1255	109	1	while	while	SCONJ
ajlm-1255	109	2	algorithms	algorithm	NOUN
ajlm-1255	109	3	have	have	AUX
ajlm-1255	109	4	been	be	AUX
ajlm-1255	109	5	developed	develop	VERB
ajlm-1255	109	6	to	to	PART
ajlm-1255	109	7	limit	limit	VERB
ajlm-1255	109	8	testing	testing	NOUN
ajlm-1255	109	9	to	to	ADP
ajlm-1255	109	10	individuals	individual	NOUN
ajlm-1255	109	11	that	that	PRON
ajlm-1255	109	12	fulfil	fulfil	VERB
ajlm-1255	109	13	certain	certain	ADJ
ajlm-1255	109	14	criteria	criterion	NOUN
ajlm-1255	109	15	,	,	PUNCT
ajlm-1255	109	16	such	such	ADJ
ajlm-1255	109	17	as	as	ADP
ajlm-1255	109	18	contact	contact	NOUN
ajlm-1255	109	19	with	with	ADP
ajlm-1255	109	20	the	the	DET
ajlm-1255	109	21	infected	infected	ADJ
ajlm-1255	109	22	patients	patient	NOUN
ajlm-1255	109	23	,	,	PUNCT
ajlm-1255	109	24	clinical	clinical	ADJ
ajlm-1255	109	25	symptoms	symptom	NOUN
ajlm-1255	109	26	of	of	ADP
ajlm-1255	109	27	covid-19	covid-19	PROPN
ajlm-1255	109	28	,	,	PUNCT
ajlm-1255	109	29	travelling	travel	VERB
ajlm-1255	109	30	history	history	NOUN
ajlm-1255	109	31	to	to	ADP
ajlm-1255	109	32	epidemic	epidemic	NOUN
ajlm-1255	109	33	countries	country	NOUN
ajlm-1255	109	34	,	,	PUNCT
ajlm-1255	109	35	etc	etc	X
ajlm-1255	109	36	.	.	X
ajlm-1255	109	37	,	,	PUNCT
ajlm-1255	109	38	testing	test	VERB
ajlm-1255	109	39	the	the	DET
ajlm-1255	109	40	entire	entire	ADJ
ajlm-1255	109	41	population	population	NOUN
ajlm-1255	109	42	has	have	AUX
ajlm-1255	109	43	been	be	AUX
ajlm-1255	109	44	recommended.33	recommended.33	NOUN
ajlm-1255	109	45	resource	resource	NOUN
ajlm-1255	109	46	limitations	limitation	NOUN
ajlm-1255	109	47	means	mean	VERB
ajlm-1255	109	48	most	most	ADJ
ajlm-1255	109	49	lmics	lmic	NOUN
ajlm-1255	109	50	can	can	AUX
ajlm-1255	109	51	not	not	PART
ajlm-1255	109	52	cope	cope	VERB
ajlm-1255	109	53	with	with	ADP
ajlm-1255	109	54	the	the	DET
ajlm-1255	109	55	up	up	NOUN
ajlm-1255	109	56	-	-	PUNCT
ajlm-1255	109	57	surge	surge	NOUN
ajlm-1255	109	58	of	of	ADP
ajlm-1255	109	59	infection	infection	NOUN
ajlm-1255	109	60	and	and	CCONJ
ajlm-1255	109	61	transmission	transmission	NOUN
ajlm-1255	109	62	.	.	PUNCT
ajlm-1255	110	1	while	while	SCONJ
ajlm-1255	110	2	testing	testing	NOUN
ajlm-1255	110	3	per	per	ADP
ajlm-1255	110	4	population	population	NOUN
ajlm-1255	110	5	is	be	AUX
ajlm-1255	110	6	high	high	ADJ
ajlm-1255	110	7	in	in	ADP
ajlm-1255	110	8	developed	develop	VERB
ajlm-1255	110	9	countries	country	NOUN
ajlm-1255	110	10	with	with	ADP
ajlm-1255	110	11	over	over	ADP
ajlm-1255	110	12	3	3	NUM
ajlm-1255	110	13	million	million	NUM
ajlm-1255	110	14	tested	test	VERB
ajlm-1255	110	15	in	in	ADP
ajlm-1255	110	16	the	the	DET
ajlm-1255	110	17	united	united	PROPN
ajlm-1255	110	18	states	states	PROPN
ajlm-1255	110	19	,	,	PUNCT
ajlm-1255	110	20	testing	testing	NOUN
ajlm-1255	110	21	per	per	ADP
ajlm-1255	110	22	population	population	NOUN
ajlm-1255	110	23	is	be	AUX
ajlm-1255	110	24	still	still	ADV
ajlm-1255	110	25	very	very	ADV
ajlm-1255	110	26	low	low	ADJ
ajlm-1255	110	27	in	in	ADP
ajlm-1255	110	28	developing	develop	VERB
ajlm-1255	110	29	countries	country	NOUN
ajlm-1255	110	30	with	with	ADP
ajlm-1255	110	31	less	less	ADJ
ajlm-1255	110	32	than	than	ADP
ajlm-1255	110	33	10	10	NUM
ajlm-1255	110	34	000	000	NUM
ajlm-1255	110	35	tested	test	VERB
ajlm-1255	110	36	in	in	ADP
ajlm-1255	110	37	nigeria	nigeria	PROPN
ajlm-1255	110	38	as	as	ADP
ajlm-1255	110	39	of	of	ADP
ajlm-1255	110	40	22	22	NUM
ajlm-1255	110	41	april	april	PROPN
ajlm-1255	110	42	2020	2020	NUM
ajlm-1255	110	43	.	.	PUNCT
ajlm-1255	111	1	therefore	therefore	ADV
ajlm-1255	111	2	,	,	PUNCT
ajlm-1255	111	3	the	the	DET
ajlm-1255	111	4	addition	addition	NOUN
ajlm-1255	111	5	of	of	ADP
ajlm-1255	111	6	validated	validated	ADJ
ajlm-1255	111	7	serological	serological	NOUN
ajlm-1255	111	8	-	-	PUNCT
ajlm-1255	111	9	based	base	VERB
ajlm-1255	111	10	rdt	rdt	PROPN
ajlm-1255	111	11	even	even	ADV
ajlm-1255	111	12	with	with	ADP
ajlm-1255	111	13	lower	low	ADJ
ajlm-1255	111	14	performance	performance	NOUN
ajlm-1255	111	15	characteristics	characteristic	NOUN
ajlm-1255	111	16	compared	compare	VERB
ajlm-1255	111	17	to	to	ADP
ajlm-1255	111	18	rt	rt	PROPN
ajlm-1255	111	19	-	-	PUNCT
ajlm-1255	111	20	pcr	pcr	PROPN
ajlm-1255	111	21	may	may	AUX
ajlm-1255	111	22	serve	serve	VERB
ajlm-1255	111	23	as	as	ADP
ajlm-1255	111	24	complementary	complementary	ADJ
ajlm-1255	111	25	tools	tool	NOUN
ajlm-1255	111	26	to	to	PART
ajlm-1255	111	27	increase	increase	VERB
ajlm-1255	111	28	the	the	DET
ajlm-1255	111	29	rate	rate	NOUN
ajlm-1255	111	30	of	of	ADP
ajlm-1255	111	31	testing	testing	NOUN
ajlm-1255	111	32	per	per	ADP
ajlm-1255	111	33	population	population	NOUN
ajlm-1255	111	34	,	,	PUNCT
ajlm-1255	111	35	especially	especially	ADV
ajlm-1255	111	36	in	in	ADP
ajlm-1255	111	37	lmics	lmic	NOUN
ajlm-1255	111	38	where	where	SCONJ
ajlm-1255	111	39	community	community	NOUN
ajlm-1255	111	40	transmission	transmission	NOUN
ajlm-1255	111	41	is	be	AUX
ajlm-1255	111	42	now	now	ADV
ajlm-1255	111	43	on	on	ADP
ajlm-1255	111	44	the	the	DET
ajlm-1255	111	45	rise	rise	NOUN
ajlm-1255	111	46	.	.	PUNCT
ajlm-1255	112	1	therefore	therefore	ADV
ajlm-1255	112	2	,	,	PUNCT
ajlm-1255	112	3	the	the	DET
ajlm-1255	112	4	use	use	NOUN
ajlm-1255	112	5	of	of	ADP
ajlm-1255	112	6	rdts	rdts	ADJ
ajlm-1255	112	7	operated	operate	VERB
ajlm-1255	112	8	as	as	ADP
ajlm-1255	112	9	lateral	lateral	ADJ
ajlm-1255	112	10	flow	flow	NOUN
ajlm-1255	112	11	immunochromatographic	immunochromatographic	ADJ
ajlm-1255	112	12	assays	assay	NOUN
ajlm-1255	112	13	to	to	PART
ajlm-1255	112	14	detect	detect	VERB
ajlm-1255	112	15	both	both	DET
ajlm-1255	112	16	igm	igm	NOUN
ajlm-1255	112	17	and	and	CCONJ
ajlm-1255	112	18	igg	igg	PROPN
ajlm-1255	112	19	on	on	ADP
ajlm-1255	112	20	separate	separate	ADJ
ajlm-1255	112	21	test	test	NOUN
ajlm-1255	112	22	lines	line	NOUN
ajlm-1255	112	23	using	use	VERB
ajlm-1255	112	24	whole	whole	ADJ
ajlm-1255	112	25	blood	blood	NOUN
ajlm-1255	112	26	,	,	PUNCT
ajlm-1255	112	27	plasma	plasma	NOUN
ajlm-1255	112	28	or	or	CCONJ
ajlm-1255	112	29	serum	serum	NOUN
ajlm-1255	112	30	samples	sample	NOUN
ajlm-1255	112	31	is	be	AUX
ajlm-1255	112	32	desirable	desirable	ADJ
ajlm-1255	112	33	for	for	ADP
ajlm-1255	112	34	lmics	lmic	NOUN
ajlm-1255	112	35	.	.	PUNCT
ajlm-1255	113	1	wang	wang	PROPN
ajlm-1255	113	2	et	et	PROPN
ajlm-1255	113	3	al	al	PROPN
ajlm-1255	113	4	.	.	PROPN
ajlm-1255	113	5	reported	report	VERB
ajlm-1255	113	6	that	that	SCONJ
ajlm-1255	113	7	the	the	DET
ajlm-1255	113	8	combination	combination	NOUN
ajlm-1255	113	9	of	of	ADP
ajlm-1255	113	10	rt	rt	ADJ
ajlm-1255	113	11	-	-	PUNCT
ajlm-1255	113	12	pcr	pcr	NOUN
ajlm-1255	113	13	testing	testing	NOUN
ajlm-1255	113	14	and	and	CCONJ
ajlm-1255	113	15	clinical	clinical	ADJ
ajlm-1255	113	16	features	feature	NOUN
ajlm-1255	113	17	for	for	ADP
ajlm-1255	113	18	diagnosis	diagnosis	NOUN
ajlm-1255	113	19	of	of	ADP
ajlm-1255	113	20	covid-19	covid-19	PROPN
ajlm-1255	113	21	facilitated	facilitate	VERB
ajlm-1255	113	22	the	the	DET
ajlm-1255	113	23	management	management	NOUN
ajlm-1255	113	24	of	of	ADP
ajlm-1255	113	25	the	the	DET
ajlm-1255	113	26	sars	sar	NOUN
ajlm-1255	113	27	-	-	PUNCT
ajlm-1255	113	28	cov-2	cov-2	NOUN
ajlm-1255	113	29	outbreak	outbreak	NOUN
ajlm-1255	113	30	in	in	ADP
ajlm-1255	113	31	china,22	china,22	NOUN
ajlm-1255	113	32	and	and	CCONJ
ajlm-1255	113	33	covid-19	covid-19	PROPN
ajlm-1255	113	34	mass	mass	NOUN
ajlm-1255	113	35	testing	testing	NOUN
ajlm-1255	113	36	facilities	facility	NOUN
ajlm-1255	113	37	have	have	AUX
ajlm-1255	113	38	been	be	AUX
ajlm-1255	113	39	strongly	strongly	ADV
ajlm-1255	113	40	advocated	advocate	VERB
ajlm-1255	113	41	to	to	PART
ajlm-1255	113	42	end	end	VERB
ajlm-1255	113	43	the	the	DET
ajlm-1255	113	44	epidemic	epidemic	NOUN
ajlm-1255	113	45	rapidly.34	rapidly.34	NOUN
ajlm-1255	113	46	the	the	DET
ajlm-1255	113	47	use	use	NOUN
ajlm-1255	113	48	of	of	ADP
ajlm-1255	113	49	rdt	rdt	PROPN
ajlm-1255	113	50	will	will	AUX
ajlm-1255	113	51	not	not	PART
ajlm-1255	113	52	only	only	ADV
ajlm-1255	113	53	allow	allow	VERB
ajlm-1255	113	54	mass	mass	ADJ
ajlm-1255	113	55	testing	testing	NOUN
ajlm-1255	113	56	facilities	facility	NOUN
ajlm-1255	113	57	in	in	ADP
ajlm-1255	113	58	lmics	lmic	NOUN
ajlm-1255	113	59	but	but	CCONJ
ajlm-1255	113	60	coupled	couple	VERB
ajlm-1255	113	61	with	with	ADP
ajlm-1255	113	62	clinical	clinical	ADJ
ajlm-1255	113	63	features	feature	NOUN
ajlm-1255	113	64	in	in	ADP
ajlm-1255	113	65	symptomatic	symptomatic	ADJ
ajlm-1255	113	66	patients	patient	NOUN
ajlm-1255	113	67	and	and	CCONJ
ajlm-1255	113	68	molecular	molecular	ADJ
ajlm-1255	113	69	testing	testing	NOUN
ajlm-1255	113	70	(	(	PUNCT
ajlm-1255	113	71	rt	rt	NOUN
ajlm-1255	113	72	-	-	PUNCT
ajlm-1255	113	73	pcr	pcr	NOUN
ajlm-1255	113	74	)	)	PUNCT
ajlm-1255	113	75	in	in	ADP
ajlm-1255	113	76	asymptomatic	asymptomatic	ADJ
ajlm-1255	113	77	populations	population	NOUN
ajlm-1255	113	78	may	may	AUX
ajlm-1255	113	79	help	help	VERB
ajlm-1255	113	80	to	to	PART
ajlm-1255	113	81	contain	contain	VERB
ajlm-1255	113	82	transmission	transmission	NOUN
ajlm-1255	113	83	in	in	ADP
ajlm-1255	113	84	lmics	lmic	NOUN
ajlm-1255	113	85	.	.	PUNCT
ajlm-1255	114	1	conclusion	conclusion	NOUN
ajlm-1255	114	2	considering	consider	VERB
ajlm-1255	114	3	the	the	DET
ajlm-1255	114	4	peculiarity	peculiarity	NOUN
ajlm-1255	114	5	of	of	ADP
ajlm-1255	114	6	lmics	lmic	NOUN
ajlm-1255	114	7	,	,	PUNCT
ajlm-1255	114	8	especially	especially	ADV
ajlm-1255	114	9	their	their	PRON
ajlm-1255	114	10	economic	economic	ADJ
ajlm-1255	114	11	situation	situation	NOUN
ajlm-1255	114	12	,	,	PUNCT
ajlm-1255	114	13	the	the	DET
ajlm-1255	114	14	standard	standard	ADJ
ajlm-1255	114	15	rt	rt	PROPN
ajlm-1255	114	16	-	-	PUNCT
ajlm-1255	114	17	pcr	pcr	PROPN
ajlm-1255	114	18	may	may	AUX
ajlm-1255	114	19	not	not	PART
ajlm-1255	114	20	be	be	AUX
ajlm-1255	114	21	able	able	ADJ
ajlm-1255	114	22	to	to	PART
ajlm-1255	114	23	cope	cope	VERB
ajlm-1255	114	24	with	with	ADP
ajlm-1255	114	25	the	the	DET
ajlm-1255	114	26	testing	testing	NOUN
ajlm-1255	114	27	needs	need	NOUN
ajlm-1255	114	28	of	of	ADP
ajlm-1255	114	29	these	these	DET
ajlm-1255	114	30	countries	country	NOUN
ajlm-1255	114	31	because	because	SCONJ
ajlm-1255	114	32	of	of	ADP
ajlm-1255	114	33	limited	limited	ADJ
ajlm-1255	114	34	infrastructure	infrastructure	NOUN
ajlm-1255	114	35	and	and	CCONJ
ajlm-1255	114	36	human	human	ADJ
ajlm-1255	114	37	resources	resource	NOUN
ajlm-1255	114	38	.	.	PUNCT
ajlm-1255	115	1	generally	generally	ADV
ajlm-1255	115	2	,	,	PUNCT
ajlm-1255	115	3	it	it	PRON
ajlm-1255	115	4	is	be	AUX
ajlm-1255	115	5	agreed	agree	VERB
ajlm-1255	115	6	that	that	SCONJ
ajlm-1255	115	7	rapid	rapid	ADJ
ajlm-1255	115	8	testing	testing	NOUN
ajlm-1255	115	9	techniques	technique	NOUN
ajlm-1255	115	10	are	be	AUX
ajlm-1255	115	11	useful	useful	ADJ
ajlm-1255	115	12	for	for	ADP
ajlm-1255	115	13	screening	screen	VERB
ajlm-1255	115	14	for	for	ADP
ajlm-1255	115	15	early	early	ADJ
ajlm-1255	115	16	detection	detection	NOUN
ajlm-1255	115	17	of	of	ADP
ajlm-1255	115	18	symptomatic	symptomatic	ADJ
ajlm-1255	115	19	cases	case	NOUN
ajlm-1255	115	20	,	,	PUNCT
ajlm-1255	115	21	which	which	PRON
ajlm-1255	115	22	is	be	AUX
ajlm-1255	115	23	crucial	crucial	ADJ
ajlm-1255	115	24	for	for	ADP
ajlm-1255	115	25	averting	avert	VERB
ajlm-1255	115	26	community	community	NOUN
ajlm-1255	115	27	or	or	CCONJ
ajlm-1255	115	28	hospital	hospital	NOUN
ajlm-1255	115	29	transmission	transmission	NOUN
ajlm-1255	115	30	and	and	CCONJ
ajlm-1255	115	31	strengthening	strengthen	VERB
ajlm-1255	115	32	contact	contact	NOUN
ajlm-1255	115	33	tracing	trace	VERB
ajlm-1255	115	34	and	and	CCONJ
ajlm-1255	115	35	active	active	ADJ
ajlm-1255	115	36	surveillance	surveillance	NOUN
ajlm-1255	115	37	.	.	PUNCT
ajlm-1255	116	1	this	this	DET
ajlm-1255	116	2	review	review	NOUN
ajlm-1255	116	3	revealed	reveal	VERB
ajlm-1255	116	4	considerable	considerable	ADJ
ajlm-1255	116	5	good	good	ADJ
ajlm-1255	116	6	performance	performance	NOUN
ajlm-1255	116	7	of	of	ADP
ajlm-1255	116	8	the	the	DET
ajlm-1255	116	9	rdt	rdt	PROPN
ajlm-1255	116	10	with	with	ADP
ajlm-1255	116	11	manufacturer	manufacturer	NOUN
ajlm-1255	116	12	sensitivity	sensitivity	NOUN
ajlm-1255	116	13	and	and	CCONJ
ajlm-1255	116	14	specificity	specificity	NOUN
ajlm-1255	116	15	using	use	VERB
ajlm-1255	116	16	varieties	variety	NOUN
ajlm-1255	116	17	of	of	ADP
ajlm-1255	116	18	samples	sample	NOUN
ajlm-1255	116	19	including	include	VERB
ajlm-1255	116	20	blood	blood	NOUN
ajlm-1255	116	21	samples	sample	NOUN
ajlm-1255	116	22	.	.	PUNCT
ajlm-1255	117	1	hence	hence	ADV
ajlm-1255	117	2	,	,	PUNCT
ajlm-1255	117	3	the	the	DET
ajlm-1255	117	4	use	use	NOUN
ajlm-1255	117	5	of	of	ADP
ajlm-1255	117	6	rdt	rdt	PROPN
ajlm-1255	117	7	kits	kit	NOUN
ajlm-1255	117	8	in	in	ADP
ajlm-1255	117	9	lmics	lmic	NOUN
ajlm-1255	117	10	may	may	AUX
ajlm-1255	117	11	increase	increase	VERB
ajlm-1255	117	12	access	access	NOUN
ajlm-1255	117	13	to	to	ADP
ajlm-1255	117	14	testing	testing	NOUN
ajlm-1255	117	15	and	and	CCONJ
ajlm-1255	117	16	better	well	ADV
ajlm-1255	117	17	triaging	triage	VERB
ajlm-1255	117	18	of	of	ADP
ajlm-1255	117	19	covid-19	covid-19	PROPN
ajlm-1255	117	20	patients	patient	NOUN
ajlm-1255	117	21	.	.	PUNCT
ajlm-1255	118	1	we	we	PRON
ajlm-1255	118	2	,	,	PUNCT
ajlm-1255	118	3	however	however	ADV
ajlm-1255	118	4	,	,	PUNCT
ajlm-1255	118	5	identified	identify	VERB
ajlm-1255	118	6	that	that	SCONJ
ajlm-1255	118	7	most	most	ADJ
ajlm-1255	118	8	of	of	ADP
ajlm-1255	118	9	the	the	DET
ajlm-1255	118	10	proposed	propose	VERB
ajlm-1255	118	11	rapid	rapid	ADJ
ajlm-1255	118	12	kits	kit	NOUN
ajlm-1255	118	13	have	have	AUX
ajlm-1255	118	14	not	not	PART
ajlm-1255	118	15	been	be	AUX
ajlm-1255	118	16	optimised	optimise	VERB
ajlm-1255	118	17	and	and	CCONJ
ajlm-1255	118	18	validated	validated	ADJ
ajlm-1255	118	19	.	.	PUNCT
ajlm-1255	119	1	it	it	PRON
ajlm-1255	119	2	is	be	AUX
ajlm-1255	119	3	important	important	ADJ
ajlm-1255	119	4	that	that	SCONJ
ajlm-1255	119	5	the	the	DET
ajlm-1255	119	6	kits	kit	NOUN
ajlm-1255	119	7	undergo	undergo	VERB
ajlm-1255	119	8	further	further	ADJ
ajlm-1255	119	9	validation	validation	NOUN
ajlm-1255	119	10	with	with	ADP
ajlm-1255	119	11	samples	sample	NOUN
ajlm-1255	119	12	from	from	ADP
ajlm-1255	119	13	countries	country	NOUN
ajlm-1255	119	14	of	of	ADP
ajlm-1255	119	15	proposed	propose	VERB
ajlm-1255	119	16	use	use	NOUN
ajlm-1255	119	17	in	in	ADP
ajlm-1255	119	18	reference	reference	NOUN
ajlm-1255	119	19	to	to	ADP
ajlm-1255	119	20	rt	rt	NOUN
ajlm-1255	119	21	-	-	PUNCT
ajlm-1255	119	22	pcr	pcr	NOUN
ajlm-1255	119	23	before	before	ADP
ajlm-1255	119	24	use	use	NOUN
ajlm-1255	119	25	.	.	PUNCT
ajlm-1255	120	1	acknowledgements	acknowledgement	NOUN
ajlm-1255	120	2	competing	compete	VERB
ajlm-1255	120	3	interests	interest	NOUN
ajlm-1255	120	4	the	the	DET
ajlm-1255	120	5	authors	author	NOUN
ajlm-1255	120	6	have	have	AUX
ajlm-1255	120	7	declared	declare	VERB
ajlm-1255	120	8	that	that	SCONJ
ajlm-1255	120	9	no	no	DET
ajlm-1255	120	10	competing	compete	VERB
ajlm-1255	120	11	interest	interest	NOUN
ajlm-1255	120	12	exists	exist	VERB
ajlm-1255	120	13	.	.	PUNCT
ajlm-1255	121	1	authors	author	NOUN
ajlm-1255	121	2	’	'	PUNCT
ajlm-1255	121	3	contributions	contribution	NOUN
ajlm-1255	121	4	o.a	o.a	PROPN
ajlm-1255	121	5	.	.	PROPN
ajlm-1255	121	6	conceived	conceive	VERB
ajlm-1255	121	7	the	the	DET
ajlm-1255	121	8	idea	idea	NOUN
ajlm-1255	121	9	for	for	ADP
ajlm-1255	121	10	the	the	DET
ajlm-1255	121	11	study	study	NOUN
ajlm-1255	121	12	.	.	PUNCT
ajlm-1255	122	1	o.a	o.a	PROPN
ajlm-1255	122	2	.	.	PROPN
ajlm-1255	122	3	,	,	PUNCT
ajlm-1255	122	4	b.i	b.i	PROPN
ajlm-1255	122	5	.	.	PROPN
ajlm-1255	122	6	,	,	PUNCT
ajlm-1255	122	7	and	and	CCONJ
ajlm-1255	122	8	a.o	a.o	PROPN
ajlm-1255	122	9	.	.	PROPN
ajlm-1255	122	10	designed	design	VERB
ajlm-1255	122	11	the	the	DET
ajlm-1255	122	12	study	study	NOUN
ajlm-1255	122	13	.	.	PUNCT
ajlm-1255	123	1	a.o	a.o	PROPN
ajlm-1255	123	2	.	.	PROPN
ajlm-1255	123	3	,	,	PUNCT
ajlm-1255	123	4	t.a.s	t.a.s	ADJ
ajlm-1255	123	5	.	.	PUNCT
ajlm-1255	123	6	,	,	PUNCT
ajlm-1255	123	7	o.m.a	o.m.a	PROPN
ajlm-1255	123	8	.	.	PUNCT
ajlm-1255	124	1	and	and	CCONJ
ajlm-1255	124	2	o.p	o.p	PROPN
ajlm-1255	124	3	.	.	PROPN
ajlm-1255	124	4	searched	search	VERB
ajlm-1255	124	5	for	for	ADP
ajlm-1255	124	6	published	publish	VERB
ajlm-1255	124	7	work	work	NOUN
ajlm-1255	124	8	.	.	PUNCT
ajlm-1255	125	1	o.a	o.a	PROPN
ajlm-1255	125	2	.	.	PROPN
ajlm-1255	125	3	and	and	CCONJ
ajlm-1255	125	4	b.i	b.i	PROPN
ajlm-1255	125	5	.	.	PROPN
ajlm-1255	125	6	reviewed	review	VERB
ajlm-1255	125	7	and	and	CCONJ
ajlm-1255	125	8	made	make	VERB
ajlm-1255	125	9	the	the	DET
ajlm-1255	125	10	selection	selection	NOUN
ajlm-1255	125	11	of	of	ADP
ajlm-1255	125	12	eligible	eligible	ADJ
ajlm-1255	125	13	studies	study	NOUN
ajlm-1255	125	14	.	.	PUNCT
ajlm-1255	126	1	a.o	a.o	PROPN
ajlm-1255	126	2	.	.	PROPN
ajlm-1255	126	3	,	,	PUNCT
ajlm-1255	126	4	t.a.s	t.a.s	ADJ
ajlm-1255	126	5	.	.	PUNCT
ajlm-1255	126	6	,	,	PUNCT
ajlm-1255	126	7	o.m.a	o.m.a	PROPN
ajlm-1255	126	8	.	.	PUNCT
ajlm-1255	126	9	and	and	CCONJ
ajlm-1255	126	10	o.p	o.p	PROPN
ajlm-1255	126	11	.	.	PROPN
ajlm-1255	126	12	extracted	extract	VERB
ajlm-1255	126	13	and	and	CCONJ
ajlm-1255	126	14	compiled	compile	VERB
ajlm-1255	126	15	the	the	DET
ajlm-1255	126	16	data	datum	NOUN
ajlm-1255	126	17	.	.	PUNCT
ajlm-1255	127	1	o.a	o.a	PROPN
ajlm-1255	127	2	.	.	PROPN
ajlm-1255	127	3	,	,	PUNCT
ajlm-1255	127	4	b.i	b.i	PROPN
ajlm-1255	127	5	.	.	PROPN
ajlm-1255	127	6	and	and	CCONJ
ajlm-1255	127	7	a.o	a.o	PROPN
ajlm-1255	127	8	.	.	PROPN
ajlm-1255	127	9	analysed	analyse	VERB
ajlm-1255	127	10	the	the	DET
ajlm-1255	127	11	data	datum	NOUN
ajlm-1255	127	12	while	while	SCONJ
ajlm-1255	127	13	b.i	b.i	PROPN
ajlm-1255	127	14	.	.	PROPN
ajlm-1255	127	15	and	and	CCONJ
ajlm-1255	127	16	a.o	a.o	PROPN
ajlm-1255	127	17	.	.	PROPN
ajlm-1255	127	18	prepared	prepare	VERB
ajlm-1255	127	19	the	the	DET
ajlm-1255	127	20	first	first	ADJ
ajlm-1255	127	21	draft	draft	NOUN
ajlm-1255	127	22	of	of	ADP
ajlm-1255	127	23	the	the	DET
ajlm-1255	127	24	article	article	NOUN
ajlm-1255	127	25	.	.	PUNCT
ajlm-1255	128	1	o.a	o.a	PROPN
ajlm-1255	128	2	.	.	PROPN
ajlm-1255	128	3	did	do	VERB
ajlm-1255	128	4	the	the	DET
ajlm-1255	128	5	final	final	ADJ
ajlm-1255	128	6	editing	editing	NOUN
ajlm-1255	128	7	of	of	ADP
ajlm-1255	128	8	the	the	DET
ajlm-1255	128	9	article	article	NOUN
ajlm-1255	128	10	.	.	PUNCT
ajlm-1255	129	1	all	all	DET
ajlm-1255	129	2	authors	author	NOUN
ajlm-1255	129	3	contributed	contribute	VERB
ajlm-1255	129	4	to	to	ADP
ajlm-1255	129	5	the	the	DET
ajlm-1255	129	6	writing	writing	NOUN
ajlm-1255	129	7	of	of	ADP
ajlm-1255	129	8	the	the	DET
ajlm-1255	129	9	article	article	NOUN
ajlm-1255	129	10	and	and	CCONJ
ajlm-1255	129	11	have	have	AUX
ajlm-1255	129	12	seen	see	VERB
ajlm-1255	129	13	and	and	CCONJ
ajlm-1255	129	14	approved	approve	VERB
ajlm-1255	129	15	the	the	DET
ajlm-1255	129	16	final	final	ADJ
ajlm-1255	129	17	version	version	NOUN
ajlm-1255	129	18	.	.	PUNCT
ajlm-1255	130	1	ethical	ethical	ADJ
ajlm-1255	130	2	considerations	consideration	NOUN
ajlm-1255	130	3	ethical	ethical	ADJ
ajlm-1255	130	4	clearance	clearance	NOUN
ajlm-1255	130	5	was	be	AUX
ajlm-1255	130	6	not	not	PART
ajlm-1255	130	7	required	require	VERB
ajlm-1255	130	8	for	for	ADP
ajlm-1255	130	9	this	this	DET
ajlm-1255	130	10	study	study	NOUN
ajlm-1255	130	11	.	.	PUNCT
ajlm-1255	131	1	funding	funding	NOUN
ajlm-1255	131	2	information	information	NOUN
ajlm-1255	131	3	this	this	DET
ajlm-1255	131	4	research	research	NOUN
ajlm-1255	131	5	received	receive	VERB
ajlm-1255	131	6	no	no	DET
ajlm-1255	131	7	specific	specific	ADJ
ajlm-1255	131	8	grant	grant	NOUN
ajlm-1255	131	9	from	from	ADP
ajlm-1255	131	10	any	any	DET
ajlm-1255	131	11	funding	funding	NOUN
ajlm-1255	131	12	agency	agency	NOUN
ajlm-1255	131	13	in	in	ADP
ajlm-1255	131	14	the	the	DET
ajlm-1255	131	15	public	public	ADJ
ajlm-1255	131	16	,	,	PUNCT
ajlm-1255	131	17	commercial	commercial	ADJ
ajlm-1255	131	18	or	or	CCONJ
ajlm-1255	131	19	not	not	PART
ajlm-1255	131	20	-	-	PUNCT
ajlm-1255	131	21	for	for	ADP
ajlm-1255	131	22	-	-	PUNCT
ajlm-1255	131	23	profit	profit	NOUN
ajlm-1255	131	24	sectors	sector	NOUN
ajlm-1255	131	25	.	.	PUNCT
ajlm-1255	132	1	data	datum	NOUN
ajlm-1255	132	2	availability	availability	NOUN
ajlm-1255	132	3	statement	statement	NOUN
ajlm-1255	132	4	data	datum	NOUN
ajlm-1255	132	5	sharing	sharing	NOUN
ajlm-1255	132	6	is	be	AUX
ajlm-1255	132	7	not	not	PART
ajlm-1255	132	8	applicable	applicable	ADJ
ajlm-1255	132	9	to	to	ADP
ajlm-1255	132	10	this	this	DET
ajlm-1255	132	11	article	article	NOUN
ajlm-1255	132	12	as	as	SCONJ
ajlm-1255	132	13	no	no	DET
ajlm-1255	132	14	new	new	ADJ
ajlm-1255	132	15	data	datum	NOUN
ajlm-1255	132	16	were	be	AUX
ajlm-1255	132	17	created	create	VERB
ajlm-1255	132	18	or	or	CCONJ
ajlm-1255	132	19	analysed	analyse	VERB
ajlm-1255	132	20	in	in	ADP
ajlm-1255	132	21	this	this	DET
ajlm-1255	132	22	study	study	NOUN
ajlm-1255	132	23	.	.	PUNCT
ajlm-1255	133	1	disclaimer	disclaimer	VERB
ajlm-1255	133	2	the	the	DET
ajlm-1255	133	3	views	view	NOUN
ajlm-1255	133	4	and	and	CCONJ
ajlm-1255	133	5	opinions	opinion	NOUN
ajlm-1255	133	6	expressed	express	VERB
ajlm-1255	133	7	in	in	ADP
ajlm-1255	133	8	this	this	DET
ajlm-1255	133	9	article	article	NOUN
ajlm-1255	133	10	are	be	AUX
ajlm-1255	133	11	those	those	PRON
ajlm-1255	133	12	of	of	ADP
ajlm-1255	133	13	the	the	DET
ajlm-1255	133	14	authors	author	NOUN
ajlm-1255	133	15	and	and	CCONJ
ajlm-1255	133	16	do	do	AUX
ajlm-1255	133	17	not	not	PART
ajlm-1255	133	18	necessarily	necessarily	ADV
ajlm-1255	133	19	reflect	reflect	VERB
ajlm-1255	133	20	the	the	DET
ajlm-1255	133	21	official	official	ADJ
ajlm-1255	133	22	policy	policy	NOUN
ajlm-1255	133	23	or	or	CCONJ
ajlm-1255	133	24	position	position	NOUN
ajlm-1255	133	25	of	of	ADP
ajlm-1255	133	26	any	any	DET
ajlm-1255	133	27	affiliated	affiliated	ADJ
ajlm-1255	133	28	agency	agency	NOUN
ajlm-1255	133	29	of	of	ADP
ajlm-1255	133	30	the	the	DET
ajlm-1255	133	31	authors	author	NOUN
ajlm-1255	133	32	.	.	PUNCT
ajlm-1255	134	1	references	reference	NOUN
ajlm-1255	134	2	zhu	zhu	PROPN
ajlm-1255	134	3	n	n	CCONJ
ajlm-1255	134	4	,	,	PUNCT
ajlm-1255	134	5	zhang	zhang	PROPN
ajlm-1255	134	6	d	d	PROPN
ajlm-1255	134	7	,	,	PUNCT
ajlm-1255	134	8	wang	wang	PROPN
ajlm-1255	134	9	w	w	PROPN
ajlm-1255	134	10	,	,	PUNCT
ajlm-1255	134	11	et	et	PROPN
ajlm-1255	134	12	al	al	PROPN
ajlm-1255	134	13	.	.	PUNCT
ajlm-1255	135	1	a	a	DET
ajlm-1255	135	2	novel	novel	ADJ
ajlm-1255	135	3	coronavirus	coronavirus	NOUN
ajlm-1255	135	4	from	from	ADP
ajlm-1255	135	5	patients	patient	NOUN
ajlm-1255	135	6	with	with	ADP
ajlm-1255	135	7	pneumonia	pneumonia	NOUN
ajlm-1255	135	8	in	in	ADP
ajlm-1255	135	9	china	china	PROPN
ajlm-1255	135	10	,	,	PUNCT
ajlm-1255	135	11	2019	2019	NUM
ajlm-1255	135	12	.	.	PUNCT
ajlm-1255	136	1	n	n	X
ajlm-1255	136	2	engl	engl	PROPN
ajlm-1255	136	3	j	j	PROPN
ajlm-1255	136	4	med	med	PROPN
ajlm-1255	136	5	.	.	PUNCT
ajlm-1255	137	1	2020;382(8):727–733	2020;382(8):727–733	NUM
ajlm-1255	137	2	.	.	PUNCT
ajlm-1255	138	1	https://doi.org/10.1056/nejmoa2001017	https://doi.org/10.1056/nejmoa2001017	PROPN
ajlm-1255	138	2	dong	dong	PROPN
ajlm-1255	138	3	e	e	PROPN
ajlm-1255	138	4	,	,	PUNCT
ajlm-1255	138	5	du	du	PROPN
ajlm-1255	138	6	h	h	PROPN
ajlm-1255	138	7	,	,	PUNCT
ajlm-1255	138	8	gardner	gardner	PROPN
ajlm-1255	138	9	l.	l.	PROPN
ajlm-1255	138	10	an	an	DET
ajlm-1255	138	11	interactive	interactive	ADJ
ajlm-1255	138	12	web	web	NOUN
ajlm-1255	138	13	-	-	PUNCT
ajlm-1255	138	14	based	base	VERB
ajlm-1255	138	15	dashboard	dashboard	NOUN
ajlm-1255	138	16	to	to	PART
ajlm-1255	138	17	track	track	VERB
ajlm-1255	138	18	covid-19	covid-19	PROPN
ajlm-1255	138	19	in	in	ADP
ajlm-1255	138	20	real	real	ADJ
ajlm-1255	138	21	time	time	NOUN
ajlm-1255	138	22	.	.	PUNCT
ajlm-1255	139	1	lancet	lancet	PROPN
ajlm-1255	139	2	infect	infect	PROPN
ajlm-1255	139	3	dis	dis	PROPN
ajlm-1255	139	4	.	.	PUNCT
ajlm-1255	140	1	2020;20(5):533–534	2020;20(5):533–534	NUM
ajlm-1255	140	2	.	.	PUNCT
ajlm-1255	140	3	https://doi.org/10.1016/s1473-3099(20)30120-1	https://doi.org/10.1016/s1473-3099(20)30120-1	PROPN
ajlm-1255	140	4	nkengasong	nkengasong	PROPN
ajlm-1255	140	5	jn	jn	PROPN
ajlm-1255	140	6	,	,	PUNCT
ajlm-1255	140	7	mankoula	mankoula	PROPN
ajlm-1255	140	8	w.	w.	PROPN
ajlm-1255	140	9	looming	loom	VERB
ajlm-1255	140	10	threat	threat	NOUN
ajlm-1255	140	11	of	of	ADP
ajlm-1255	140	12	covid-19	covid-19	PROPN
ajlm-1255	140	13	infection	infection	NOUN
ajlm-1255	140	14	in	in	ADP
ajlm-1255	140	15	africa	africa	PROPN
ajlm-1255	140	16	:	:	PUNCT
ajlm-1255	140	17	act	act	VERB
ajlm-1255	140	18	collectively	collectively	ADV
ajlm-1255	140	19	,	,	PUNCT
ajlm-1255	140	20	and	and	CCONJ
ajlm-1255	140	21	fast	fast	ADV
ajlm-1255	140	22	.	.	PUNCT
ajlm-1255	141	1	lancet	lancet	PROPN
ajlm-1255	141	2	(	(	PUNCT
ajlm-1255	141	3	london	london	PROPN
ajlm-1255	141	4	,	,	PUNCT
ajlm-1255	141	5	england	england	PROPN
ajlm-1255	141	6	)	)	PUNCT
ajlm-1255	141	7	.	.	PUNCT
ajlm-1255	142	1	2020;395(10227):841–842	2020;395(10227):841–842	X
ajlm-1255	142	2	.	.	PUNCT
ajlm-1255	143	1	https://doi.org/10.1016/s0140-6736(20)30464-5	https://doi.org/10.1016/s0140-6736(20)30464-5	PROPN
ajlm-1255	143	2	khadka	khadka	PROPN
ajlm-1255	143	3	s	s	PROPN
ajlm-1255	143	4	,	,	PUNCT
ajlm-1255	143	5	hashmi	hashmi	PROPN
ajlm-1255	143	6	fk	fk	PROPN
ajlm-1255	143	7	,	,	PUNCT
ajlm-1255	143	8	usman	usman	PROPN
ajlm-1255	143	9	m.	m.	NOUN
ajlm-1255	143	10	preventing	prevent	VERB
ajlm-1255	143	11	covid-19	covid-19	PROPN
ajlm-1255	143	12	in	in	ADP
ajlm-1255	143	13	lowand	lowand	ADJ
ajlm-1255	143	14	middle	middle	ADJ
ajlm-1255	143	15	-	-	PUNCT
ajlm-1255	143	16	income	income	NOUN
ajlm-1255	143	17	countries	country	NOUN
ajlm-1255	143	18	.	.	PUNCT
ajlm-1255	144	1	drugs	drug	NOUN
ajlm-1255	144	2	ther	ther	ADV
ajlm-1255	144	3	perspect	perspect	VERB
ajlm-1255	144	4	.	.	PUNCT
ajlm-1255	145	1	2020:1–3	2020:1–3	NUM
ajlm-1255	145	2	.	.	PUNCT
ajlm-1255	145	3	https://doi.org/10.1007/s40267-020-00728-8	https://doi.org/10.1007/s40267-020-00728-8	PROPN
ajlm-1255	146	1	wang	wang	PROPN
ajlm-1255	146	2	x	x	PROPN
ajlm-1255	146	3	,	,	PUNCT
ajlm-1255	146	4	yao	yao	PROPN
ajlm-1255	146	5	h	h	NOUN
ajlm-1255	146	6	,	,	PUNCT
ajlm-1255	146	7	xu	xu	PROPN
ajlm-1255	146	8	x	x	NOUN
ajlm-1255	146	9	,	,	PUNCT
ajlm-1255	146	10	et	et	PROPN
ajlm-1255	146	11	al	al	PROPN
ajlm-1255	146	12	.	.	PUNCT
ajlm-1255	146	13	limits	limit	NOUN
ajlm-1255	146	14	of	of	ADP
ajlm-1255	146	15	detection	detection	NOUN
ajlm-1255	146	16	of	of	ADP
ajlm-1255	146	17	six	six	NUM
ajlm-1255	146	18	approved	approve	VERB
ajlm-1255	146	19	rt	rt	ADJ
ajlm-1255	146	20	-	-	PUNCT
ajlm-1255	146	21	pcr	pcr	ADJ
ajlm-1255	146	22	kits	kit	NOUN
ajlm-1255	146	23	for	for	ADP
ajlm-1255	146	24	the	the	DET
ajlm-1255	146	25	novel	novel	ADJ
ajlm-1255	146	26	sars	sar	NOUN
ajlm-1255	146	27	-	-	PUNCT
ajlm-1255	146	28	coronavirus-2	coronavirus-2	NUM
ajlm-1255	146	29	(	(	PUNCT
ajlm-1255	146	30	sars	sar	NOUN
ajlm-1255	146	31	-	-	PUNCT
ajlm-1255	146	32	cov-2	cov-2	NOUN
ajlm-1255	146	33	)	)	PUNCT
ajlm-1255	146	34	.	.	PUNCT
ajlm-1255	147	1	clin	clin	PROPN
ajlm-1255	147	2	chem	chem	PROPN
ajlm-1255	147	3	.	.	PUNCT
ajlm-1255	148	1	2020;66(7):977–979	2020;66(7):977–979	NUM
ajlm-1255	148	2	.	.	PROPN
ajlm-1255	148	3	https://doi.org/10.1093/clinchem/hvaa099	https://doi.org/10.1093/clinchem/hvaa099	PROPN
ajlm-1255	148	4	chan	chan	PROPN
ajlm-1255	148	5	jf	jf	PROPN
ajlm-1255	148	6	,	,	PUNCT
ajlm-1255	148	7	yip	yip	PROPN
ajlm-1255	148	8	cc	cc	PROPN
ajlm-1255	148	9	,	,	PUNCT
ajlm-1255	148	10	to	to	ADP
ajlm-1255	148	11	kk	kk	PROPN
ajlm-1255	148	12	,	,	PUNCT
ajlm-1255	148	13	et	et	PROPN
ajlm-1255	148	14	al	al	PROPN
ajlm-1255	148	15	.	.	PROPN
ajlm-1255	148	16	improved	improve	VERB
ajlm-1255	148	17	molecular	molecular	ADJ
ajlm-1255	148	18	diagnosis	diagnosis	NOUN
ajlm-1255	148	19	of	of	ADP
ajlm-1255	148	20	covid-19	covid-19	PROPN
ajlm-1255	148	21	by	by	ADP
ajlm-1255	148	22	the	the	DET
ajlm-1255	148	23	novel	novel	NOUN
ajlm-1255	148	24	,	,	PUNCT
ajlm-1255	148	25	highly	highly	ADV
ajlm-1255	148	26	sensitive	sensitive	ADJ
ajlm-1255	148	27	and	and	CCONJ
ajlm-1255	148	28	specific	specific	ADJ
ajlm-1255	148	29	covid-19	covid-19	PROPN
ajlm-1255	148	30	-	-	PUNCT
ajlm-1255	148	31	rdrp	rdrp	NOUN
ajlm-1255	148	32	/	/	SYM
ajlm-1255	148	33	hel	hel	VERB
ajlm-1255	148	34	real	real	ADJ
ajlm-1255	148	35	-	-	PUNCT
ajlm-1255	148	36	time	time	NOUN
ajlm-1255	148	37	reverse	reverse	ADJ
ajlm-1255	148	38	transcription	transcription	NOUN
ajlm-1255	148	39	-	-	PUNCT
ajlm-1255	148	40	pcr	pcr	NOUN
ajlm-1255	148	41	assay	assay	NOUN
ajlm-1255	148	42	validated	validate	VERB
ajlm-1255	148	43	in	in	ADP
ajlm-1255	148	44	vitro	vitro	X
ajlm-1255	148	45	and	and	CCONJ
ajlm-1255	148	46	with	with	ADP
ajlm-1255	148	47	clinical	clinical	ADJ
ajlm-1255	148	48	specimens	specimen	NOUN
ajlm-1255	148	49	.	.	PUNCT
ajlm-1255	149	1	j	j	PROPN
ajlm-1255	149	2	clin	clin	PROPN
ajlm-1255	149	3	microbiol	microbiol	PROPN
ajlm-1255	149	4	.	.	PUNCT
ajlm-1255	150	1	2020;58(5):e00310	2020;58(5):e00310	NUM
ajlm-1255	150	2	–	–	PUNCT
ajlm-1255	150	3	e00320	e00320	NOUN
ajlm-1255	150	4	.	.	PUNCT
ajlm-1255	151	1	https://doi.org/10.1128/jcm.00310-20	https://doi.org/10.1128/jcm.00310-20	PROPN
ajlm-1255	151	2	loeffelholz	loeffelholz	PROPN
ajlm-1255	151	3	mj	mj	PROPN
ajlm-1255	151	4	,	,	PUNCT
ajlm-1255	151	5	tang	tang	PROPN
ajlm-1255	151	6	y	y	PROPN
ajlm-1255	151	7	-	-	PUNCT
ajlm-1255	151	8	w.	w.	PROPN
ajlm-1255	151	9	laboratory	laboratory	NOUN
ajlm-1255	151	10	diagnosis	diagnosis	NOUN
ajlm-1255	151	11	of	of	ADP
ajlm-1255	151	12	emerging	emerge	VERB
ajlm-1255	151	13	human	human	ADJ
ajlm-1255	151	14	coronavirus	coronavirus	NOUN
ajlm-1255	151	15	infections	infection	NOUN
ajlm-1255	151	16	–	–	PUNCT
ajlm-1255	151	17	the	the	DET
ajlm-1255	151	18	state	state	NOUN
ajlm-1255	151	19	of	of	ADP
ajlm-1255	151	20	the	the	DET
ajlm-1255	151	21	art	art	NOUN
ajlm-1255	151	22	.	.	PUNCT
ajlm-1255	152	1	emerg	emerg	PROPN
ajlm-1255	152	2	microb	microb	NOUN
ajlm-1255	152	3	infect	infect	NOUN
ajlm-1255	152	4	.	.	PUNCT
ajlm-1255	153	1	2020;9(1):747–756	2020;9(1):747–756	X
ajlm-1255	153	2	.	.	PUNCT
ajlm-1255	153	3	https://doi.org/10.1080/22221751.2020.1745095	https://doi.org/10.1080/22221751.2020.1745095	PROPN
ajlm-1255	153	4	arevalo	arevalo	PROPN
ajlm-1255	153	5	-	-	PUNCT
ajlm-1255	153	6	rodriguez	rodriguez	PROPN
ajlm-1255	153	7	i	i	PROPN
ajlm-1255	153	8	,	,	PUNCT
ajlm-1255	153	9	buitrago	buitrago	PROPN
ajlm-1255	153	10	-	-	PUNCT
ajlm-1255	153	11	garcia	garcia	PROPN
ajlm-1255	153	12	d	d	PROPN
ajlm-1255	153	13	,	,	PUNCT
ajlm-1255	153	14	simancas	simancas	ADJ
ajlm-1255	153	15	-	-	PUNCT
ajlm-1255	153	16	racines	racine	NOUN
ajlm-1255	153	17	d	d	NOUN
ajlm-1255	153	18	,	,	PUNCT
ajlm-1255	153	19	et	et	PROPN
ajlm-1255	153	20	al	al	PROPN
ajlm-1255	153	21	.	.	PUNCT
ajlm-1255	153	22	false	false	ADJ
ajlm-1255	153	23	-	-	PUNCT
ajlm-1255	153	24	negative	negative	ADJ
ajlm-1255	153	25	results	result	NOUN
ajlm-1255	153	26	of	of	ADP
ajlm-1255	153	27	initial	initial	ADJ
ajlm-1255	153	28	rt	rt	ADJ
ajlm-1255	153	29	-	-	PUNCT
ajlm-1255	153	30	pcr	pcr	ADJ
ajlm-1255	153	31	assays	assay	NOUN
ajlm-1255	153	32	for	for	ADP
ajlm-1255	153	33	covid-19	covid-19	PROPN
ajlm-1255	153	34	:	:	PUNCT
ajlm-1255	153	35	a	a	DET
ajlm-1255	153	36	systematic	systematic	ADJ
ajlm-1255	153	37	review	review	NOUN
ajlm-1255	153	38	.	.	PUNCT
ajlm-1255	154	1	medrxiv	medrxiv	INTJ
ajlm-1255	154	2	.	.	PUNCT
ajlm-1255	155	1	2020:2020.04.16.20066787	2020:2020.04.16.20066787	NUM
ajlm-1255	155	2	.	.	PUNCT
ajlm-1255	155	3	https://doi.org/10.1101/2020.04	https://doi.org/10.1101/2020.04	PROPN
ajlm-1255	155	4	younes	younes	PROPN
ajlm-1255	155	5	n	n	CCONJ
ajlm-1255	155	6	,	,	PUNCT
ajlm-1255	155	7	al	al	PROPN
ajlm-1255	155	8	-	-	PUNCT
ajlm-1255	155	9	sadeq	sadeq	PROPN
ajlm-1255	155	10	dw	dw	PROPN
ajlm-1255	155	11	,	,	PUNCT
ajlm-1255	155	12	al	al	PROPN
ajlm-1255	155	13	-	-	PUNCT
ajlm-1255	155	14	jighefee	jighefee	PROPN
ajlm-1255	155	15	h	h	NOUN
ajlm-1255	155	16	,	,	PUNCT
ajlm-1255	155	17	et	et	PROPN
ajlm-1255	155	18	al	al	PROPN
ajlm-1255	155	19	.	.	PUNCT
ajlm-1255	155	20	challenges	challenge	NOUN
ajlm-1255	155	21	in	in	ADP
ajlm-1255	155	22	laboratory	laboratory	NOUN
ajlm-1255	155	23	diagnosis	diagnosis	NOUN
ajlm-1255	155	24	of	of	ADP
ajlm-1255	155	25	the	the	DET
ajlm-1255	155	26	novel	novel	ADJ
ajlm-1255	155	27	coronavirus	coronavirus	NOUN
ajlm-1255	155	28	sars	sar	NOUN
ajlm-1255	155	29	-	-	PUNCT
ajlm-1255	155	30	cov-2	cov-2	NOUN
ajlm-1255	155	31	.	.	PUNCT
ajlm-1255	156	1	viruses	virus	NOUN
ajlm-1255	156	2	.	.	PUNCT
ajlm-1255	157	1	2020;12(6):582	2020;12(6):582	NUM
ajlm-1255	157	2	.	.	PUNCT
ajlm-1255	158	1	https://doi.org/10.3390/v12060582	https://doi.org/10.3390/v12060582	NUM
ajlm-1255	158	2	zhong	zhong	PROPN
ajlm-1255	158	3	l	l	PROPN
ajlm-1255	158	4	,	,	PUNCT
ajlm-1255	158	5	chuan	chuan	PROPN
ajlm-1255	158	6	j	j	PROPN
ajlm-1255	158	7	,	,	PUNCT
ajlm-1255	158	8	gong	gong	PROPN
ajlm-1255	158	9	b	b	PROPN
ajlm-1255	158	10	,	,	PUNCT
ajlm-1255	158	11	et	et	PROPN
ajlm-1255	158	12	al	al	PROPN
ajlm-1255	158	13	.	.	PUNCT
ajlm-1255	158	14	detection	detection	NOUN
ajlm-1255	158	15	of	of	ADP
ajlm-1255	158	16	serum	serum	NOUN
ajlm-1255	158	17	igm	igm	PROPN
ajlm-1255	158	18	and	and	CCONJ
ajlm-1255	158	19	igg	igg	PROPN
ajlm-1255	158	20	for	for	ADP
ajlm-1255	158	21	covid-19	covid-19	PROPN
ajlm-1255	158	22	diagnosis	diagnosis	NOUN
ajlm-1255	158	23	.	.	PUNCT
ajlm-1255	159	1	sci	sci	PROPN
ajlm-1255	159	2	china	china	PROPN
ajlm-1255	159	3	life	life	PROPN
ajlm-1255	159	4	sci	sci	PROPN
ajlm-1255	159	5	.	.	PUNCT
ajlm-1255	159	6	2020;63(5):777–780	2020;63(5):777–780	PROPN
ajlm-1255	159	7	.	.	PROPN
ajlm-1255	159	8	https://doi.org/10.1007/s11427-020-1688-9	https://doi.org/10.1007/s11427-020-1688-9	PROPN
ajlm-1255	159	9	haveri	haveri	PROPN
ajlm-1255	159	10	a	a	PRON
ajlm-1255	159	11	,	,	PUNCT
ajlm-1255	159	12	smura	smura	X
ajlm-1255	159	13	t	t	PROPN
ajlm-1255	159	14	,	,	PUNCT
ajlm-1255	159	15	kuivanen	kuivanen	NOUN
ajlm-1255	159	16	s	s	PROPN
ajlm-1255	159	17	,	,	PUNCT
ajlm-1255	159	18	et	et	PROPN
ajlm-1255	159	19	al	al	PROPN
ajlm-1255	159	20	.	.	PROPN
ajlm-1255	159	21	serological	serological	ADJ
ajlm-1255	159	22	and	and	CCONJ
ajlm-1255	159	23	molecular	molecular	ADJ
ajlm-1255	159	24	findings	finding	NOUN
ajlm-1255	159	25	during	during	ADP
ajlm-1255	159	26	sars	sar	NOUN
ajlm-1255	159	27	-	-	PUNCT
ajlm-1255	159	28	cov-2	cov-2	PART
ajlm-1255	159	29	infection	infection	NOUN
ajlm-1255	159	30	:	:	PUNCT
ajlm-1255	159	31	the	the	DET
ajlm-1255	159	32	first	first	ADJ
ajlm-1255	159	33	case	case	NOUN
ajlm-1255	159	34	study	study	NOUN
ajlm-1255	159	35	in	in	ADP
ajlm-1255	159	36	finland	finland	PROPN
ajlm-1255	159	37	,	,	PUNCT
ajlm-1255	159	38	january	january	PROPN
ajlm-1255	159	39	to	to	ADP
ajlm-1255	159	40	february	february	PROPN
ajlm-1255	159	41	2020	2020	NUM
ajlm-1255	159	42	.	.	PUNCT
ajlm-1255	160	1	euro	euro	NOUN
ajlm-1255	160	2	surveill	surveill	NOUN
ajlm-1255	160	3	.	.	PUNCT
ajlm-1255	161	1	2020;25(11):2000266	2020;25(11):2000266	X
ajlm-1255	161	2	.	.	PUNCT
ajlm-1255	161	3	https://doi.org/10.2807/1560-7917.es.2020.25.11.2000266	https://doi.org/10.2807/1560-7917.es.2020.25.11.2000266	PROPN
ajlm-1255	161	4	patel	patel	PROPN
ajlm-1255	161	5	r	r	NOUN
ajlm-1255	161	6	,	,	PUNCT
ajlm-1255	161	7	babady	babady	ADJ
ajlm-1255	161	8	e	e	NOUN
ajlm-1255	161	9	,	,	PUNCT
ajlm-1255	161	10	theel	theel	NOUN
ajlm-1255	161	11	es	es	NOUN
ajlm-1255	161	12	,	,	PUNCT
ajlm-1255	161	13	et	et	PROPN
ajlm-1255	161	14	al	al	PROPN
ajlm-1255	161	15	.	.	PROPN
ajlm-1255	161	16	report	report	NOUN
ajlm-1255	161	17	from	from	ADP
ajlm-1255	161	18	the	the	DET
ajlm-1255	161	19	american	american	ADJ
ajlm-1255	161	20	society	society	NOUN
ajlm-1255	161	21	for	for	ADP
ajlm-1255	161	22	microbiology	microbiology	NOUN
ajlm-1255	161	23	covid-19	covid-19	PROPN
ajlm-1255	161	24	international	international	ADJ
ajlm-1255	161	25	summit	summit	NOUN
ajlm-1255	161	26	,	,	PUNCT
ajlm-1255	161	27	23	23	NUM
ajlm-1255	161	28	march	march	NOUN
ajlm-1255	161	29	2020	2020	NUM
ajlm-1255	161	30	:	:	PUNCT
ajlm-1255	161	31	value	value	NOUN
ajlm-1255	161	32	of	of	ADP
ajlm-1255	161	33	diagnostic	diagnostic	ADJ
ajlm-1255	161	34	testing	testing	NOUN
ajlm-1255	161	35	for	for	ADP
ajlm-1255	161	36	sars	sar	NOUN
ajlm-1255	161	37	-	-	PUNCT
ajlm-1255	161	38	cov-2	cov-2	NOUN
ajlm-1255	161	39	/	/	SYM
ajlm-1255	161	40	covid-19	covid-19	PROPN
ajlm-1255	161	41	.	.	PUNCT
ajlm-1255	161	42	mbio	mbio	PROPN
ajlm-1255	161	43	.	.	PUNCT
ajlm-1255	162	1	2020;11(2):e00722–20	2020;11(2):e00722–20	NUM
ajlm-1255	162	2	.	.	PUNCT
ajlm-1255	162	3	https://doi.org/10.1128/mbio.00722-20	https://doi.org/10.1128/mbio.00722-20	PROPN
ajlm-1255	162	4	arksey	arksey	PROPN
ajlm-1255	162	5	h	h	NOUN
ajlm-1255	162	6	,	,	PUNCT
ajlm-1255	162	7	o’malley	o’malley	VERB
ajlm-1255	162	8	l.	l.	NOUN
ajlm-1255	162	9	scoping	scope	VERB
ajlm-1255	162	10	studies	study	NOUN
ajlm-1255	162	11	:	:	PUNCT
ajlm-1255	162	12	towards	towards	ADP
ajlm-1255	162	13	a	a	DET
ajlm-1255	162	14	methodological	methodological	ADJ
ajlm-1255	162	15	framework	framework	NOUN
ajlm-1255	162	16	.	.	PUNCT
ajlm-1255	163	1	int	int	NOUN
ajlm-1255	163	2	j	j	PROPN
ajlm-1255	163	3	soc	soc	PROPN
ajlm-1255	163	4	res	re	VERB
ajlm-1255	163	5	methodol	methodol	NOUN
ajlm-1255	163	6	.	.	PUNCT
ajlm-1255	164	1	2005;8(1):19–32	2005;8(1):19–32	NUM
ajlm-1255	164	2	.	.	PUNCT
ajlm-1255	164	3	https://doi.org/10.1080/1364557032000119616	https://doi.org/10.1080/1364557032000119616	PROPN
ajlm-1255	164	4	adhikari	adhikari	PROPN
ajlm-1255	164	5	sp	sp	PROPN
ajlm-1255	164	6	,	,	PUNCT
ajlm-1255	164	7	meng	meng	PROPN
ajlm-1255	164	8	s	s	PROPN
ajlm-1255	164	9	,	,	PUNCT
ajlm-1255	164	10	wu	wu	PROPN
ajlm-1255	164	11	yj	yj	PROPN
ajlm-1255	164	12	,	,	PUNCT
ajlm-1255	164	13	et	et	PROPN
ajlm-1255	164	14	al	al	PROPN
ajlm-1255	164	15	.	.	PUNCT
ajlm-1255	165	1	epidemiology	epidemiology	NOUN
ajlm-1255	165	2	,	,	PUNCT
ajlm-1255	165	3	causes	cause	NOUN
ajlm-1255	165	4	,	,	PUNCT
ajlm-1255	165	5	clinical	clinical	ADJ
ajlm-1255	165	6	manifestation	manifestation	NOUN
ajlm-1255	165	7	and	and	CCONJ
ajlm-1255	165	8	diagnosis	diagnosis	NOUN
ajlm-1255	165	9	,	,	PUNCT
ajlm-1255	165	10	prevention	prevention	NOUN
ajlm-1255	165	11	and	and	CCONJ
ajlm-1255	165	12	control	control	NOUN
ajlm-1255	165	13	of	of	ADP
ajlm-1255	165	14	coronavirus	coronavirus	NOUN
ajlm-1255	165	15	disease	disease	NOUN
ajlm-1255	165	16	(	(	PUNCT
ajlm-1255	165	17	covid-19	covid-19	PROPN
ajlm-1255	165	18	)	)	PUNCT
ajlm-1255	165	19	during	during	ADP
ajlm-1255	165	20	the	the	DET
ajlm-1255	165	21	early	early	ADJ
ajlm-1255	165	22	outbreak	outbreak	NOUN
ajlm-1255	165	23	period	period	NOUN
ajlm-1255	165	24	:	:	PUNCT
ajlm-1255	165	25	a	a	DET
ajlm-1255	165	26	scoping	scope	VERB
ajlm-1255	165	27	review	review	NOUN
ajlm-1255	165	28	.	.	PUNCT
ajlm-1255	166	1	infect	infect	VERB
ajlm-1255	166	2	dis	dis	PROPN
ajlm-1255	166	3	poverty	poverty	NOUN
ajlm-1255	166	4	.	.	PUNCT
ajlm-1255	167	1	2020;9(1):020–00646	2020;9(1):020–00646	NUM
ajlm-1255	167	2	.	.	PUNCT
ajlm-1255	168	1	https://doi.org/10.1186/s40249-020-00646-x	https://doi.org/10.1186/s40249-020-00646-x	PROPN
ajlm-1255	168	2	tahamtan	tahamtan	PROPN
ajlm-1255	168	3	a	a	NOUN
ajlm-1255	168	4	,	,	PUNCT
ajlm-1255	168	5	ardebili	ardebili	NOUN
ajlm-1255	168	6	a.	a.	NOUN
ajlm-1255	168	7	real	real	ADJ
ajlm-1255	168	8	-	-	PUNCT
ajlm-1255	168	9	time	time	NOUN
ajlm-1255	168	10	rt	rt	NOUN
ajlm-1255	168	11	-	-	PUNCT
ajlm-1255	168	12	pcr	pcr	NOUN
ajlm-1255	168	13	in	in	ADP
ajlm-1255	168	14	covid-19	covid-19	PROPN
ajlm-1255	168	15	detection	detection	NOUN
ajlm-1255	168	16	:	:	PUNCT
ajlm-1255	168	17	issues	issue	NOUN
ajlm-1255	168	18	affecting	affect	VERB
ajlm-1255	168	19	the	the	DET
ajlm-1255	168	20	results	result	NOUN
ajlm-1255	168	21	.	.	PUNCT
ajlm-1255	169	1	expert	expert	NOUN
ajlm-1255	169	2	rev	rev	VERB
ajlm-1255	169	3	mol	mol	ADP
ajlm-1255	169	4	diagn	diagn	NOUN
ajlm-1255	169	5	.	.	PUNCT
ajlm-1255	170	1	2020;20(5):453–454	2020;20(5):453–454	X
ajlm-1255	170	2	.	.	PUNCT
ajlm-1255	170	3	https://doi.org/10.1080/14737159.2020.1757437	https://doi.org/10.1080/14737159.2020.1757437	PROPN
ajlm-1255	171	1	zhao	zhao	PROPN
ajlm-1255	171	2	j	j	PROPN
ajlm-1255	171	3	,	,	PUNCT
ajlm-1255	171	4	yuan	yuan	PROPN
ajlm-1255	171	5	q	q	PROPN
ajlm-1255	171	6	,	,	PUNCT
ajlm-1255	171	7	wang	wang	PROPN
ajlm-1255	171	8	h	h	PROPN
ajlm-1255	171	9	,	,	PUNCT
ajlm-1255	171	10	et	et	PROPN
ajlm-1255	171	11	al	al	PROPN
ajlm-1255	171	12	.	.	PUNCT
ajlm-1255	172	1	antibody	antibody	NOUN
ajlm-1255	172	2	responses	response	NOUN
ajlm-1255	172	3	to	to	ADP
ajlm-1255	172	4	sars	sar	NOUN
ajlm-1255	172	5	-	-	PUNCT
ajlm-1255	172	6	cov-2	cov-2	NOUN
ajlm-1255	172	7	in	in	ADP
ajlm-1255	172	8	patients	patient	NOUN
ajlm-1255	172	9	of	of	ADP
ajlm-1255	172	10	novel	novel	ADJ
ajlm-1255	172	11	coronavirus	coronavirus	NOUN
ajlm-1255	172	12	disease	disease	NOUN
ajlm-1255	172	13	2019	2019	NUM
ajlm-1255	172	14	.	.	PUNCT
ajlm-1255	173	1	clin	clin	PROPN
ajlm-1255	173	2	infect	infect	PROPN
ajlm-1255	173	3	dis	dis	PROPN
ajlm-1255	173	4	.	.	PUNCT
ajlm-1255	174	1	2020;ciaa344	2020;ciaa344	PROPN
ajlm-1255	174	2	.	.	PUNCT
ajlm-1255	174	3	https://doi.org/101093/cid/ciaa344	https://doi.org/101093/cid/ciaa344	PUNCT
ajlm-1255	174	4	okba	okba	PROPN
ajlm-1255	174	5	nma	nma	PROPN
ajlm-1255	174	6	,	,	PUNCT
ajlm-1255	174	7	muller	muller	PROPN
ajlm-1255	174	8	ma	ma	PROPN
ajlm-1255	174	9	,	,	PUNCT
ajlm-1255	174	10	li	li	PROPN
ajlm-1255	174	11	w	w	PROPN
ajlm-1255	174	12	,	,	PUNCT
ajlm-1255	174	13	et	et	PROPN
ajlm-1255	174	14	al	al	PROPN
ajlm-1255	174	15	.	.	PUNCT
ajlm-1255	175	1	sars	sars	PROPN
ajlm-1255	175	2	-	-	PUNCT
ajlm-1255	175	3	cov-2	cov-2	ADP
ajlm-1255	175	4	specific	specific	ADJ
ajlm-1255	175	5	antibody	antibody	NOUN
ajlm-1255	175	6	responses	response	NOUN
ajlm-1255	175	7	in	in	ADP
ajlm-1255	175	8	covid-19	covid-19	PROPN
ajlm-1255	175	9	patients	patient	NOUN
ajlm-1255	175	10	.	.	PUNCT
ajlm-1255	176	1	medrxiv	medrxiv	INTJ
ajlm-1255	176	2	.	.	PUNCT
ajlm-1255	177	1	2020:2020.03.18.20038059	2020:2020.03.18.20038059	X
ajlm-1255	177	2	.	.	PROPN
ajlm-1255	177	3	gorse	gorse	PROPN
ajlm-1255	177	4	gj	gj	PROPN
ajlm-1255	177	5	,	,	PUNCT
ajlm-1255	177	6	donovan	donovan	PROPN
ajlm-1255	177	7	mm	mm	PROPN
ajlm-1255	177	8	,	,	PUNCT
ajlm-1255	177	9	patel	patel	PROPN
ajlm-1255	177	10	gb	gb	PROPN
ajlm-1255	177	11	.	.	PUNCT
ajlm-1255	177	12	antibodies	antibodie	VERB
ajlm-1255	177	13	to	to	ADP
ajlm-1255	177	14	coronaviruses	coronaviruse	NOUN
ajlm-1255	177	15	are	be	AUX
ajlm-1255	177	16	higher	high	ADJ
ajlm-1255	177	17	in	in	ADP
ajlm-1255	177	18	older	old	ADJ
ajlm-1255	177	19	compared	compare	VERB
ajlm-1255	177	20	with	with	ADP
ajlm-1255	177	21	younger	young	ADJ
ajlm-1255	177	22	adults	adult	NOUN
ajlm-1255	177	23	and	and	CCONJ
ajlm-1255	177	24	binding	bind	VERB
ajlm-1255	177	25	antibodies	antibody	NOUN
ajlm-1255	177	26	are	be	AUX
ajlm-1255	177	27	more	more	ADV
ajlm-1255	177	28	sensitive	sensitive	ADJ
ajlm-1255	177	29	than	than	ADP
ajlm-1255	177	30	neutralizing	neutralize	VERB
ajlm-1255	177	31	antibodies	antibody	NOUN
ajlm-1255	177	32	in	in	ADP
ajlm-1255	177	33	identifying	identify	VERB
ajlm-1255	177	34	coronavirus	coronavirus	NOUN
ajlm-1255	177	35	-	-	PUNCT
ajlm-1255	177	36	associated	associate	VERB
ajlm-1255	177	37	illnesses	illness	NOUN
ajlm-1255	177	38	.	.	PUNCT
ajlm-1255	178	1	j	j	PROPN
ajlm-1255	178	2	med	med	PROPN
ajlm-1255	178	3	virol	virol	NOUN
ajlm-1255	178	4	.	.	PUNCT
ajlm-1255	179	1	2020;92(5):512–517	2020;92(5):512–517	X
ajlm-1255	179	2	.	.	X
ajlm-1255	179	3	https://doi.org/10.1002/jmv.25715	https://doi.org/10.1002/jmv.25715	NOUN
ajlm-1255	179	4	who	who	PRON
ajlm-1255	179	5	.	.	PUNCT
ajlm-1255	180	1	advice	advice	NOUN
ajlm-1255	180	2	on	on	ADP
ajlm-1255	180	3	the	the	DET
ajlm-1255	180	4	use	use	NOUN
ajlm-1255	180	5	of	of	ADP
ajlm-1255	180	6	point	point	NOUN
ajlm-1255	180	7	-	-	PUNCT
ajlm-1255	180	8	of	of	ADP
ajlm-1255	180	9	-	-	PUNCT
ajlm-1255	180	10	care	care	NOUN
ajlm-1255	180	11	immunodiagnostic	immunodiagnostic	ADJ
ajlm-1255	180	12	tests	test	NOUN
ajlm-1255	180	13	for	for	ADP
ajlm-1255	180	14	covid-19	covid-19	PROPN
ajlm-1255	181	1	[	[	X
ajlm-1255	181	2	homepage	homepage	NOUN
ajlm-1255	181	3	on	on	ADP
ajlm-1255	181	4	the	the	DET
ajlm-1255	181	5	internet	internet	NOUN
ajlm-1255	181	6	]	]	PUNCT
ajlm-1255	181	7	.	.	PUNCT
ajlm-1255	182	1	scientific	scientific	ADJ
ajlm-1255	182	2	brief	brief	ADJ
ajlm-1255	182	3	8	8	NUM
ajlm-1255	182	4	april	april	NOUN
ajlm-1255	182	5	2020	2020	NUM
ajlm-1255	183	1	[	[	X
ajlm-1255	183	2	cited	cite	VERB
ajlm-1255	183	3	2020	2020	NUM
ajlm-1255	183	4	apr	apr	NOUN
ajlm-1255	183	5	08	08	NUM
ajlm-1255	183	6	]	]	PUNCT
ajlm-1255	183	7	.	.	PUNCT
ajlm-1255	184	1	available	available	ADJ
ajlm-1255	184	2	from	from	ADP
ajlm-1255	184	3	:	:	PUNCT
ajlm-1255	184	4	who/2019	who/2019	X
ajlm-1255	184	5	-	-	PUNCT
ajlm-1255	184	6	ncov	ncov	NOUN
ajlm-1255	184	7	/	/	SYM
ajlm-1255	184	8	sci_brief	sci_brief	NOUN
ajlm-1255	184	9	/	/	SYM
ajlm-1255	184	10	poc_immunodiagnostics/20201	poc_immunodiagnostics/20201	PROPN
ajlm-1255	184	11	cassaniti	cassaniti	NOUN
ajlm-1255	184	12	i	i	NOUN
ajlm-1255	184	13	,	,	PUNCT
ajlm-1255	184	14	novazzi	novazzi	NOUN
ajlm-1255	184	15	f	f	PROPN
ajlm-1255	184	16	,	,	PUNCT
ajlm-1255	184	17	giardina	giardina	PROPN
ajlm-1255	184	18	f	f	PROPN
ajlm-1255	184	19	,	,	PUNCT
ajlm-1255	184	20	et	et	PROPN
ajlm-1255	184	21	al	al	PROPN
ajlm-1255	184	22	.	.	PUNCT
ajlm-1255	185	1	performance	performance	NOUN
ajlm-1255	185	2	of	of	ADP
ajlm-1255	185	3	vivadiag	vivadiag	ADJ
ajlm-1255	185	4	covid-19	covid-19	PROPN
ajlm-1255	185	5	igm	igm	PROPN
ajlm-1255	185	6	/	/	SYM
ajlm-1255	185	7	igg	igg	PROPN
ajlm-1255	185	8	rapid	rapid	ADJ
ajlm-1255	185	9	test	test	NOUN
ajlm-1255	185	10	is	be	AUX
ajlm-1255	185	11	inadequate	inadequate	ADJ
ajlm-1255	185	12	for	for	ADP
ajlm-1255	185	13	diagnosis	diagnosis	NOUN
ajlm-1255	185	14	of	of	ADP
ajlm-1255	185	15	covid-19	covid-19	PROPN
ajlm-1255	185	16	in	in	ADP
ajlm-1255	185	17	acute	acute	ADJ
ajlm-1255	185	18	patients	patient	NOUN
ajlm-1255	185	19	referring	refer	VERB
ajlm-1255	185	20	to	to	ADP
ajlm-1255	185	21	emergency	emergency	NOUN
ajlm-1255	185	22	room	room	NOUN
ajlm-1255	185	23	department	department	NOUN
ajlm-1255	185	24	.	.	PUNCT
ajlm-1255	186	1	j	j	PROPN
ajlm-1255	186	2	med	med	PROPN
ajlm-1255	186	3	virol	virol	NOUN
ajlm-1255	186	4	.	.	PUNCT
ajlm-1255	187	1	2020	2020	NUM
ajlm-1255	187	2	mar	mar	PROPN
ajlm-1255	187	3	30	30	NUM
ajlm-1255	187	4	.	.	PUNCT
ajlm-1255	188	1	https://doi.org/10.1002/jmv.25800	https://doi.org/10.1002/jmv.25800	PROPN
ajlm-1255	188	2	who	who	PRON
ajlm-1255	188	3	.	.	PUNCT
ajlm-1255	189	1	coronavirus	coronavirus	NOUN
ajlm-1255	189	2	disease	disease	NOUN
ajlm-1255	189	3	(	(	PUNCT
ajlm-1255	189	4	covid-19	covid-19	PROPN
ajlm-1255	189	5	)	)	PUNCT
ajlm-1255	189	6	technical	technical	ADJ
ajlm-1255	189	7	guidance	guidance	NOUN
ajlm-1255	189	8	:	:	PUNCT
ajlm-1255	189	9	laboratory	laboratory	NOUN
ajlm-1255	189	10	testing	testing	NOUN
ajlm-1255	189	11	for	for	ADP
ajlm-1255	189	12	2019	2019	NUM
ajlm-1255	189	13	-	-	PUNCT
ajlm-1255	189	14	ncov	ncov	ADV
ajlm-1255	189	15	in	in	ADP
ajlm-1255	189	16	humans	human	NOUN
ajlm-1255	189	17	[	[	X
ajlm-1255	189	18	homepage	homepage	NOUN
ajlm-1255	189	19	on	on	ADP
ajlm-1255	189	20	the	the	DET
ajlm-1255	189	21	internet	internet	NOUN
ajlm-1255	189	22	]	]	PUNCT
ajlm-1255	189	23	.	.	PUNCT
ajlm-1255	190	1	[	[	X
ajlm-1255	190	2	cited	cite	VERB
ajlm-1255	190	3	2020	2020	NUM
ajlm-1255	190	4	apr	apr	NOUN
ajlm-1255	190	5	08	08	NUM
ajlm-1255	190	6	]	]	PUNCT
ajlm-1255	190	7	.	.	PUNCT
ajlm-1255	191	1	available	available	ADJ
ajlm-1255	191	2	from	from	ADP
ajlm-1255	191	3	:	:	PUNCT
ajlm-1255	191	4	www.who.int	www.who.int	NOUN
ajlm-1255	191	5	;	;	PUNCT
ajlm-1255	191	6	[	[	X
ajlm-1255	191	7	cited	cite	VERB
ajlm-1255	191	8	2020	2020	NUM
ajlm-1255	191	9	apr	apr	NOUN
ajlm-1255	191	10	06	06	NUM
ajlm-1255	191	11	]	]	PUNCT
ajlm-1255	191	12	.	.	PUNCT
ajlm-1255	192	1	wang	wang	PROPN
ajlm-1255	192	2	y	y	PROPN
ajlm-1255	192	3	,	,	PUNCT
ajlm-1255	192	4	kang	kang	PROPN
ajlm-1255	192	5	h	h	PROPN
ajlm-1255	192	6	,	,	PUNCT
ajlm-1255	192	7	liu	liu	PROPN
ajlm-1255	192	8	x	x	PROPN
ajlm-1255	192	9	,	,	PUNCT
ajlm-1255	192	10	tong	tong	PROPN
ajlm-1255	192	11	z.	z.	PROPN
ajlm-1255	192	12	combination	combination	NOUN
ajlm-1255	192	13	of	of	ADP
ajlm-1255	192	14	rt	rt	NOUN
ajlm-1255	192	15	-	-	PUNCT
ajlm-1255	192	16	qpcr	qpcr	ADV
ajlm-1255	192	17	testing	testing	NOUN
ajlm-1255	192	18	and	and	CCONJ
ajlm-1255	192	19	clinical	clinical	ADJ
ajlm-1255	192	20	features	feature	NOUN
ajlm-1255	192	21	for	for	ADP
ajlm-1255	192	22	diagnosis	diagnosis	NOUN
ajlm-1255	192	23	of	of	ADP
ajlm-1255	192	24	covid-19	covid-19	PROPN
ajlm-1255	192	25	facilitates	facilitate	VERB
ajlm-1255	192	26	management	management	NOUN
ajlm-1255	192	27	of	of	ADP
ajlm-1255	192	28	sars	sar	NOUN
ajlm-1255	192	29	-	-	PUNCT
ajlm-1255	192	30	cov-2	cov-2	PART
ajlm-1255	192	31	outbreak	outbreak	NOUN
ajlm-1255	192	32	.	.	PUNCT
ajlm-1255	193	1	j	j	PROPN
ajlm-1255	193	2	med	med	PROPN
ajlm-1255	193	3	virol	virol	NOUN
ajlm-1255	193	4	.	.	PUNCT
ajlm-1255	194	1	2020;92(6):538–539	2020;92(6):538–539	NUM
ajlm-1255	194	2	.	.	PUNCT
ajlm-1255	195	1	stackelberg	stackelberg	PROPN
ajlm-1255	195	2	o	o	NOUN
ajlm-1255	195	3	,	,	PUNCT
ajlm-1255	195	4	esmaeilzadeh	esmaeilzadeh	NOUN
ajlm-1255	195	5	m	m	PROPN
ajlm-1255	195	6	,	,	PUNCT
ajlm-1255	195	7	olsen	olsen	PROPN
ajlm-1255	195	8	b	b	PROPN
ajlm-1255	195	9	,	,	PUNCT
ajlm-1255	195	10	lundkvist	lundkvist	NOUN
ajlm-1255	195	11	å	å	NOUN
ajlm-1255	195	12	.	.	PUNCT
ajlm-1255	196	1	[	[	X
ajlm-1255	196	2	rapid	rapid	ADJ
ajlm-1255	196	3	point	point	NOUN
ajlm-1255	196	4	-	-	PUNCT
ajlm-1255	196	5	of	of	ADP
ajlm-1255	196	6	-	-	PUNCT
ajlm-1255	196	7	care	care	NOUN
ajlm-1255	196	8	serology	serology	NOUN
ajlm-1255	196	9	testing	testing	NOUN
ajlm-1255	196	10	for	for	ADP
ajlm-1255	196	11	sars	sar	NOUN
ajlm-1255	196	12	-	-	PUNCT
ajlm-1255	196	13	cov-2	cov-2	NOUN
ajlm-1255	196	14	]	]	PUNCT
ajlm-1255	196	15	.	.	PUNCT
ajlm-1255	197	1	lakartidningen	lakartidningen	PROPN
ajlm-1255	197	2	,	,	PUNCT
ajlm-1255	197	3	stockholm	stockholm	PROPN
ajlm-1255	197	4	.	.	PUNCT
ajlm-1255	198	1	2020;117	2020;117	NUM
ajlm-1255	198	2	.	.	PUNCT
ajlm-1255	199	1	malaysia	malaysia	PROPN
ajlm-1255	199	2	moh	moh	PROPN
ajlm-1255	199	3	.	.	PUNCT
ajlm-1255	200	1	guidelines	guideline	NOUN
ajlm-1255	200	2	on	on	ADP
ajlm-1255	200	3	covid-19	covid-19	PROPN
ajlm-1255	200	4	management	management	NOUN
ajlm-1255	200	5	in	in	ADP
ajlm-1255	200	6	malaysia	malaysia	PROPN
ajlm-1255	200	7	.	.	PUNCT
ajlm-1255	201	1	5th	5th	ADJ
ajlm-1255	201	2	ed	ed	NOUN
ajlm-1255	201	3	.	.	PUNCT
ajlm-1255	202	1	the	the	DET
ajlm-1255	202	2	ministry	ministry	PROPN
ajlm-1255	202	3	of	of	ADP
ajlm-1255	202	4	health	health	PROPN
ajlm-1255	202	5	malaysia	malaysia	PROPN
ajlm-1255	202	6	:	:	PUNCT
ajlm-1255	202	7	putrajaya	putrajaya	PROPN
ajlm-1255	202	8	;	;	PUNCT
ajlm-1255	202	9	2020	2020	NUM
ajlm-1255	202	10	.	.	PUNCT
ajlm-1255	203	1	control	control	NOUN
ajlm-1255	203	2	.	.	PUNCT
ajlm-1255	204	1	ecfdpa	ecfdpa	PROPN
ajlm-1255	204	2	.	.	PUNCT
ajlm-1255	205	1	novel	novel	ADJ
ajlm-1255	205	2	coronavirus	coronavirus	NOUN
ajlm-1255	205	3	(	(	PUNCT
ajlm-1255	205	4	sars	sar	NOUN
ajlm-1255	205	5	-	-	PUNCT
ajlm-1255	205	6	cov-2	cov-2	NOUN
ajlm-1255	205	7	)	)	PUNCT
ajlm-1255	205	8	discharge	discharge	NOUN
ajlm-1255	205	9	criteria	criterion	NOUN
ajlm-1255	205	10	for	for	ADP
ajlm-1255	205	11	confirmed	confirm	VERB
ajlm-1255	205	12	covid-19	covid-19	PROPN
ajlm-1255	205	13	cases	case	NOUN
ajlm-1255	205	14	–	–	PUNCT
ajlm-1255	205	15	when	when	SCONJ
ajlm-1255	205	16	is	be	AUX
ajlm-1255	205	17	it	it	PRON
ajlm-1255	205	18	safe	safe	ADJ
ajlm-1255	205	19	to	to	PART
ajlm-1255	205	20	discharge	discharge	VERB
ajlm-1255	205	21	covid-19	covid-19	PROPN
ajlm-1255	205	22	cases	case	NOUN
ajlm-1255	205	23	from	from	ADP
ajlm-1255	205	24	the	the	DET
ajlm-1255	205	25	hospital	hospital	NOUN
ajlm-1255	205	26	or	or	CCONJ
ajlm-1255	205	27	end	end	VERB
ajlm-1255	205	28	home	home	NOUN
ajlm-1255	205	29	isolation	isolation	NOUN
ajlm-1255	205	30	?	?	PUNCT
ajlm-1255	206	1	[	[	X
ajlm-1255	206	2	homepage	homepage	NOUN
ajlm-1255	206	3	on	on	ADP
ajlm-1255	206	4	the	the	DET
ajlm-1255	206	5	internet	internet	NOUN
ajlm-1255	206	6	]	]	PUNCT
ajlm-1255	206	7	.	.	PUNCT
ajlm-1255	207	1	[	[	X
ajlm-1255	207	2	cited	cite	VERB
ajlm-1255	207	3	2020	2020	NUM
ajlm-1255	207	4	apr	apr	VERB
ajlm-1255	207	5	10	10	NUM
ajlm-1255	207	6	]	]	PUNCT
ajlm-1255	207	7	.	.	PUNCT
ajlm-1255	208	1	available	available	ADJ
ajlm-1255	208	2	from	from	ADP
ajlm-1255	208	3	:	:	PUNCT
ajlm-1255	208	4	https://www.ecdceuropaeu/sites/default/files/documents/covid-19-discharge-criteria.pdf	https://www.ecdceuropaeu/sites/default/files/documents/covid-19-discharge-criteria.pdf	PROPN
ajlm-1255	208	5	chan	chan	PROPN
ajlm-1255	208	6	pk	pk	PROPN
ajlm-1255	208	7	,	,	PUNCT
ajlm-1255	208	8	ng	ng	PROPN
ajlm-1255	208	9	kc	kc	PROPN
ajlm-1255	208	10	,	,	PUNCT
ajlm-1255	208	11	chan	chan	PROPN
ajlm-1255	208	12	rc	rc	PROPN
ajlm-1255	208	13	,	,	PUNCT
ajlm-1255	208	14	et	et	PROPN
ajlm-1255	208	15	al	al	PROPN
ajlm-1255	208	16	.	.	PROPN
ajlm-1255	208	17	immunofluorescence	immunofluorescence	NOUN
ajlm-1255	208	18	assay	assay	VERB
ajlm-1255	208	19	for	for	ADP
ajlm-1255	208	20	serologic	serologic	ADJ
ajlm-1255	208	21	diagnosis	diagnosis	NOUN
ajlm-1255	208	22	of	of	ADP
ajlm-1255	208	23	sars	sar	NOUN
ajlm-1255	208	24	.	.	PUNCT
ajlm-1255	209	1	emerg	emerg	PROPN
ajlm-1255	209	2	infect	infect	PROPN
ajlm-1255	209	3	dis	dis	PROPN
ajlm-1255	209	4	.	.	PUNCT
ajlm-1255	210	1	2004;10(3):530–532	2004;10(3):530–532	X
ajlm-1255	210	2	.	.	PUNCT
ajlm-1255	210	3	https://doi.org/10.3201/eid1003.030493	https://doi.org/10.3201/eid1003.030493	PROPN
ajlm-1255	210	4	lee	lee	PROPN
ajlm-1255	210	5	cy	cy	PROPN
ajlm-1255	210	6	,	,	PUNCT
ajlm-1255	210	7	lin	lin	PROPN
ajlm-1255	210	8	rtp	rtp	PROPN
ajlm-1255	210	9	,	,	PUNCT
ajlm-1255	210	10	renia	renia	PROPN
ajlm-1255	210	11	l	l	PROPN
ajlm-1255	210	12	,	,	PUNCT
ajlm-1255	210	13	ng	ng	PROPN
ajlm-1255	210	14	lfp	lfp	PROPN
ajlm-1255	210	15	.	.	PUNCT
ajlm-1255	211	1	serological	serological	ADJ
ajlm-1255	211	2	approaches	approach	NOUN
ajlm-1255	211	3	for	for	ADP
ajlm-1255	211	4	covid-19	covid-19	PROPN
ajlm-1255	211	5	:	:	PUNCT
ajlm-1255	211	6	epidemiologic	epidemiologic	ADJ
ajlm-1255	211	7	perspective	perspective	NOUN
ajlm-1255	211	8	on	on	ADP
ajlm-1255	211	9	surveillance	surveillance	NOUN
ajlm-1255	211	10	and	and	CCONJ
ajlm-1255	211	11	control	control	NOUN
ajlm-1255	211	12	.	.	PUNCT
ajlm-1255	212	1	front	front	ADJ
ajlm-1255	212	2	immunol	immunol	NOUN
ajlm-1255	212	3	.	.	PUNCT
ajlm-1255	213	1	2020;11:879	2020;11:879	NUM
ajlm-1255	213	2	.	.	PUNCT
ajlm-1255	214	1	https://doi.org/10.3389/fimmu.2020.00879	https://doi.org/10.3389/fimmu.2020.00879	NOUN
ajlm-1255	214	2	guo	guo	PROPN
ajlm-1255	214	3	l	l	NOUN
ajlm-1255	214	4	,	,	PUNCT
ajlm-1255	214	5	ren	ren	PROPN
ajlm-1255	214	6	l	l	PROPN
ajlm-1255	214	7	,	,	PUNCT
ajlm-1255	214	8	yang	yang	PROPN
ajlm-1255	214	9	s	s	PROPN
ajlm-1255	214	10	,	,	PUNCT
ajlm-1255	214	11	et	et	PROPN
ajlm-1255	214	12	al	al	PROPN
ajlm-1255	214	13	.	.	PUNCT
ajlm-1255	214	14	profiling	profile	VERB
ajlm-1255	214	15	early	early	ADJ
ajlm-1255	214	16	humoral	humoral	ADJ
ajlm-1255	214	17	response	response	NOUN
ajlm-1255	214	18	to	to	PART
ajlm-1255	214	19	diagnose	diagnose	VERB
ajlm-1255	214	20	novel	novel	ADJ
ajlm-1255	214	21	coronavirus	coronavirus	NOUN
ajlm-1255	214	22	disease	disease	NOUN
ajlm-1255	214	23	(	(	PUNCT
ajlm-1255	214	24	covid-19	covid-19	PROPN
ajlm-1255	214	25	)	)	PUNCT
ajlm-1255	214	26	.	.	PUNCT
ajlm-1255	215	1	clin	clin	PROPN
ajlm-1255	215	2	infect	infect	PROPN
ajlm-1255	215	3	dis	dis	PROPN
ajlm-1255	215	4	.	.	PUNCT
ajlm-1255	216	1	2020;71(15):778–785	2020;71(15):778–785	NUM
ajlm-1255	216	2	.	.	PUNCT
ajlm-1255	217	1	https://doi.org/10.1093/cid/ciaa310	https://doi.org/10.1093/cid/ciaa310	PROPN
ajlm-1255	217	2	zainol	zainol	PROPN
ajlm-1255	217	3	rashid	rashid	PROPN
ajlm-1255	217	4	z	z	PROPN
ajlm-1255	217	5	,	,	PUNCT
ajlm-1255	217	6	othman	othman	PROPN
ajlm-1255	217	7	sn	sn	PROPN
ajlm-1255	217	8	,	,	PUNCT
ajlm-1255	217	9	abdul	abdul	PROPN
ajlm-1255	217	10	samat	samat	PROPN
ajlm-1255	217	11	mn	mn	PROPN
ajlm-1255	217	12	,	,	PUNCT
ajlm-1255	217	13	ali	ali	PROPN
ajlm-1255	217	14	uk	uk	PROPN
ajlm-1255	217	15	,	,	PUNCT
ajlm-1255	217	16	wong	wong	PROPN
ajlm-1255	217	17	kk	kk	PROPN
ajlm-1255	217	18	.	.	PUNCT
ajlm-1255	218	1	diagnostic	diagnostic	ADJ
ajlm-1255	218	2	performance	performance	NOUN
ajlm-1255	218	3	of	of	ADP
ajlm-1255	218	4	covid-19	covid-19	PROPN
ajlm-1255	218	5	serology	serology	NOUN
ajlm-1255	218	6	assays	assay	NOUN
ajlm-1255	218	7	.	.	PUNCT
ajlm-1255	219	1	malaysian	malaysian	ADJ
ajlm-1255	219	2	j	j	PROPN
ajlm-1255	219	3	pathol	pathol	NOUN
ajlm-1255	219	4	.	.	PUNCT
ajlm-1255	220	1	2020;42(1):13–21	2020;42(1):13–21	X
ajlm-1255	220	2	.	.	X
ajlm-1255	220	3	castro	castro	PROPN
ajlm-1255	220	4	r	r	VERB
ajlm-1255	220	5	,	,	PUNCT
ajlm-1255	220	6	luz	luz	NOUN
ajlm-1255	220	7	pm	pm	NOUN
ajlm-1255	220	8	,	,	PUNCT
ajlm-1255	220	9	wakimoto	wakimoto	PROPN
ajlm-1255	220	10	md	md	PROPN
ajlm-1255	220	11	,	,	PUNCT
ajlm-1255	220	12	veloso	veloso	PROPN
ajlm-1255	220	13	vg	vg	PROPN
ajlm-1255	220	14	,	,	PUNCT
ajlm-1255	220	15	grinsztejn	grinsztejn	PROPN
ajlm-1255	220	16	b	b	NUM
ajlm-1255	220	17	,	,	PUNCT
ajlm-1255	220	18	perazzo	perazzo	PROPN
ajlm-1255	220	19	h.	h.	PROPN
ajlm-1255	220	20	covid-19	covid-19	PROPN
ajlm-1255	220	21	:	:	PUNCT
ajlm-1255	221	1	a	a	DET
ajlm-1255	221	2	meta	meta	ADJ
ajlm-1255	221	3	-	-	PUNCT
ajlm-1255	221	4	analysis	analysis	NOUN
ajlm-1255	221	5	of	of	ADP
ajlm-1255	221	6	diagnostic	diagnostic	ADJ
ajlm-1255	221	7	test	test	NOUN
ajlm-1255	221	8	accuracy	accuracy	NOUN
ajlm-1255	221	9	of	of	ADP
ajlm-1255	221	10	commercial	commercial	ADJ
ajlm-1255	221	11	assays	assay	NOUN
ajlm-1255	221	12	registered	register	VERB
ajlm-1255	221	13	in	in	ADP
ajlm-1255	221	14	brazil	brazil	PROPN
ajlm-1255	221	15	.	.	PUNCT
ajlm-1255	222	1	braz	braz	PROPN
ajlm-1255	222	2	j	j	PROPN
ajlm-1255	222	3	infect	infect	PROPN
ajlm-1255	222	4	dis	dis	PROPN
ajlm-1255	222	5	.	.	PUNCT
ajlm-1255	223	1	2020;24(2):180–187	2020;24(2):180–187	NUM
ajlm-1255	223	2	.	.	PUNCT
ajlm-1255	223	3	https://doi.org/10.1016/j.bjid.2020.04.003	https://doi.org/10.1016/j.bjid.2020.04.003	PROPN
ajlm-1255	223	4	zhang	zhang	PROPN
ajlm-1255	223	5	p	p	PROPN
ajlm-1255	223	6	,	,	PUNCT
ajlm-1255	223	7	gao	gao	PROPN
ajlm-1255	223	8	q	q	PROPN
ajlm-1255	223	9	,	,	PUNCT
ajlm-1255	223	10	wang	wang	PROPN
ajlm-1255	223	11	t	t	PROPN
ajlm-1255	223	12	,	,	PUNCT
ajlm-1255	223	13	et	et	PROPN
ajlm-1255	223	14	al	al	PROPN
ajlm-1255	223	15	.	.	PUNCT
ajlm-1255	223	16	evaluation	evaluation	NOUN
ajlm-1255	223	17	of	of	ADP
ajlm-1255	223	18	recombinant	recombinant	ADJ
ajlm-1255	223	19	nucleocapsid	nucleocapsid	ADJ
ajlm-1255	223	20	and	and	CCONJ
ajlm-1255	223	21	spike	spike	ADJ
ajlm-1255	223	22	proteins	protein	NOUN
ajlm-1255	223	23	for	for	ADP
ajlm-1255	223	24	serological	serological	ADJ
ajlm-1255	223	25	diagnosis	diagnosis	NOUN
ajlm-1255	223	26	of	of	ADP
ajlm-1255	223	27	novel	novel	ADJ
ajlm-1255	223	28	coronavirus	coronavirus	NOUN
ajlm-1255	223	29	disease	disease	NOUN
ajlm-1255	223	30	2019	2019	NUM
ajlm-1255	223	31	(	(	PUNCT
ajlm-1255	223	32	covid-19	covid-19	PROPN
ajlm-1255	223	33	)	)	PUNCT
ajlm-1255	223	34	.	.	PUNCT
ajlm-1255	224	1	medrxiv	medrxiv	PROPN
ajlm-1255	224	2	.	.	PUNCT
ajlm-1255	225	1	2020:2020.03.17.20036954	2020:2020.03.17.20036954	X
ajlm-1255	225	2	.	.	PUNCT
ajlm-1255	226	1	https://doi.org/10.1101/2020.03.17.20036954	https://doi.org/10.1101/2020.03.17.20036954	PROPN
ajlm-1255	226	2	liu	liu	PROPN
ajlm-1255	226	3	y	y	PROPN
ajlm-1255	226	4	,	,	PUNCT
ajlm-1255	226	5	liu	liu	PROPN
ajlm-1255	226	6	y	y	PROPN
ajlm-1255	226	7	,	,	PUNCT
ajlm-1255	226	8	diao	diao	PROPN
ajlm-1255	226	9	b	b	PROPN
ajlm-1255	226	10	,	,	PUNCT
ajlm-1255	226	11	et	et	PROPN
ajlm-1255	226	12	al	al	PROPN
ajlm-1255	226	13	.	.	PUNCT
ajlm-1255	227	1	diagnostic	diagnostic	ADJ
ajlm-1255	227	2	indexes	index	NOUN
ajlm-1255	227	3	of	of	ADP
ajlm-1255	227	4	a	a	DET
ajlm-1255	227	5	rapid	rapid	ADJ
ajlm-1255	227	6	igg	igg	PROPN
ajlm-1255	227	7	/	/	SYM
ajlm-1255	227	8	igm	igm	PROPN
ajlm-1255	227	9	combined	combine	VERB
ajlm-1255	227	10	antibody	antibody	NOUN
ajlm-1255	227	11	test	test	NOUN
ajlm-1255	227	12	for	for	ADP
ajlm-1255	227	13	sars	sar	NOUN
ajlm-1255	227	14	-	-	PUNCT
ajlm-1255	227	15	cov-2	cov-2	NOUN
ajlm-1255	227	16	.	.	PUNCT
ajlm-1255	228	1	medrxiv	medrxiv	X
ajlm-1255	228	2	.	.	PUNCT
ajlm-1255	229	1	2020:2020.03.26.20044883	2020:2020.03.26.20044883	NUM
ajlm-1255	229	2	.	.	PUNCT
ajlm-1255	230	1	https://doi.org/10.1101/2020.03.26.20044883	https://doi.org/10.1101/2020.03.26.20044883	PROPN
ajlm-1255	230	2	julian	julian	PROPN
ajlm-1255	230	3	p.	p.	PROPN
ajlm-1255	230	4	covid-19	covid-19	PROPN
ajlm-1255	230	5	mass	mass	PROPN
ajlm-1255	230	6	testing	testing	NOUN
ajlm-1255	230	7	facilities	facility	NOUN
ajlm-1255	230	8	could	could	AUX
ajlm-1255	230	9	end	end	VERB
ajlm-1255	230	10	the	the	DET
ajlm-1255	230	11	epidemic	epidemic	NOUN
ajlm-1255	230	12	rapidly	rapidly	ADV
ajlm-1255	230	13	.	.	PUNCT
ajlm-1255	231	1	bmj	bmj	PROPN
ajlm-1255	231	2	.	.	PUNCT
ajlm-1255	231	3	2020;368	2020;368	NUM
ajlm-1255	231	4	:	:	PUNCT
ajlm-1255	231	5	m1163	m1163	PROPN
ajlm-1255	231	6	.	.	PROPN
ajlm-1255	231	7	https://doi.org/10.1136/bmj.m1163	https://doi.org/10.1136/bmj.m1163	PROPN
ajlm-1255	231	8	bioconcept	bioconcept	PROPN
ajlm-1255	231	9	c.	c.	PROPN
ajlm-1255	231	10	covid-19	covid-19	PROPN
ajlm-1255	231	11	ag	ag	PROPN
ajlm-1255	231	12	resp	resp	NOUN
ajlm-1255	231	13	-	-	PUNCT
ajlm-1255	231	14	strip	strip	NOUN
ajlm-1255	232	1	[	[	X
ajlm-1255	232	2	homepage	homepage	NOUN
ajlm-1255	232	3	on	on	ADP
ajlm-1255	232	4	the	the	DET
ajlm-1255	232	5	internet	internet	NOUN
ajlm-1255	232	6	]	]	PUNCT
ajlm-1255	232	7	.	.	PUNCT
ajlm-1255	232	8	2020	2020	NUM
ajlm-1255	233	1	[	[	X
ajlm-1255	233	2	cited	cite	VERB
ajlm-1255	233	3	2020	2020	NUM
ajlm-1255	233	4	apr	apr	NOUN
ajlm-1255	233	5	29	29	NUM
ajlm-1255	233	6	]	]	PUNCT
ajlm-1255	233	7	.	.	PUNCT
ajlm-1255	234	1	available	available	ADJ
ajlm-1255	234	2	from	from	ADP
ajlm-1255	234	3	:	:	PUNCT
ajlm-1255	234	4	https://www.corisbiocom/products/human-field/covid-19.php	https://www.corisbiocom/products/human-field/covid-19.php	PROPN
ajlm-1255	234	5	(	(	PUNCT
ajlm-1255	234	6	kemri	kemri	PROPN
ajlm-1255	234	7	)	)	PUNCT
ajlm-1255	234	8	kmri	kmri	PROPN
ajlm-1255	234	9	.	.	PUNCT
ajlm-1255	235	1	covid-19	covid-19	PROPN
ajlm-1255	235	2	results	result	VERB
ajlm-1255	235	3	in	in	ADP
ajlm-1255	235	4	15	15	NUM
ajlm-1255	235	5	minutes	minute	NOUN
ajlm-1255	235	6	:	:	PUNCT
ajlm-1255	235	7	kemri	kemri	PROPN
ajlm-1255	235	8	starts	start	VERB
ajlm-1255	235	9	manufacturing	manufacture	VERB
ajlm-1255	235	10	rapid	rapid	ADJ
ajlm-1255	235	11	test	test	NOUN
ajlm-1255	235	12	kits	kit	NOUN
ajlm-1255	235	13	,	,	PUNCT
ajlm-1255	235	14	kenya	kenya	PROPN
ajlm-1255	235	15	medical	medical	PROPN
ajlm-1255	235	16	research	research	PROPN
ajlm-1255	235	17	institute	institute	PROPN
ajlm-1255	235	18	(	(	PUNCT
ajlm-1255	235	19	kemri	kemri	PROPN
ajlm-1255	235	20	)	)	PUNCT
ajlm-1255	235	21	has	have	AUX
ajlm-1255	235	22	started	start	VERB
ajlm-1255	235	23	manufacturing	manufacture	VERB
ajlm-1255	235	24	covid-19	covid-19	PROPN
ajlm-1255	235	25	rapid	rapid	ADJ
ajlm-1255	235	26	test	test	NOUN
ajlm-1255	235	27	kits	kit	NOUN
ajlm-1255	235	28	to	to	PART
ajlm-1255	235	29	ease	ease	VERB
ajlm-1255	235	30	the	the	DET
ajlm-1255	235	31	testing	testing	NOUN
ajlm-1255	235	32	burden	burden	NOUN
ajlm-1255	235	33	at	at	ADP
ajlm-1255	235	34	the	the	DET
ajlm-1255	235	35	state	state	NOUN
ajlm-1255	235	36	’s	’s	PART
ajlm-1255	235	37	facilities	facility	NOUN
ajlm-1255	236	1	[	[	X
ajlm-1255	236	2	homepage	homepage	NOUN
ajlm-1255	236	3	on	on	ADP
ajlm-1255	236	4	the	the	DET
ajlm-1255	236	5	internet	internet	NOUN
ajlm-1255	236	6	]	]	PUNCT
ajlm-1255	236	7	.	.	PUNCT
ajlm-1255	236	8	2020	2020	NUM
ajlm-1255	237	1	[	[	X
ajlm-1255	237	2	cited	cite	VERB
ajlm-1255	237	3	2020	2020	NUM
ajlm-1255	237	4	apr	apr	NOUN
ajlm-1255	237	5	07	07	NUM
ajlm-1255	237	6	]	]	PUNCT
ajlm-1255	237	7	.	.	PUNCT
ajlm-1255	238	1	available	available	ADJ
ajlm-1255	238	2	from	from	ADP
ajlm-1255	238	3	:	:	PUNCT
ajlm-1255	238	4	www.standardmediacoke/article/2001367222/kemri-starts-manufacturing-covid-19-rapid-test-kits	www.standardmediacoke/article/2001367222/kemri-starts-manufacturing-covid-19-rapid-test-kits	PROPN
ajlm-1255	238	5	cassette	cassette	PROPN
ajlm-1255	238	6	cc	cc	PROPN
ajlm-1255	238	7	-	-	NOUN
ajlm-1255	238	8	ii	ii	NOUN
ajlm-1255	238	9	.	.	PUNCT
ajlm-1255	239	1	singapore	singapore	PROPN
ajlm-1255	239	2	’s	’s	PART
ajlm-1255	239	3	camtech	camtech	NOUN
ajlm-1255	239	4	,	,	PUNCT
ajlm-1255	239	5	jn	jn	PROPN
ajlm-1255	239	6	medsys	medsy	NOUN
ajlm-1255	239	7	to	to	PART
ajlm-1255	239	8	increase	increase	VERB
ajlm-1255	239	9	production	production	NOUN
ajlm-1255	239	10	of	of	ADP
ajlm-1255	239	11	covid-19	covid-19	PROPN
ajlm-1255	239	12	test	test	NOUN
ajlm-1255	239	13	kits	kit	NOUN
ajlm-1255	239	14	.	.	PUNCT
ajlm-1255	239	15	2020	2020	NUM
ajlm-1255	240	1	[	[	X
ajlm-1255	240	2	homepage	homepage	NOUN
ajlm-1255	240	3	on	on	ADP
ajlm-1255	240	4	the	the	DET
ajlm-1255	240	5	internet	internet	NOUN
ajlm-1255	240	6	]	]	PUNCT
ajlm-1255	240	7	.	.	PUNCT
ajlm-1255	241	1	[	[	X
ajlm-1255	241	2	cited	cite	VERB
ajlm-1255	241	3	2020	2020	NUM
ajlm-1255	241	4	apr	apr	NOUN
ajlm-1255	241	5	16	16	NUM
ajlm-1255	241	6	]	]	PUNCT
ajlm-1255	241	7	.	.	PUNCT
ajlm-1255	242	1	available	available	ADJ
ajlm-1255	242	2	from	from	ADP
ajlm-1255	242	3	:	:	PUNCT
ajlm-1255	242	4	https://www.mobihealthnewscom/news/asia-pacific/singapore-s-camtech-jn-medsys-increase-production-covid-19-test-kits	https://www.mobihealthnewscom/news/asia-pacific/singapore-s-camtech-jn-medsys-increase-production-covid-19-test-kit	NOUN
ajlm-1255	242	5	biosensor	biosensor	NOUN
ajlm-1255	242	6	s.	s.	PROPN
ajlm-1255	242	7	standard	standard	PROPN
ajlm-1255	242	8	q	q	PROPN
ajlm-1255	242	9	covid-19	covid-19	PROPN
ajlm-1255	242	10	ag	ag	PROPN
ajlm-1255	243	1	[	[	X
ajlm-1255	243	2	homepage	homepage	NOUN
ajlm-1255	243	3	on	on	ADP
ajlm-1255	243	4	the	the	DET
ajlm-1255	243	5	internet	internet	NOUN
ajlm-1255	243	6	]	]	PUNCT
ajlm-1255	243	7	.	.	PUNCT
ajlm-1255	244	1	2020	2020	NUM
ajlm-1255	245	1	[	[	X
ajlm-1255	245	2	cited	cite	VERB
ajlm-1255	245	3	2020	2020	NUM
ajlm-1255	245	4	apr	apr	NOUN
ajlm-1255	245	5	10	10	NUM
ajlm-1255	245	6	]	]	PUNCT
ajlm-1255	245	7	.	.	PUNCT
ajlm-1255	246	1	available	available	ADJ
ajlm-1255	246	2	from	from	ADP
ajlm-1255	246	3	:	:	PUNCT
ajlm-1255	246	4	http://www.sdbiosensorcom/xe/product/7672	http://www.sdbiosensorcom/xe/product/7672	PROPN
ajlm-1255	246	5	eua	eua	PROPN
ajlm-1255	246	6	beua	beua	AUX
ajlm-1255	246	7	.	.	PUNCT
ajlm-1255	247	1	bodysphere	bodysphere	PROPN
ajlm-1255	247	2	touts	tout	VERB
ajlm-1255	247	3	2	2	NUM
ajlm-1255	247	4	-	-	PUNCT
ajlm-1255	247	5	minute	minute	NOUN
ajlm-1255	247	6	covid-19	covid-19	PROPN
ajlm-1255	247	7	test	test	NOUN
ajlm-1255	248	1	[	[	X
ajlm-1255	248	2	homepage	homepage	NOUN
ajlm-1255	248	3	on	on	ADP
ajlm-1255	248	4	the	the	DET
ajlm-1255	248	5	internet	internet	NOUN
ajlm-1255	248	6	]	]	PUNCT
ajlm-1255	248	7	.	.	PUNCT
ajlm-1255	248	8	2020	2020	NUM
ajlm-1255	249	1	[	[	X
ajlm-1255	249	2	cited	cite	VERB
ajlm-1255	249	3	2020	2020	NUM
ajlm-1255	249	4	apr	apr	NOUN
ajlm-1255	249	5	02	02	NUM
ajlm-1255	249	6	]	]	PUNCT
ajlm-1255	249	7	available	available	ADJ
ajlm-1255	249	8	from	from	ADP
ajlm-1255	249	9	:	:	PUNCT
ajlm-1255	249	10	https://www.massdevicecom/fda-clears-bodysphere-2-minute-covid-19-test/	https://www.massdevicecom/fda-clears-bodysphere-2-minute-covid-19-test/	PRON
ajlm-1255	249	11	diagnostics	diagnostic	NOUN
ajlm-1255	249	12	oc	oc	PROPN
ajlm-1255	249	13	.	.	PUNCT
ajlm-1255	250	1	ortho	ortho	PROPN
ajlm-1255	250	2	clinical	clinical	ADJ
ajlm-1255	250	3	diagnostics	diagnostic	NOUN
ajlm-1255	250	4	pick	pick	VERB
ajlm-1255	250	5	up	up	ADP
ajlm-1255	250	6	eua	eua	PROPN
ajlm-1255	250	7	for	for	ADP
ajlm-1255	250	8	covid-19	covid-19	PROPN
ajlm-1255	250	9	total	total	ADJ
ajlm-1255	250	10	antibody	antibody	NOUN
ajlm-1255	250	11	assay	assay	VERB
ajlm-1255	251	1	[	[	X
ajlm-1255	251	2	homepage	homepage	NOUN
ajlm-1255	251	3	on	on	ADP
ajlm-1255	251	4	the	the	DET
ajlm-1255	251	5	internet	internet	NOUN
ajlm-1255	251	6	]	]	PUNCT
ajlm-1255	251	7	.	.	PUNCT
ajlm-1255	251	8	2020	2020	NUM
ajlm-1255	252	1	[	[	X
ajlm-1255	252	2	cited	cite	VERB
ajlm-1255	252	3	2020	2020	NUM
ajlm-1255	252	4	apr	apr	VERB
ajlm-1255	252	5	15	15	NUM
ajlm-1255	252	6	]	]	PUNCT
ajlm-1255	252	7	.	.	PUNCT
ajlm-1255	253	1	available	available	ADJ
ajlm-1255	253	2	from	from	ADP
ajlm-1255	253	3	:	:	PUNCT
ajlm-1255	253	4	www.middionlinecom/ortho-clinical-diagnosics-picks-eva-covid-19-total-antibody-assay	www.middionlinecom/ortho-clinical-diagnosics-picks-eva-covid-19-total-antibody-assay	PROPN
ajlm-1255	253	5	li	li	PROPN
ajlm-1255	253	6	z	z	PROPN
ajlm-1255	253	7	,	,	PUNCT
ajlm-1255	253	8	yi	yi	PROPN
ajlm-1255	253	9	y	y	PROPN
ajlm-1255	253	10	,	,	PUNCT
ajlm-1255	253	11	luo	luo	PROPN
ajlm-1255	254	1	x	x	PROPN
ajlm-1255	254	2	,	,	PUNCT
ajlm-1255	254	3	et	et	PROPN
ajlm-1255	254	4	al	al	PROPN
ajlm-1255	254	5	.	.	PROPN
ajlm-1255	254	6	development	development	PROPN
ajlm-1255	254	7	and	and	CCONJ
ajlm-1255	254	8	clinical	clinical	ADJ
ajlm-1255	254	9	application	application	NOUN
ajlm-1255	254	10	of	of	ADP
ajlm-1255	254	11	a	a	DET
ajlm-1255	254	12	rapid	rapid	ADJ
ajlm-1255	254	13	igm	igm	PROPN
ajlm-1255	254	14	-	-	PUNCT
ajlm-1255	254	15	igg	igg	PROPN
ajlm-1255	254	16	combined	combine	VERB
ajlm-1255	254	17	antibody	antibody	NOUN
ajlm-1255	254	18	test	test	NOUN
ajlm-1255	254	19	for	for	ADP
ajlm-1255	254	20	sars	sar	NOUN
ajlm-1255	254	21	-	-	PUNCT
ajlm-1255	254	22	cov-2	cov-2	NOUN
ajlm-1255	254	23	infection	infection	NOUN
ajlm-1255	254	24	diagnosis	diagnosis	NOUN
ajlm-1255	254	25	.	.	PUNCT
ajlm-1255	255	1	j	j	PROPN
ajlm-1255	255	2	med	med	PROPN
ajlm-1255	255	3	virol	virol	NOUN
ajlm-1255	255	4	.	.	PUNCT
ajlm-1255	256	1	2020	2020	NUM
ajlm-1255	256	2	.	.	PUNCT
ajlm-1255	257	1	https://doi.org/10.1002/jmv.25727	https://doi.org/10.1002/jmv.25727	PROPN
ajlm-1255	257	2	fellmann	fellmann	PROPN
ajlm-1255	257	3	f.	f.	PROPN
ajlm-1255	257	4	jetzt	jetzt	PROPN
ajlm-1255	257	5	beginnt	beginnt	PROPN
ajlm-1255	257	6	die	die	VERB
ajlm-1255	257	7	suche	suche	PROPN
ajlm-1255	257	8	nach	nach	PROPN
ajlm-1255	257	9	den	den	PROPN
ajlm-1255	257	10	genesenen	genesenen	NOUN
ajlm-1255	257	11	.	.	PUNCT
ajlm-1255	258	1	tages	tage	NOUN
ajlm-1255	258	2	anzeiger	anzeiger	NOUN
ajlm-1255	258	3	.	.	PUNCT
ajlm-1255	259	1	euroimmun	euroimmun	PROPN
ajlm-1255	259	2	medical	medical	ADJ
ajlm-1255	259	3	laboratory	laboratory	NOUN
ajlm-1255	259	4	diagnostics	diagnostic	NOUN
ajlm-1255	259	5	and	and	CCONJ
ajlm-1255	259	6	epitope	epitope	NOUN
ajlm-1255	259	7	diagnostics	diagnostic	NOUN
ajlm-1255	259	8	;	;	PUNCT
ajlm-1255	259	9	germany	germany	PROPN
ajlm-1255	259	10	:	:	PUNCT
ajlm-1255	259	11	lubeck	lubeck	NOUN
ajlm-1255	259	12	.	.	PUNCT
ajlm-1255	260	1	2020	2020	NUM
ajlm-1255	260	2	.	.	PUNCT
ajlm-1255	261	1	liu	liu	PROPN
ajlm-1255	261	2	r	r	PROPN
ajlm-1255	261	3	,	,	PUNCT
ajlm-1255	261	4	liu	liu	PROPN
ajlm-1255	261	5	x	x	PROPN
ajlm-1255	261	6	,	,	PUNCT
ajlm-1255	261	7	han	han	PROPN
ajlm-1255	261	8	h	h	PROPN
ajlm-1255	261	9	,	,	PUNCT
ajlm-1255	261	10	et	et	PROPN
ajlm-1255	261	11	al	al	PROPN
ajlm-1255	261	12	.	.	PUNCT
ajlm-1255	262	1	the	the	DET
ajlm-1255	262	2	comparative	comparative	ADJ
ajlm-1255	262	3	superiority	superiority	NOUN
ajlm-1255	262	4	of	of	ADP
ajlm-1255	262	5	igm	igm	PROPN
ajlm-1255	262	6	-	-	PUNCT
ajlm-1255	262	7	igg	igg	PROPN
ajlm-1255	262	8	antibody	antibody	NOUN
ajlm-1255	262	9	test	test	NOUN
ajlm-1255	262	10	to	to	ADP
ajlm-1255	262	11	real	real	ADJ
ajlm-1255	262	12	-	-	PUNCT
ajlm-1255	262	13	time	time	NOUN
ajlm-1255	262	14	reverse	reverse	ADJ
ajlm-1255	262	15	transcriptase	transcriptase	NOUN
ajlm-1255	262	16	pcr	pcr	ADJ
ajlm-1255	262	17	detection	detection	NOUN
ajlm-1255	262	18	for	for	ADP
ajlm-1255	262	19	sars	sar	NOUN
ajlm-1255	262	20	-	-	PUNCT
ajlm-1255	262	21	cov-2	cov-2	NOUN
ajlm-1255	262	22	infection	infection	NOUN
ajlm-1255	262	23	diagnosis	diagnosis	NOUN
ajlm-1255	262	24	.	.	PUNCT
ajlm-1255	263	1	preprints	preprint	NOUN
ajlm-1255	263	2	from	from	ADP
ajlm-1255	263	3	medrxiv	medrxiv	NOUN
ajlm-1255	263	4	and	and	CCONJ
ajlm-1255	263	5	biorxiv	biorxiv	NOUN
ajlm-1255	263	6	.	.	PUNCT
ajlm-1255	264	1	2020	2020	NUM
ajlm-1255	264	2	.	.	PUNCT
ajlm-1255	265	1	https://doi.org/10.1101/2020.03.28.20045765	https://doi.org/10.1101/2020.03.28.20045765	PROPN
ajlm-1255	265	2	artronlab	artronlab	NOUN
ajlm-1255	265	3	.	.	PUNCT
ajlm-1255	266	1	one	one	NUM
ajlm-1255	266	2	step	step	NOUN
ajlm-1255	266	3	novel	novel	NOUN
ajlm-1255	266	4	coronavirus	coronavirus	NOUN
ajlm-1255	266	5	(	(	PUNCT
ajlm-1255	266	6	covid-19	covid-19	PROPN
ajlm-1255	266	7	)	)	PUNCT
ajlm-1255	266	8	igm	igm	PROPN
ajlm-1255	266	9	/	/	SYM
ajlm-1255	266	10	igg	igg	PROPN
ajlm-1255	266	11	antibody	antibody	NOUN
ajlm-1255	266	12	test	test	NOUN
ajlm-1255	266	13	kit	kit	NOUN
ajlm-1255	267	1	[	[	X
ajlm-1255	267	2	homepage	homepage	NOUN
ajlm-1255	267	3	on	on	ADP
ajlm-1255	267	4	the	the	DET
ajlm-1255	267	5	internet	internet	NOUN
ajlm-1255	267	6	]	]	PUNCT
ajlm-1255	267	7	.	.	PUNCT
ajlm-1255	268	1	2020	2020	NUM
ajlm-1255	268	2	.	.	PUNCT
ajlm-1255	269	1	available	available	ADJ
ajlm-1255	269	2	from	from	ADP
ajlm-1255	269	3	:	:	PUNCT
ajlm-1255	269	4	http://www.artronlabcom/products/covbrochure-ver2.pdf	http://www.artronlabcom/products/covbrochure-ver2.pdf	PROPN
ajlm-1255	269	5	xiang	xiang	PROPN
ajlm-1255	269	6	j	j	PROPN
ajlm-1255	269	7	,	,	PUNCT
ajlm-1255	269	8	yan	yan	PROPN
ajlm-1255	269	9	m	m	PROPN
ajlm-1255	269	10	,	,	PUNCT
ajlm-1255	269	11	li	li	PROPN
ajlm-1255	269	12	h	h	PROPN
ajlm-1255	269	13	,	,	PUNCT
ajlm-1255	269	14	et	et	PROPN
ajlm-1255	269	15	al	al	PROPN
ajlm-1255	269	16	.	.	PUNCT
ajlm-1255	269	17	evaluation	evaluation	NOUN
ajlm-1255	269	18	of	of	ADP
ajlm-1255	269	19	enzyme	enzyme	NOUN
ajlm-1255	269	20	-	-	PUNCT
ajlm-1255	269	21	linked	link	VERB
ajlm-1255	269	22	immunoassay	immunoassay	NOUN
ajlm-1255	269	23	and	and	CCONJ
ajlm-1255	269	24	colloidal	colloidal	NOUN
ajlm-1255	269	25	goldimmunochromatographic	goldimmunochromatographic	ADJ
ajlm-1255	269	26	assay	assay	NOUN
ajlm-1255	269	27	kit	kit	NOUN
ajlm-1255	269	28	for	for	ADP
ajlm-1255	269	29	detection	detection	NOUN
ajlm-1255	269	30	of	of	ADP
ajlm-1255	269	31	novel	novel	ADJ
ajlm-1255	269	32	coronavirus	coronavirus	NOUN
ajlm-1255	269	33	(	(	PUNCT
ajlm-1255	269	34	sars	sar	NOUN
ajlm-1255	269	35	-	-	PUNCT
ajlm-1255	269	36	cov-2	cov-2	NOUN
ajlm-1255	269	37	)	)	PUNCT
ajlm-1255	269	38	causing	cause	VERB
ajlm-1255	269	39	an	an	DET
ajlm-1255	269	40	outbreak	outbreak	NOUN
ajlm-1255	269	41	of	of	ADP
ajlm-1255	269	42	pneumonia	pneumonia	NOUN
ajlm-1255	269	43	(	(	PUNCT
ajlm-1255	269	44	covid-19	covid-19	PROPN
ajlm-1255	269	45	)	)	PUNCT
ajlm-1255	269	46	.	.	PUNCT
ajlm-1255	270	1	pre	pre	PROPN
ajlm-1255	271	1	print	print	NOUN
ajlm-1255	271	2	medrxiv	medrxiv	PROPN
ajlm-1255	271	3	preprint	preprint	NOUN
ajlm-1255	271	4	https://doi.org/101101/202002272002878	https://doi.org/101101/202002272002878	ADJ
ajlm-1255	271	5	thermogenesis	thermogenesis	NOUN
ajlm-1255	271	6	.	.	PUNCT
ajlm-1255	272	1	a	a	DET
ajlm-1255	272	2	rapid	rapid	ADJ
ajlm-1255	272	3	covid-19	covid-19	PROPN
ajlm-1255	272	4	igm	igm	PROPN
ajlm-1255	272	5	/	/	SYM
ajlm-1255	272	6	igg	igg	PROPN
ajlm-1255	272	7	serological	serological	ADJ
ajlm-1255	272	8	test	test	NOUN
ajlm-1255	272	9	for	for	ADP
ajlm-1255	272	10	point	point	NOUN
ajlm-1255	272	11	-	-	PUNCT
ajlm-1255	272	12	of	of	ADP
ajlm-1255	272	13	-	-	PUNCT
ajlm-1255	272	14	care	care	NOUN
ajlm-1255	272	15	[	[	X
ajlm-1255	272	16	homepage	homepage	NOUN
ajlm-1255	272	17	on	on	ADP
ajlm-1255	272	18	the	the	DET
ajlm-1255	272	19	internet	internet	NOUN
ajlm-1255	272	20	]	]	PUNCT
ajlm-1255	272	21	.	.	PUNCT
ajlm-1255	273	1	[	[	X
ajlm-1255	273	2	cited	cite	VERB
ajlm-1255	273	3	2020	2020	NUM
ajlm-1255	273	4	apr	apr	NOUN
ajlm-1255	273	5	09	09	NUM
ajlm-1255	273	6	]	]	PUNCT
ajlm-1255	273	7	.	.	PUNCT
ajlm-1255	274	1	available	available	ADJ
ajlm-1255	274	2	from	from	ADP
ajlm-1255	274	3	:	:	PUNCT
ajlm-1255	274	4	https://www.thermogenesiscom/rapid-covid-19-point-of-care-diagnostic-test/	https://www.thermogenesiscom/rapid-covid-19-point-of-care-diagnostic-test/	PROPN
ajlm-1255	274	5	cassette	cassette	NOUN
ajlm-1255	274	6	at	at	ADP
ajlm-1255	274	7	-	-	PUNCT
ajlm-1255	274	8	niirt	niirt	NOUN
ajlm-1255	274	9	.	.	PUNCT
ajlm-1255	275	1	2019	2019	NUM
ajlm-1255	275	2	-	-	PUNCT
ajlm-1255	275	3	ncov	ncov	ADP
ajlm-1255	275	4	igg	igg	PROPN
ajlm-1255	275	5	/	/	SYM
ajlm-1255	275	6	igm	igm	PROPN
ajlm-1255	275	7	rapid	rapid	ADJ
ajlm-1255	275	8	test	test	NOUN
ajlm-1255	275	9	cassette	cassette	NOUN
ajlm-1255	276	1	[	[	X
ajlm-1255	276	2	homepge	homepge	NOUN
ajlm-1255	276	3	on	on	ADP
ajlm-1255	276	4	the	the	DET
ajlm-1255	276	5	internet	internet	NOUN
ajlm-1255	276	6	]	]	PUNCT
ajlm-1255	276	7	.	.	PUNCT
ajlm-1255	277	1	2020	2020	NUM
ajlm-1255	278	1	[	[	X
ajlm-1255	278	2	cited	cite	VERB
ajlm-1255	278	3	2020	2020	NUM
ajlm-1255	278	4	feb	feb	PROPN
ajlm-1255	278	5	18	18	NUM
ajlm-1255	278	6	]	]	PUNCT
ajlm-1255	278	7	.	.	PUNCT
ajlm-1255	279	1	available	available	ADJ
ajlm-1255	279	2	from	from	ADP
ajlm-1255	279	3	:	:	PUNCT
ajlm-1255	279	4	https://www.assaygeniecom/content/assay%20genie%20rapid%20covid%20poc%20test.pdf	https://www.assaygeniecom/content/assay%20genie%20rapid%20covid%20poc%20test.pdf	PROPN
ajlm-1255	279	5	bd	bd	PROPN
ajlm-1255	279	6	btw	btw	PROPN
ajlm-1255	279	7	.	.	PUNCT
ajlm-1255	280	1	biomedomics	biomedomic	NOUN
ajlm-1255	280	2	teams	team	NOUN
ajlm-1255	280	3	with	with	ADP
ajlm-1255	280	4	bd	bd	PROPN
ajlm-1255	280	5	to	to	PART
ajlm-1255	280	6	launch	launch	VERB
ajlm-1255	280	7	rapid	rapid	ADJ
ajlm-1255	280	8	covid-19	covid-19	PROPN
ajlm-1255	280	9	test	test	NOUN
ajlm-1255	281	1	[	[	X
ajlm-1255	281	2	homepage	homepage	NOUN
ajlm-1255	281	3	on	on	ADP
ajlm-1255	281	4	the	the	DET
ajlm-1255	281	5	internet	internet	NOUN
ajlm-1255	281	6	]	]	PUNCT
ajlm-1255	281	7	.	.	PUNCT
ajlm-1255	282	1	[	[	X
ajlm-1255	282	2	cited	cite	VERB
ajlm-1255	282	3	2020	2020	NUM
ajlm-1255	282	4	apr	apr	NOUN
ajlm-1255	282	5	06	06	NUM
ajlm-1255	282	6	]	]	PUNCT
ajlm-1255	282	7	.	.	PUNCT
ajlm-1255	283	1	available	available	ADJ
ajlm-1255	283	2	from	from	ADP
ajlm-1255	283	3	:	:	PUNCT
ajlm-1255	283	4	https://www.ncbiotechorg/news/biomedomics-teams-bd-launch-rapid-covid-19-test	https://www.ncbiotechorg/news/biomedomics-teams-bd-launch-rapid-covid-19-test	PROPN
ajlm-1255	283	5	kit	kit	PROPN
ajlm-1255	283	6	tbtc-	tbtc-	PROPN
ajlm-1255	283	7	.	.	PROPN
ajlm-1255	283	8	nadalr	nadalr	PROPN
ajlm-1255	283	9	covid-19	covid-19	PROPN
ajlm-1255	283	10	igg	igg	PROPN
ajlm-1255	283	11	/	/	SYM
ajlm-1255	283	12	igm	igm	PROPN
ajlm-1255	283	13	test	test	NOUN
ajlm-1255	283	14	instruction	instruction	NOUN
ajlm-1255	283	15	manure	manure	NOUN
ajlm-1255	284	1	[	[	X
ajlm-1255	284	2	homepage	homepage	NOUN
ajlm-1255	284	3	on	on	ADP
ajlm-1255	284	4	the	the	DET
ajlm-1255	284	5	internet	internet	NOUN
ajlm-1255	284	6	]	]	PUNCT
ajlm-1255	284	7	.	.	PUNCT
ajlm-1255	285	1	2020	2020	NUM
ajlm-1255	286	1	[	[	X
ajlm-1255	286	2	cited	cite	VERB
ajlm-1255	286	3	2020	2020	NUM
ajlm-1255	286	4	apr	apr	NOUN
ajlm-1255	286	5	20	20	NUM
ajlm-1255	286	6	]	]	PUNCT
ajlm-1255	286	7	.	.	PUNCT
ajlm-1255	287	1	available	available	ADJ
ajlm-1255	287	2	from	from	ADP
ajlm-1255	287	3	:	:	PUNCT
ajlm-1255	287	4	https://www.dailymailcouk/news/article-8128327/test-test-covid-kits-10-minute-finger-prick-tests-mask-diagnose-instantly.html	https://www.dailymailcouk/news/article-8128327/test-test-covid-kits-10-minute-finger-prick-tests-mask-diagnose-instantly.html	NOUN